{ "version": "2.2", "instance": { "ny20077915x1_s4.htm": { "nsprefix": "pasg", "nsuri": "http://passagebio.com/20260721", "dts": { "inline": { "local": [ "ny20077915x1_s4.htm" ] }, "schema": { "local": [ "pasg-20260721.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2004/ref-2004-08-10.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/2023/calculation-1.1.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd", "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd", "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd", "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd", "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd", "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd", "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd", "https://xbrl.sec.gov/country/2025/country-2025.xsd", "https://xbrl.sec.gov/currency/2025/currency-2025.xsd", "https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd", "https://xbrl.sec.gov/dei/2025/dei-2025.xsd", "https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd", "https://xbrl.sec.gov/exch/2025/exch-2025.xsd", "https://xbrl.sec.gov/naics/2025/naics-2025.xsd", "https://xbrl.sec.gov/sic/2025/sic-2025.xsd", "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd" ] }, "calculationLink": { "local": [ "pasg-20260721_cal.xml" ] }, "definitionLink": { "local": [ "pasg-20260721_def.xml" ] }, "labelLink": { "local": [ "pasg-20260721_lab.xml" ] }, "presentationLink": { "local": [ "pasg-20260721_pre.xml" ] } }, "keyStandard": 248, "keyCustom": 79, "axisStandard": 20, "axisCustom": 0, "memberStandard": 32, "memberCustom": 23, "hidden": { "total": 17, "http://fasb.org/us-gaap/2025": 14, "http://xbrl.sec.gov/dei/2025": 3 }, "contextCount": 200, "entityCount": 1, "segmentCount": 59, "elementCount": 506, "unitCount": 8, "baseTaxonomies": { "http://fasb.org/us-gaap/2025": 862, "http://xbrl.sec.gov/dei/2025": 7 }, "report": { "R1": { "role": "http://passagebio.com/role/DocumentAndEntityInformation", "longName": "000100 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c20260101to20260331", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20260101to20260331", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true, "unique": true } }, "R2": { "role": "http://passagebio.com/role/BalanceSheetsFy", "longName": "010000 - Statement - Balance Sheets (FY)", "shortName": "Balance Sheets (FY)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "c20241231", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": { "contextRef": "c20241231", "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "unique": true } }, "R3": { "role": "http://passagebio.com/role/BalanceSheetsFyParenthetical", "longName": "010100 - Statement - Balance Sheets (FY) (Parenthetical)", "shortName": "Balance Sheets (FY) (Parenthetical)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "c20260331", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "U002", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R4": { "role": "http://passagebio.com/role/StatementsOfOperationsAndComprehensiveLossFy", "longName": "020000 - Statement - Statements of Operations and Comprehensive Loss (FY)", "shortName": "Statements of Operations and Comprehensive Loss (FY)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "c20260101to20260331", "name": "us-gaap:ResearchAndDevelopmentExpense", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R5": { "role": "http://passagebio.com/role/StatementsOfStockholdersEquityFy", "longName": "030000 - Statement - Statements of Stockholders' Equity (FY)", "shortName": "Statements of Stockholders' Equity (FY)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "c20231231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember", "name": "us-gaap:StockholdersEquity", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": { "contextRef": "c20240101to20241231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember", "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "unique": true } }, "R6": { "role": "http://passagebio.com/role/StatementsOfCashFlowsFy", "longName": "040000 - Statement - Statements of Cash Flows (FY)", "shortName": "Statements of Cash Flows (FY)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "c20250101to20251231", "name": "us-gaap:NetIncomeLoss", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": { "contextRef": "c20250101to20251231", "name": "us-gaap:ShareBasedCompensation", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "unique": true } }, "R7": { "role": "http://passagebio.com/role/BalanceSheetsQ1", "longName": "050000 - Statement - Balance Sheets (Q1)", "shortName": "Balance Sheets (Q1)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "c20260331", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": { "contextRef": "c20260331", "name": "us-gaap:PrepaidExpenseAndOtherAssetsCurrent", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "unique": true } }, "R8": { "role": "http://passagebio.com/role/BalanceSheetsQ1Parenthetical", "longName": "050100 - Statement - Balance Sheets (Q1) (Parenthetical)", "shortName": "Balance Sheets (Q1) (Parenthetical)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "8", "firstAnchor": { "contextRef": "c20260331", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "U002", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R9": { "role": "http://passagebio.com/role/StatementsOfOperationsAndComprehensiveLossQ1", "longName": "060000 - Statement - Statements of Operations and Comprehensive Loss (Q1)", "shortName": "Statements of Operations and Comprehensive Loss (Q1)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Statements", "order": "9", "firstAnchor": { "contextRef": "c20260101to20260331", "name": "us-gaap:ResearchAndDevelopmentExpense", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R10": { "role": "http://passagebio.com/role/StatementsOfStockholdersEquityQ1", "longName": "070000 - Statement - Statements of Stockholders' Equity (Q1)", "shortName": "Statements of Stockholders' Equity (Q1)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Statements", "order": "10", "firstAnchor": { "contextRef": "c20231231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember", "name": "us-gaap:StockholdersEquity", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R11": { "role": "http://passagebio.com/role/StatementsOfCashFlowsQ1", "longName": "080000 - Statement - Statements of Cash Flows (Q1)", "shortName": "Statements of Cash Flows (Q1)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Statements", "order": "11", "firstAnchor": { "contextRef": "c20250101to20250331", "name": "us-gaap:NetIncomeLoss", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": { "contextRef": "c20250101to20250331", "name": "us-gaap:ShareBasedCompensation", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "unique": true } }, "R12": { "role": "http://passagebio.com/role/NatureOfOperationsFy", "longName": "090100 - Disclosure - Nature of Operations (FY)", "shortName": "Nature of Operations (FY)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "c20260101to20260331", "name": "us-gaap:NatureOfOperations", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R13": { "role": "http://passagebio.com/role/RisksAndLiquidityFy", "longName": "090200 - Disclosure - Risks and Liquidity (FY)", "shortName": "Risks and Liquidity (FY)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "c20260101to20260331", "name": "pasg:RisksAndLiquidityTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R14": { "role": "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesFy", "longName": "090300 - Disclosure - Summary of Significant Accounting Policies (FY)", "shortName": "Summary of Significant Accounting Policies (FY)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "c20260101to20260331", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R15": { "role": "http://passagebio.com/role/CashCashEquivalentsAndMarketableSecuritiesFy", "longName": "090400 - Disclosure - Cash, Cash Equivalents, and Marketable Securities (FY)", "shortName": "Cash, Cash Equivalents, and Marketable Securities (FY)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "c20250101to20251231", "name": "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20250101to20251231", "name": "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true, "unique": true } }, "R16": { "role": "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsFy", "longName": "090500 - Disclosure - Fair Value of Financial Instruments and Non-Financial Instruments (FY)", "shortName": "Fair Value of Financial Instruments and Non-Financial Instruments (FY)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "c20260101to20260331", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R17": { "role": "http://passagebio.com/role/PropertyAndEquipmentNetFy", "longName": "090600 - Disclosure - Property and Equipment, Net (FY)", "shortName": "Property and Equipment, Net (FY)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "c20260101to20260331", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R18": { "role": "http://passagebio.com/role/AccruedExpensesAndOtherCurrentLiabilitiesFy", "longName": "090700 - Disclosure - Accrued Expenses and Other Current Liabilities (FY)", "shortName": "Accrued Expenses and Other Current Liabilities (FY)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "c20260101to20260331", "name": "pasg:AccruedExpensesAndOtherCurrentLiabilitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R19": { "role": "http://passagebio.com/role/GemmaLicenseAgreementFy", "longName": "090800 - Disclosure - Gemma License Agreement (FY)", "shortName": "Gemma License Agreement (FY)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "c20260101to20260331", "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R20": { "role": "http://passagebio.com/role/SeveranceFy", "longName": "090900 - Disclosure - Severance (FY)", "shortName": "Severance (FY)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "c20260101to20260331", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R21": { "role": "http://passagebio.com/role/LeasesFy", "longName": "091000 - Disclosure - Leases (FY)", "shortName": "Leases (FY)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "c20260101to20260331", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R22": { "role": "http://passagebio.com/role/CommitmentsAndContingenciesFy", "longName": "091100 - Disclosure - Commitments and Contingencies (FY)", "shortName": "Commitments and Contingencies (FY)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "c20260101to20260331", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R23": { "role": "http://passagebio.com/role/CommonStockFy", "longName": "091200 - Disclosure - Common Stock (FY)", "shortName": "Common Stock (FY)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "c20250101to20251231", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20250101to20251231", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true, "unique": true } }, "R24": { "role": "http://passagebio.com/role/SharebasedCompensationFy", "longName": "091300 - Disclosure - Share-Based Compensation (FY)", "shortName": "Share-Based Compensation (FY)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Notes", "order": "24", "firstAnchor": { "contextRef": "c20260101to20260331", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R25": { "role": "http://passagebio.com/role/IncomeTaxesFy", "longName": "091400 - Disclosure - Income Taxes (FY)", "shortName": "Income Taxes (FY)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Notes", "order": "25", "firstAnchor": { "contextRef": "c20250101to20251231", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20250101to20251231", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true, "unique": true } }, "R26": { "role": "http://passagebio.com/role/SegmentReportingFy", "longName": "091500 - Disclosure - Segment Reporting (FY)", "shortName": "Segment Reporting (FY)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Notes", "order": "26", "firstAnchor": { "contextRef": "c20260101to20260331", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R27": { "role": "http://passagebio.com/role/SubsequentEventsFy", "longName": "091600 - Disclosure - Subsequent Events (FY)", "shortName": "Subsequent Events (FY)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Notes", "order": "27", "firstAnchor": { "contextRef": "c20260101to20260331", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R28": { "role": "http://passagebio.com/role/NatureOfOperationsQ1", "longName": "091700 - Disclosure - Nature of Operations (Q1)", "shortName": "Nature of Operations (Q1)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Notes", "order": "28", "firstAnchor": { "contextRef": "c20260101to20260331", "name": "us-gaap:NatureOfOperations", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R29": { "role": "http://passagebio.com/role/RisksLiquidityAndGoingConcernQ1", "longName": "091800 - Disclosure - Risks, Liquidity, and Going Concern (Q1)", "shortName": "Risks, Liquidity, and Going Concern (Q1)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Notes", "order": "29", "firstAnchor": { "contextRef": "c20260101to20260331", "name": "pasg:RisksAndLiquidityTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R30": { "role": "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesQ1", "longName": "091900 - Disclosure - Summary of Significant Accounting Policies (Q1)", "shortName": "Summary of Significant Accounting Policies (Q1)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Notes", "order": "30", "firstAnchor": { "contextRef": "c20260101to20260331", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R31": { "role": "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsQ1", "longName": "092000 - Disclosure - Fair Value of Financial Instruments and Non-Financial Instruments (Q1)", "shortName": "Fair Value of Financial Instruments and Non-Financial Instruments (Q1)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Notes", "order": "31", "firstAnchor": { "contextRef": "c20260101to20260331", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R32": { "role": "http://passagebio.com/role/PropertyAndEquipmentNetQ1", "longName": "092100 - Disclosure - Property and Equipment, Net (Q1)", "shortName": "Property and Equipment, Net (Q1)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Notes", "order": "32", "firstAnchor": { "contextRef": "c20260101to20260331", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R33": { "role": "http://passagebio.com/role/AccruedExpensesAndOtherCurrentLiabilitiesQ1", "longName": "092200 - Disclosure - Accrued Expenses and Other Current Liabilities (Q1)", "shortName": "Accrued Expenses and Other Current Liabilities (Q1)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Notes", "order": "33", "firstAnchor": { "contextRef": "c20260101to20260331", "name": "pasg:AccruedExpensesAndOtherCurrentLiabilitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R34": { "role": "http://passagebio.com/role/GemmaLicenseAgreementQ1", "longName": "092300 - Disclosure - Gemma License Agreement (Q1)", "shortName": "Gemma License Agreement (Q1)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Notes", "order": "34", "firstAnchor": { "contextRef": "c20260101to20260331", "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R35": { "role": "http://passagebio.com/role/SeveranceQ1", "longName": "092400 - Disclosure - Severance (Q1)", "shortName": "Severance (Q1)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Notes", "order": "35", "firstAnchor": { "contextRef": "c20260101to20260331", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R36": { "role": "http://passagebio.com/role/LeasesQ1", "longName": "092500 - Disclosure - Leases (Q1)", "shortName": "Leases (Q1)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Notes", "order": "36", "firstAnchor": { "contextRef": "c20260101to20260331", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R37": { "role": "http://passagebio.com/role/CommitmentsAndContingenciesQ1", "longName": "092600 - Disclosure - Commitments and Contingencies (Q1)", "shortName": "Commitments and Contingencies (Q1)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Notes", "order": "37", "firstAnchor": { "contextRef": "c20260101to20260331", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R38": { "role": "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationQ1", "longName": "092700 - Disclosure - Stockholder's Equity and Share-Based Compensation (Q1)", "shortName": "Stockholder's Equity and Share-Based Compensation (Q1)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Notes", "order": "38", "firstAnchor": { "contextRef": "c20260101to20260331", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R39": { "role": "http://passagebio.com/role/SegmentReportingQ1", "longName": "092800 - Disclosure - Segment Reporting (Q1)", "shortName": "Segment Reporting (Q1)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Notes", "order": "39", "firstAnchor": { "contextRef": "c20260101to20260331", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R40": { "role": "http://passagebio.com/role/SubsequentEventsQ1", "longName": "092900 - Disclosure - Subsequent Events (Q1)", "shortName": "Subsequent Events (Q1)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Notes", "order": "40", "firstAnchor": { "contextRef": "c20260101to20260331", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R41": { "role": "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesFyPolicies", "longName": "100300 - Disclosure - Summary of Significant Accounting Policies (FY) (Policies)", "shortName": "Summary of Significant Accounting Policies (FY) (Policies)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "policies", "menuCat": "Policies", "order": "41", "firstAnchor": { "contextRef": "c20260101to20260331", "name": "pasg:BasisOfPresentationPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": { "contextRef": "c20250101to20251231", "name": "us-gaap:IncomeTaxPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "unique": true } }, "R42": { "role": "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesQ1Policies", "longName": "101900 - Disclosure - Summary of Significant Accounting Policies (Q1) (Policies)", "shortName": "Summary of Significant Accounting Policies (Q1) (Policies)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "policies", "menuCat": "Policies", "order": "42", "firstAnchor": { "contextRef": "c20260101to20260331", "name": "pasg:BasisOfPresentationPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": { "contextRef": "c20260101to20260331", "name": "pasg:InterimFinancialStatementsPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "unique": true } }, "R43": { "role": "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesFyTables", "longName": "110300 - Disclosure - Summary of Significant Accounting Policies (FY) (Tables)", "shortName": "Summary of Significant Accounting Policies (FY) (Tables)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "tables", "menuCat": "Tables", "order": "43", "firstAnchor": { "contextRef": "c20260101to20260331", "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R44": { "role": "http://passagebio.com/role/CashCashEquivalentsAndMarketableSecuritiesFyTables", "longName": "110400 - Disclosure - Cash, Cash Equivalents, and Marketable Securities (FY) (Tables)", "shortName": "Cash, Cash Equivalents, and Marketable Securities (FY) (Tables)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "tables", "menuCat": "Tables", "order": "44", "firstAnchor": { "contextRef": "c20250101to20251231", "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20250101to20251231", "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true, "unique": true } }, "R45": { "role": "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsFyTables", "longName": "110500 - Disclosure - Fair Value of Financial Instruments and Non-Financial Instruments (FY) (Tables)", "shortName": "Fair Value of Financial Instruments and Non-Financial Instruments (FY) (Tables)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "tables", "menuCat": "Tables", "order": "45", "firstAnchor": { "contextRef": "c20250101to20251231", "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20250101to20251231", "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true, "unique": true } }, "R46": { "role": "http://passagebio.com/role/PropertyAndEquipmentNetFyTables", "longName": "110600 - Disclosure - Property and Equipment, Net (FY) (Tables)", "shortName": "Property and Equipment, Net (FY) (Tables)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "tables", "menuCat": "Tables", "order": "46", "firstAnchor": { "contextRef": "c20260101to20260331", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R47": { "role": "http://passagebio.com/role/AccruedExpensesAndOtherCurrentLiabilitiesFyTables", "longName": "110700 - Disclosure - Accrued Expenses and Other Current Liabilities (FY) (Tables)", "shortName": "Accrued Expenses and Other Current Liabilities (FY) (Tables)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "tables", "menuCat": "Tables", "order": "47", "firstAnchor": { "contextRef": "c20260101to20260331", "name": "pasg:ScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R48": { "role": "http://passagebio.com/role/LeasesFyTables", "longName": "111000 - Disclosure - Leases (FY) (Tables)", "shortName": "Leases (FY) (Tables)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "tables", "menuCat": "Tables", "order": "48", "firstAnchor": { "contextRef": "c20260101to20260331", "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R49": { "role": "http://passagebio.com/role/SharebasedCompensationFyTables", "longName": "111300 - Disclosure - Share-Based Compensation (FY) (Tables)", "shortName": "Share-Based Compensation (FY) (Tables)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "tables", "menuCat": "Tables", "order": "49", "firstAnchor": { "contextRef": "c20260101to20260331", "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R50": { "role": "http://passagebio.com/role/IncomeTaxesFyTables", "longName": "111400 - Disclosure - Income Taxes (FY) (Tables)", "shortName": "Income Taxes (FY) (Tables)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "tables", "menuCat": "Tables", "order": "50", "firstAnchor": { "contextRef": "c20250101to20251231", "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20250101to20251231", "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true, "unique": true } }, "R51": { "role": "http://passagebio.com/role/SegmentReportingFyTables", "longName": "111500 - Disclosure - Segment Reporting (FY) (Tables)", "shortName": "Segment Reporting (FY) (Tables)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "tables", "menuCat": "Tables", "order": "51", "firstAnchor": { "contextRef": "c20260101to20260331", "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R52": { "role": "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesQ1Tables", "longName": "111900 - Disclosure - Summary of Significant Accounting Policies (Q1) (Tables)", "shortName": "Summary of Significant Accounting Policies (Q1) (Tables)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "tables", "menuCat": "Tables", "order": "52", "firstAnchor": { "contextRef": "c20260101to20260331", "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R53": { "role": "http://passagebio.com/role/PropertyAndEquipmentNetQ1Tables", "longName": "112100 - Disclosure - Property and Equipment, Net (Q1) (Tables)", "shortName": "Property and Equipment, Net (Q1) (Tables)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "tables", "menuCat": "Tables", "order": "53", "firstAnchor": { "contextRef": "c20260101to20260331", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R54": { "role": "http://passagebio.com/role/AccruedExpensesAndOtherCurrentLiabilitiesQ1Tables", "longName": "112200 - Disclosure - Accrued Expenses and Other Current Liabilities (Q1) (Tables)", "shortName": "Accrued Expenses and Other Current Liabilities (Q1) (Tables)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "tables", "menuCat": "Tables", "order": "54", "firstAnchor": { "contextRef": "c20260101to20260331", "name": "pasg:ScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R55": { "role": "http://passagebio.com/role/LeasesQ1Tables", "longName": "112500 - Disclosure - Leases (Q1) (Tables)", "shortName": "Leases (Q1) (Tables)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "tables", "menuCat": "Tables", "order": "55", "firstAnchor": { "contextRef": "c20260101to20260331", "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R56": { "role": "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationQ1Tables", "longName": "112700 - Disclosure - Stockholder's Equity and Share-Based Compensation (Q1) (Tables)", "shortName": "Stockholder's Equity and Share-Based Compensation (Q1) (Tables)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "tables", "menuCat": "Tables", "order": "56", "firstAnchor": { "contextRef": "c20260101to20260331", "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R57": { "role": "http://passagebio.com/role/SegmentReportingQ1Tables", "longName": "112800 - Disclosure - Segment Reporting (Q1) (Tables)", "shortName": "Segment Reporting (Q1) (Tables)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "tables", "menuCat": "Tables", "order": "57", "firstAnchor": { "contextRef": "c20260101to20260331", "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R58": { "role": "http://passagebio.com/role/RisksAndLiquidityFyDetails", "longName": "120200 - Disclosure - Risks and Liquidity (FY) (Details)", "shortName": "Risks and Liquidity (FY) (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "c20251231", "name": "us-gaap:RetainedEarningsAccumulatedDeficit", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R59": { "role": "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesFyDetails", "longName": "120300 - Disclosure - Summary of Significant Accounting Policies (FY) (Details)", "shortName": "Summary of Significant Accounting Policies (FY) (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "c20260331", "name": "us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": { "contextRef": "c20240101to20241231", "name": "pasg:GainLossOnSaleOfTaxCredits", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "div", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "unique": true } }, "R60": { "role": "http://passagebio.com/role/CashCashEquivalentsAndMarketableSecuritiesPortfolioOfCashAndCashEquivalentsFyDetails", "longName": "120400 - Disclosure - Cash, Cash Equivalents, and Marketable Securities - Portfolio of Cash and Cash Equivalents (FY) (Details)", "shortName": "Cash, Cash Equivalents, and Marketable Securities - Portfolio of Cash and Cash Equivalents (FY) (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "c20251231", "name": "us-gaap:CashEquivalentsAtCarryingValue", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "div", "td", "tr", "table", "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20251231", "name": "us-gaap:CashEquivalentsAtCarryingValue", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "div", "td", "tr", "table", "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true, "unique": true } }, "R61": { "role": "http://passagebio.com/role/CashCashEquivalentsAndMarketableSecuritiesPortfolioOfMarketableSecuritiesFyDetails", "longName": "120402 - Disclosure - Cash, Cash Equivalents, and Marketable Securities - Portfolio of Marketable Securities (FY) (Details)", "shortName": "Cash, Cash Equivalents, and Marketable Securities - Portfolio of Marketable Securities (FY) (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "c20241231", "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "div", "td", "tr", "table", "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20241231", "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "div", "td", "tr", "table", "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true, "unique": true } }, "R62": { "role": "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsRecurringBasisFyDetails", "longName": "120500 - Disclosure - Fair Value of Financial Instruments and Non-Financial Instruments (Recurring basis) (FY) (Details)", "shortName": "Fair Value of Financial Instruments and Non-Financial Instruments (Recurring basis) (FY) (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "c20251231", "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "div", "td", "tr", "table", "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": { "contextRef": "c20251231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember", "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "div", "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "unique": true } }, "R63": { "role": "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsNonrecurringBasisFyDetails", "longName": "120502 - Disclosure - Fair Value of Financial Instruments and Non-Financial Instruments (Nonrecurring Basis) (FY) (Details)", "shortName": "Fair Value of Financial Instruments and Non-Financial Instruments (Nonrecurring Basis) (FY) (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "63", "firstAnchor": { "contextRef": "c20250101to20251231", "name": "us-gaap:ImpairmentOfLongLivedAssetsHeldForUse", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnNonrecurringBasisTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": { "contextRef": "c20251231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsNonrecurringMember", "name": "us-gaap:PropertyPlantAndEquipmentFairValueDisclosure", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "div", "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnNonrecurringBasisTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "unique": true } }, "R64": { "role": "http://passagebio.com/role/PropertyAndEquipmentNetFyDetails", "longName": "120600 - Disclosure - Property and Equipment, Net (FY) (Details)", "shortName": "Property and Equipment, Net (FY) (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "64", "firstAnchor": { "contextRef": "c20260331", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "div", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": { "contextRef": "c20241231_PropertyPlantAndEquipmentByTypeAxis_LaboratoryEquipmentMember", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "unique": true } }, "R65": { "role": "http://passagebio.com/role/PropertyAndEquipmentNetNarrativeFyDetails", "longName": "120602 - Disclosure - Property and Equipment, Net - Narrative (FY) (Details)", "shortName": "Property and Equipment, Net - Narrative (FY) (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "65", "firstAnchor": { "contextRef": "c20250101to20251231", "name": "us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "div", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": { "contextRef": "c20250101to20251231_DisposalGroupClassificationAxis_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember_LongLivedAssetsHeldForSaleByAssetTypeAxis_LaboratoryEquipmentMember", "name": "us-gaap:Depreciation", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "unique": true } }, "R66": { "role": "http://passagebio.com/role/AccruedExpensesAndOtherCurrentLiabilitiesFyDetails", "longName": "120700 - Disclosure - Accrued Expenses and Other Current Liabilities (FY) (Details)", "shortName": "Accrued Expenses and Other Current Liabilities (FY) (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "66", "firstAnchor": { "contextRef": "c20260331", "name": "us-gaap:AccruedProfessionalFeesCurrent", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "div", "td", "tr", "table", "pasg:ScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R67": { "role": "http://passagebio.com/role/GemmaLicenseAgreementFyDetails", "longName": "120800 - Disclosure - Gemma License Agreement (FY) (Details)", "shortName": "Gemma License Agreement (FY) (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "67", "firstAnchor": { "contextRef": "c20240731", "name": "pasg:UpfrontLicenseFeeReceivable", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": { "contextRef": "c20240731_TypeOfArrangementAxis_ArrangementWithGemmaBiotherapeuticsIncMember", "name": "pasg:ShortTermLicenseFeeDueAndReceivable", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "unique": true } }, "R68": { "role": "http://passagebio.com/role/SeveranceFyDetails", "longName": "120900 - Disclosure - Severance (FY) (Details)", "shortName": "Severance (FY) (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "68", "firstAnchor": { "contextRef": "c20250101to20250131_RestructuringCostAndReserveAxis_EmployeeSeveranceMember", "name": "us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent", "unitRef": "U004", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R69": { "role": "http://passagebio.com/role/LeasesFyDetails", "longName": "121000 - Disclosure - Leases (FY) (Details)", "shortName": "Leases (FY) (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "69", "firstAnchor": { "contextRef": "c20260101to20260331", "name": "us-gaap:SubleaseIncome", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": { "contextRef": "c20251231", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "div", "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "unique": true } }, "R70": { "role": "http://passagebio.com/role/LeasesOperatingLeaseCostFyDetails", "longName": "121002 - Disclosure - Leases - Operating lease cost (FY) (Details)", "shortName": "Leases - Operating lease cost (FY) (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "70", "firstAnchor": { "contextRef": "c20260101to20260331", "name": "us-gaap:OperatingLeaseCost", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R71": { "role": "http://passagebio.com/role/LeasesSubleaseIncomeFyDetails", "longName": "121004 - Disclosure - Leases - Sublease income (FY) (Details)", "shortName": "Leases - Sublease income (FY) (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "71", "firstAnchor": { "contextRef": "c20260101to20260331", "name": "us-gaap:SubleaseIncome", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R72": { "role": "http://passagebio.com/role/CommitmentsAndContingenciesCollaborationAgreementsFyDetails", "longName": "121100 - Disclosure - Commitments and Contingencies - Collaboration Agreements (FY) (Details)", "shortName": "Commitments and Contingencies - Collaboration Agreements (FY) (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "72", "firstAnchor": { "contextRef": "c20260331", "name": "pasg:NonRefundableAggregateFeesPayablePerProductIndication", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R73": { "role": "http://passagebio.com/role/CommonStockFyDetails", "longName": "121200 - Disclosure - Common Stock (FY) (Details)", "shortName": "Common Stock (FY) (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "73", "firstAnchor": { "contextRef": "c20240101to20241231", "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R74": { "role": "http://passagebio.com/role/SharebasedCompensationEquityIncentivePlanEsppFyDetails", "longName": "121300 - Disclosure - Share-Based Compensation - Equity Incentive Plan & ESPP (FY) (Details)", "shortName": "Share-Based Compensation - Equity Incentive Plan & ESPP (FY) (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "74", "firstAnchor": { "contextRef": "c20260101to20260331", "name": "pasg:NumberOfEquityIncentivePlans", "unitRef": "U007", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": { "contextRef": "c20251231_PlanNameAxis_EquityIncentivePlan2020Member", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "unitRef": "U003", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "unique": true } }, "R75": { "role": "http://passagebio.com/role/SharebasedCompensationSharebasedCompensationExpenseFyDetails", "longName": "121302 - Disclosure - Share-Based Compensation - Share-based compensation expense (FY) (Details)", "shortName": "Share-Based Compensation - Share-based compensation expense (FY) (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "75", "firstAnchor": { "contextRef": "c20260101to20260331", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R76": { "role": "http://passagebio.com/role/SharebasedCompensationStockOptionActivityFyDetails", "longName": "121304 - Disclosure - Share-Based Compensation - Stock Option Activity (FY) (Details)", "shortName": "Share-Based Compensation - Stock Option Activity (FY) (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "76", "firstAnchor": { "contextRef": "c20251231", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "U003", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "div", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": { "contextRef": "c20250101to20251231", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod", "unitRef": "U003", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "div", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "unique": true } }, "R77": { "role": "http://passagebio.com/role/SharebasedCompensationAssumptionsUsedInDeterminingFairValueEarlyExerciseOfStockOptionsFyDetails", "longName": "121306 - Disclosure - Share-Based Compensation - Assumptions Used in Determining Fair Value & Early exercise of Stock Options (FY) (Details)", "shortName": "Share-Based Compensation - Assumptions Used in Determining Fair Value & Early exercise of Stock Options (FY) (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "77", "firstAnchor": { "contextRef": "c20250101to20251231", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "unitRef": "U004", "xsiNil": "false", "lang": null, "decimals": "3", "ancestors": [ "div", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": { "contextRef": "c20250101to20251231", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "unitRef": "U004", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "div", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "unique": true } }, "R78": { "role": "http://passagebio.com/role/SharebasedCompensationRestrictedStockUnitsFyDetails", "longName": "121308 - Disclosure - Share-Based Compensation - Restricted Stock Units (FY) (Details)", "shortName": "Share-Based Compensation - Restricted Stock Units (FY) (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "78", "firstAnchor": { "contextRef": "c20251231_AwardTypeAxis_RestrictedStockUnitsRSUMember", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "unitRef": "U003", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "div", "td", "tr", "table", "us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": { "contextRef": "c20250101to20251231_AwardTypeAxis_RestrictedStockUnitsRSUMember", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "unitRef": "U003", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "div", "td", "tr", "table", "us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "unique": true } }, "R79": { "role": "http://passagebio.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesFyDetails", "longName": "121400 - Disclosure - Income Taxes - Deferred tax assets and liabilities (FY) (Details)", "shortName": "Income Taxes - Deferred tax assets and liabilities (FY) (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "79", "firstAnchor": { "contextRef": "c20251231", "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20251231", "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true, "unique": true } }, "R80": { "role": "http://passagebio.com/role/IncomeTaxesReconciliationOfFederalIncomeTaxRateToEffectiveTaxRateFyDetails", "longName": "121402 - Disclosure - Income Taxes - Reconciliation of the federal income tax rate to the effective tax rate (FY) (Details)", "shortName": "Income Taxes - Reconciliation of the federal income tax rate to the effective tax rate (FY) (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "80", "firstAnchor": { "contextRef": "c20250101to20251231", "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "div", "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20250101to20251231", "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "div", "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true, "unique": true } }, "R81": { "role": "http://passagebio.com/role/IncomeTaxesFyDetails", "longName": "121404 - Disclosure - Income Taxes (FY) (Details)", "shortName": "Income Taxes (FY) (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "81", "firstAnchor": { "contextRef": "c20250101to20251231", "name": "us-gaap:IncomeTaxesPaidNet", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "us-gaap:IncomeTaxesPaidNet", "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20250101to20251231", "name": "us-gaap:IncomeTaxesPaidNet", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "us-gaap:IncomeTaxesPaidNet", "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true, "unique": true } }, "R82": { "role": "http://passagebio.com/role/IncomeTaxesNetOperatingLossesFyDetails", "longName": "121406 - Disclosure - Income Taxes - Net operating losses (FY) (Details)", "shortName": "Income Taxes - Net operating losses (FY) (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "82", "firstAnchor": { "contextRef": "c20251231", "name": "us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20251231", "name": "us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true, "unique": true } }, "R83": { "role": "http://passagebio.com/role/SegmentReportingFyDetails", "longName": "121500 - Disclosure - Segment Reporting (FY) (Details)", "shortName": "Segment Reporting (FY) (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "83", "firstAnchor": { "contextRef": "c20260101to20260331", "name": "us-gaap:ResearchAndDevelopmentExpense", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R84": { "role": "http://passagebio.com/role/SubsequentEventsFyDetails", "longName": "121600 - Disclosure - Subsequent Events (FY) (Details)", "shortName": "Subsequent Events (FY) (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "84", "firstAnchor": { "contextRef": "c20260101to20260331", "name": "us-gaap:SubleaseIncome", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R85": { "role": "http://passagebio.com/role/RisksLiquidityAndGoingConcernQ1Details", "longName": "121800 - Disclosure - Risks, Liquidity, and Going Concern (Q1) (Details)", "shortName": "Risks, Liquidity, and Going Concern (Q1) (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "85", "firstAnchor": { "contextRef": "c20260331", "name": "us-gaap:RetainedEarningsAccumulatedDeficit", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": { "contextRef": "c20260331_SubsidiarySaleOfStockAxis_AttheMarketFacilityAgreementMember", "name": "pasg:RemainingCapacityOfValueOfSharesAvailableToBeSold", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "unique": true } }, "R86": { "role": "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesQ1Details", "longName": "121900 - Disclosure - Summary of Significant Accounting Policies (Q1) (Details)", "shortName": "Summary of Significant Accounting Policies (Q1) (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "86", "firstAnchor": { "contextRef": "c20250714to20250714", "name": "us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits", "unitRef": "U003", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "div", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R87": { "role": "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsQ1Details", "longName": "122000 - Disclosure - Fair Value of Financial Instruments and Non-Financial Instruments (Q1) (Details)", "shortName": "Fair Value of Financial Instruments and Non-Financial Instruments (Q1) (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "87", "firstAnchor": { "contextRef": "c20250101to20251231", "name": "us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "div", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": { "contextRef": "c20260101to20260331_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsNonrecurringMember", "name": "us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "unique": true } }, "R88": { "role": "http://passagebio.com/role/PropertyAndEquipmentNetQ1Details", "longName": "122100 - Disclosure - Property and Equipment, Net (Q1) (Details)", "shortName": "Property and Equipment, Net (Q1) (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "88", "firstAnchor": { "contextRef": "c20260331", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "div", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R89": { "role": "http://passagebio.com/role/PropertyAndEquipmentNetNarrativeQ1Details", "longName": "122102 - Disclosure - Property and Equipment, Net - Narrative (Q1) (Details)", "shortName": "Property and Equipment, Net - Narrative (Q1) (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "89", "firstAnchor": { "contextRef": "c20260304to20260304", "name": "pasg:EarlyLeaseTerminationFee", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R90": { "role": "http://passagebio.com/role/AccruedExpensesAndOtherCurrentLiabilitiesQ1Details", "longName": "122200 - Disclosure - Accrued Expenses and Other Current Liabilities (Q1) (Details)", "shortName": "Accrued Expenses and Other Current Liabilities (Q1) (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "90", "firstAnchor": { "contextRef": "c20260331", "name": "us-gaap:AccruedProfessionalFeesCurrent", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "div", "td", "tr", "table", "pasg:ScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R91": { "role": "http://passagebio.com/role/GemmaLicenseAgreementQ1Details", "longName": "122300 - Disclosure - Gemma License Agreement (Q1) (Details)", "shortName": "Gemma License Agreement (Q1) (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "91", "firstAnchor": { "contextRef": "c20240731", "name": "pasg:UpfrontLicenseFeeReceivable", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": { "contextRef": "c20240731_TypeOfArrangementAxis_ArrangementWithGemmaBiotherapeuticsIncMember", "name": "pasg:LicenseFeeDueAndReceivable", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "unique": true } }, "R92": { "role": "http://passagebio.com/role/SeveranceQ1Details", "longName": "122400 - Disclosure - Severance (Q1) (Details)", "shortName": "Severance (Q1) (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "92", "firstAnchor": { "contextRef": "c20250101to20250131_RestructuringCostAndReserveAxis_EmployeeSeveranceMember", "name": "us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent", "unitRef": "U004", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R93": { "role": "http://passagebio.com/role/LeasesQ1Details", "longName": "122500 - Disclosure - Leases (Q1) (Details)", "shortName": "Leases (Q1) (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "93", "firstAnchor": { "contextRef": "c20260101to20260331", "name": "us-gaap:SubleaseIncome", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": { "contextRef": "c20260331", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "div", "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "unique": true } }, "R94": { "role": "http://passagebio.com/role/LeasesOperatingLeaseCostQ1Details", "longName": "122502 - Disclosure - Leases - Operating lease cost (Q1) (Details)", "shortName": "Leases - Operating lease cost (Q1) (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "94", "firstAnchor": { "contextRef": "c20260101to20260331", "name": "us-gaap:OperatingLeaseCost", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R95": { "role": "http://passagebio.com/role/LeasesSubleaseIncomeQ1Details", "longName": "122504 - Disclosure - Leases - Sublease income (Q1) (Details)", "shortName": "Leases - Sublease income (Q1) (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "95", "firstAnchor": { "contextRef": "c20260101to20260331", "name": "us-gaap:SubleaseIncome", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R96": { "role": "http://passagebio.com/role/CommitmentsAndContingenciesCollaborationAgreementsQ1Details", "longName": "122600 - Disclosure - Commitments and Contingencies - Collaboration Agreements (Q1) (Details)", "shortName": "Commitments and Contingencies - Collaboration Agreements (Q1) (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "96", "firstAnchor": { "contextRef": "c20260331", "name": "pasg:NonRefundableAggregateFeesPayablePerProductIndication", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R97": { "role": "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationEquityIncentivePlanEsppQ1Details", "longName": "122700 - Disclosure - Stockholder's Equity and Share-Based Compensation - Equity Incentive Plan & ESPP (Q1) (Details)", "shortName": "Stockholder's Equity and Share-Based Compensation - Equity Incentive Plan & ESPP (Q1) (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "97", "firstAnchor": { "contextRef": "c20260101to20260331", "name": "pasg:NumberOfEquityIncentivePlans", "unitRef": "U007", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R98": { "role": "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationSharebasedCompensationExpenseQ1Details", "longName": "122702 - Disclosure - Stockholder's Equity and Share-Based Compensation - Share-based compensation expense (Q1) (Details)", "shortName": "Stockholder's Equity and Share-Based Compensation - Share-based compensation expense (Q1) (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "98", "firstAnchor": { "contextRef": "c20260101to20260331", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R99": { "role": "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationStockOptionActivityQ1Details", "longName": "122704 - Disclosure - Stockholder's Equity and Share-Based Compensation - Stock Option Activity (Q1) (Details)", "shortName": "Stockholder's Equity and Share-Based Compensation - Stock Option Activity (Q1) (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "99", "firstAnchor": { "contextRef": "c20251231", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "U003", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "div", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": null }, "R100": { "role": "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationAssumptionsUsedInDeterminingFairValueEarlyExerciseOfStockOptionsQ1Details", "longName": "122706 - Disclosure - Stockholder's Equity and Share-Based Compensation - Assumptions Used in Determining Fair Value & Early exercise of Stock Options (Q1) (Details)", "shortName": "Stockholder's Equity and Share-Based Compensation - Assumptions Used in Determining Fair Value & Early exercise of Stock Options (Q1) (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "100", "firstAnchor": { "contextRef": "c20250101to20251231", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "unitRef": "U004", "xsiNil": "false", "lang": null, "decimals": "3", "ancestors": [ "div", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": { "contextRef": "c20260101to20260331_AwardTypeAxis_EmployeeStockOptionMember", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "unitRef": "U004", "xsiNil": "false", "lang": null, "decimals": "3", "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "unique": true } }, "R101": { "role": "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationRestrictedStockUnitsQ1Details", "longName": "122708 - Disclosure - Stockholder's Equity and Share-Based Compensation - Restricted Stock Units (Q1) (Details)", "shortName": "Stockholder's Equity and Share-Based Compensation - Restricted Stock Units (Q1) (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "101", "firstAnchor": { "contextRef": "c20260101to20260331", "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": { "contextRef": "c20260101to20260331_AwardTypeAxis_RestrictedStockUnitsRSUMember", "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "unique": true } }, "R102": { "role": "http://passagebio.com/role/SegmentReportingQ1Details", "longName": "122800 - Disclosure - Segment Reporting (Q1) (Details)", "shortName": "Segment Reporting (Q1) (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "102", "firstAnchor": { "contextRef": "c20260101to20260331", "name": "us-gaap:ResearchAndDevelopmentExpense", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true }, "uniqueAnchor": { "contextRef": "c20260101to20260331_StatementBusinessSegmentsAxis_GeneticMedicinesSegmentMember", "name": "us-gaap:GainLossOnTerminationOfLease", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "div", "td", "tr", "table", "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "unique": true } }, "R103": { "role": "http://passagebio.com/role/SubsequentEventsQ1Details", "longName": "122900 - Disclosure - Subsequent Events (Q1) (Details)", "shortName": "Subsequent Events (Q1) (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "103", "firstAnchor": { "contextRef": "c20260428to20260428_SubsequentEventTypeAxis_SubsequentEventMember", "name": "pasg:RestructuringPlanReductionInWorkforcePercentage", "unitRef": "U004", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20260428to20260428_SubsequentEventTypeAxis_SubsequentEventMember", "name": "pasg:RestructuringPlanReductionInWorkforcePercentage", "unitRef": "U004", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_s4.htm", "first": true, "unique": true } } }, "tag": { "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies" } } }, "auth_ref": [] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://passagebio.com/role/BalanceSheetsFy": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://passagebio.com/role/BalanceSheetsFy", "http://passagebio.com/role/BalanceSheetsQ1" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable", "label": "Accounts Payable, Current", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r42", "r764" ] }, "pasg_AccruedDivestitureFeesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://passagebio.com/20260721", "localname": "AccruedDivestitureFeesCurrent", "crdr": "credit", "calculation": { "http://passagebio.com/role/AccruedExpensesAndOtherCurrentLiabilitiesFyDetails": { "parentTag": "pasg_AccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://passagebio.com/role/AccruedExpensesAndOtherCurrentLiabilitiesFyDetails", "http://passagebio.com/role/AccruedExpensesAndOtherCurrentLiabilitiesQ1Details", "http://passagebio.com/role/CommitmentsAndContingenciesCollaborationAgreementsFyDetails", "http://passagebio.com/role/CommitmentsAndContingenciesCollaborationAgreementsQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for divestiture fees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Divestiture Fees, Current", "terseLabel": "Divestiture fee due to Catalent" } } }, "auth_ref": [] }, "pasg_AccruedExpensesAndOtherCurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://passagebio.com/20260721", "localname": "AccruedExpensesAndOtherCurrentLiabilities", "crdr": "credit", "calculation": { "http://passagebio.com/role/BalanceSheetsFy": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 }, "http://passagebio.com/role/AccruedExpensesAndOtherCurrentLiabilitiesFyDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://passagebio.com/role/AccruedExpensesAndOtherCurrentLiabilitiesFyDetails", "http://passagebio.com/role/AccruedExpensesAndOtherCurrentLiabilitiesQ1Details", "http://passagebio.com/role/BalanceSheetsFy", "http://passagebio.com/role/BalanceSheetsQ1" ], "lang": { "en-us": { "role": { "documentation": "The carrying balance as of the balance sheet of accrued expenses and other current liabilities.", "label": "Accrued Expenses and Other Current Liabilities.", "terseLabel": "Accrued expenses and other current liabilities", "totalLabel": "Accrued expenses and other current liabilities" } } }, "auth_ref": [] }, "pasg_AccruedExpensesAndOtherCurrentLiabilitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://passagebio.com/20260721", "localname": "AccruedExpensesAndOtherCurrentLiabilitiesDisclosureTextBlock", "presentation": [ "http://passagebio.com/role/AccruedExpensesAndOtherCurrentLiabilitiesFy", "http://passagebio.com/role/AccruedExpensesAndOtherCurrentLiabilitiesQ1" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of information pertaining to accrued expenses and other current liabilities.", "label": "Accrued Expenses And Other Current Liabilities Disclosure [Text Block]", "terseLabel": "Accrued Expenses and Other Current Liabilities" } } }, "auth_ref": [] }, "us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccruedLiabilitiesAndOtherLiabilitiesAbstract", "lang": { "en-us": { "role": { "label": "Accrued Expenses and Other Current Liabilities" } } }, "auth_ref": [] }, "us-gaap_AccruedProfessionalFeesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccruedProfessionalFeesCurrent", "crdr": "credit", "calculation": { "http://passagebio.com/role/AccruedExpensesAndOtherCurrentLiabilitiesFyDetails": { "parentTag": "pasg_AccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://passagebio.com/role/AccruedExpensesAndOtherCurrentLiabilitiesFyDetails", "http://passagebio.com/role/AccruedExpensesAndOtherCurrentLiabilitiesQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Professional fees", "label": "Accrued Professional Fees, Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r44" ] }, "pasg_AccruedResearchAndDevelopmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://passagebio.com/20260721", "localname": "AccruedResearchAndDevelopmentExpense", "crdr": "credit", "calculation": { "http://passagebio.com/role/AccruedExpensesAndOtherCurrentLiabilitiesFyDetails": { "parentTag": "pasg_AccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://passagebio.com/role/AccruedExpensesAndOtherCurrentLiabilitiesFyDetails", "http://passagebio.com/role/AccruedExpensesAndOtherCurrentLiabilitiesQ1Details" ], "lang": { "en-us": { "role": { "documentation": "The carrying balance as of the balance sheet of accrued research and development expense.", "label": "Accrued Research And Development Expense", "terseLabel": "Research and development" } } }, "auth_ref": [] }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://passagebio.com/role/PropertyAndEquipmentNetFyDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://passagebio.com/role/PropertyAndEquipmentNetFyDetails", "http://passagebio.com/role/PropertyAndEquipmentNetQ1Details" ], "lang": { "en-us": { "role": { "negatedLabel": "Accumulated depreciation and amortization", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services." } } }, "auth_ref": [ "r31", "r111", "r592" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://passagebio.com/role/BalanceSheetsFy": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://passagebio.com/role/BalanceSheetsFy" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated other comprehensive income (loss)", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source." } } }, "auth_ref": [ "r18", "r19", "r57", "r117", "r588", "r620", "r621", "r888" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://passagebio.com/role/StatementsOfStockholdersEquityFy", "http://passagebio.com/role/StatementsOfStockholdersEquityQ1" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated other comprehensive income (loss)", "label": "AOCI Attributable to Parent [Member]", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r1", "r10", "r19", "r462", "r465", "r535", "r616", "r617", "r808", "r809", "r810", "r820", "r821", "r822", "r823" ] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://passagebio.com/role/BalanceSheetsFy": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://passagebio.com/role/BalanceSheetsFy", "http://passagebio.com/role/BalanceSheetsQ1" ], "lang": { "en-us": { "role": { "terseLabel": "Additional paidin capital", "label": "Additional Paid in Capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r52", "r764", "r956" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://passagebio.com/role/StatementsOfStockholdersEquityFy", "http://passagebio.com/role/StatementsOfStockholdersEquityQ1" ], "lang": { "en-us": { "role": { "verboseLabel": "Additional paidin capital", "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r632", "r820", "r821", "r822", "r823", "r889", "r958" ] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "crdr": "credit", "presentation": [ "http://passagebio.com/role/StatementsOfStockholdersEquityFy", "http://passagebio.com/role/StatementsOfStockholdersEquityQ1" ], "lang": { "en-us": { "role": { "terseLabel": "Sharebased compensation expense", "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition", "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement." } } }, "auth_ref": [ "r355" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://passagebio.com/role/StatementsOfCashFlowsFy", "http://passagebio.com/role/StatementsOfCashFlowsQ1" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustments to reconcile net loss to net cash provided by (used in) operating activities:", "label": "Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "presentation": [ "http://passagebio.com/role/SharebasedCompensationEquityIncentivePlanEsppFyDetails", "http://passagebio.com/role/SharebasedCompensationSharebasedCompensationExpenseFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationEquityIncentivePlanEsppQ1Details", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationSharebasedCompensationExpenseQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based compensation expense", "label": "Share-Based Payment Arrangement, Expense", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized." } } }, "auth_ref": [ "r387", "r393", "r402" ] }, "pasg_AmendedAndRestatedResearchCollaborationAndLicenseAgreementWithPennMember": { "xbrltype": "domainItemType", "nsuri": "http://passagebio.com/20260721", "localname": "AmendedAndRestatedResearchCollaborationAndLicenseAgreementWithPennMember", "presentation": [ "http://passagebio.com/role/CommitmentsAndContingenciesCollaborationAgreementsFyDetails", "http://passagebio.com/role/CommitmentsAndContingenciesCollaborationAgreementsQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to amended and restated research, collaboration and license agreement with Penn.", "label": "Amended and restated agreement with Penn [Member]", "terseLabel": "Amended and restated agreement" } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AmendmentFlag", "presentation": [ "http://passagebio.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_AmortizationOfDebtDiscountPremium": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AmortizationOfDebtDiscountPremium", "crdr": "debit", "calculation": { "http://passagebio.com/role/StatementsOfCashFlowsFy": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 7.0 }, "http://passagebio.com/role/StatementsOfCashFlowsQ1": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://passagebio.com/role/StatementsOfCashFlowsFy", "http://passagebio.com/role/StatementsOfCashFlowsQ1" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization of premium and discount on marketable securities, net", "label": "Amortization of Debt Discount (Premium)", "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense." } } }, "auth_ref": [ "r5", "r61", "r301", "r906" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesFyDetails", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Amount of antidilutive securities excluded from computation of earnings per share", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r170" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "presentation": [ "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesFyDetails", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesQ1Details" ], "lang": { "en-us": { "role": { "label": "Antidilutive Securities [Axis]", "documentation": "Information by type of antidilutive security." } } }, "auth_ref": [ "r170" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "presentation": [ "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesFyDetails", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesQ1Details" ], "lang": { "en-us": { "role": { "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "terseLabel": "Summary of Significant Accounting Policies", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r170" ] }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AntidilutiveSecuritiesNameDomain", "presentation": [ "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesFyDetails", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesQ1Details" ], "lang": { "en-us": { "role": { "label": "Antidilutive Securities, Name [Domain]", "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented." } } }, "auth_ref": [ "r170" ] }, "us-gaap_AreaOfLand": { "xbrltype": "areaItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AreaOfLand", "presentation": [ "http://passagebio.com/role/LeasesFyDetails", "http://passagebio.com/role/LeasesQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Area leased", "label": "Area of Land", "documentation": "Area of land held." } } }, "auth_ref": [] }, "pasg_AreaOfLandSubleasedPercentage": { "xbrltype": "percentItemType", "nsuri": "http://passagebio.com/20260721", "localname": "AreaOfLandSubleasedPercentage", "presentation": [ "http://passagebio.com/role/LeasesFyDetails", "http://passagebio.com/role/LeasesQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Represents are of land sub leased of the total area under lease.", "label": "Area of Land subleased, Percentage", "terseLabel": "Subleased area of land" } } }, "auth_ref": [] }, "pasg_AreaSubleased": { "xbrltype": "areaItemType", "nsuri": "http://passagebio.com/20260721", "localname": "AreaSubleased", "presentation": [ "http://passagebio.com/role/LeasesFyDetails", "http://passagebio.com/role/LeasesQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Area subleased.", "label": "Area Subleased" } } }, "auth_ref": [] }, "pasg_ArrangementWithGemmaBiotherapeuticsIncMember": { "xbrltype": "domainItemType", "nsuri": "http://passagebio.com/20260721", "localname": "ArrangementWithGemmaBiotherapeuticsIncMember", "presentation": [ "http://passagebio.com/role/CommitmentsAndContingenciesCollaborationAgreementsFyDetails", "http://passagebio.com/role/CommitmentsAndContingenciesCollaborationAgreementsQ1Details", "http://passagebio.com/role/GemmaLicenseAgreementFyDetails", "http://passagebio.com/role/GemmaLicenseAgreementQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to the arrangement with Gemma Biotherapeutics Inc.", "label": "Arrangement With Gemma Biotherapeutics Inc [Member]", "terseLabel": "Gemma License Agreement" } } }, "auth_ref": [] }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ArrangementsAndNonarrangementTransactionsMember", "presentation": [ "http://passagebio.com/role/CommitmentsAndContingenciesCollaborationAgreementsFyDetails", "http://passagebio.com/role/CommitmentsAndContingenciesCollaborationAgreementsQ1Details", "http://passagebio.com/role/GemmaLicenseAgreementFyDetails", "http://passagebio.com/role/GemmaLicenseAgreementQ1Details" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]", "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r451" ] }, "us-gaap_AssetImpairmentCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AssetImpairmentCharges", "crdr": "debit", "calculation": { "http://passagebio.com/role/StatementsOfOperationsAndComprehensiveLossFy": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 2.0 }, "http://passagebio.com/role/StatementsOfCashFlowsFy": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 11.0 }, "http://passagebio.com/role/StatementsOfCashFlowsQ1": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 12.0 }, "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsNonrecurringBasisFyDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsNonrecurringBasisFyDetails", "http://passagebio.com/role/LeasesFyDetails", "http://passagebio.com/role/SegmentReportingFyDetails", "http://passagebio.com/role/SegmentReportingQ1Details", "http://passagebio.com/role/StatementsOfCashFlowsFy", "http://passagebio.com/role/StatementsOfCashFlowsQ1", "http://passagebio.com/role/StatementsOfOperationsAndComprehensiveLossFy", "http://passagebio.com/role/StatementsOfOperationsAndComprehensiveLossQ1" ], "lang": { "en-us": { "role": { "verboseLabel": "Impairment of long-lived assets", "totalLabel": "Total impairment losses", "label": "Asset Impairment Charges", "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill." } } }, "auth_ref": [ "r5", "r29", "r766", "r767" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "Assets", "crdr": "debit", "calculation": { "http://passagebio.com/role/BalanceSheetsFy": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://passagebio.com/role/BalanceSheetsFy", "http://passagebio.com/role/BalanceSheetsQ1" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "label": "Assets", "documentation": "Amount of asset recognized for present right to economic benefit." } } }, "auth_ref": [ "r82", "r89", "r113", "r141", "r142", "r143", "r173", "r185", "r203", "r207", "r246", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r452", "r454", "r503", "r577", "r578", "r584", "r657", "r722", "r723", "r732", "r764", "r770", "r771", "r783", "r842", "r843", "r912" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AssetsAbstract", "presentation": [ "http://passagebio.com/role/BalanceSheetsFy", "http://passagebio.com/role/BalanceSheetsQ1" ], "lang": { "en-us": { "role": { "terseLabel": "Assets", "label": "Assets [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://passagebio.com/role/BalanceSheetsFy": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://passagebio.com/role/BalanceSheetsFy", "http://passagebio.com/role/BalanceSheetsQ1" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Assets, Current", "documentation": "Amount of asset recognized for present right to economic benefit, classified as current." } } }, "auth_ref": [ "r107", "r118", "r141", "r142", "r143", "r246", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r452", "r454", "r503", "r764", "r842", "r843", "r912" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AssetsCurrentAbstract", "presentation": [ "http://passagebio.com/role/BalanceSheetsFy", "http://passagebio.com/role/BalanceSheetsQ1" ], "lang": { "en-us": { "role": { "terseLabel": "Current assets:", "label": "Assets, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AssetsFairValueDisclosure", "crdr": "debit", "calculation": { "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsRecurringBasisFyDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsNonrecurringBasisFyDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsNonrecurringBasisFyDetails", "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsRecurringBasisFyDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total financial assets", "label": "Assets, Fair Value Disclosure", "documentation": "Fair value portion of asset recognized for present right to economic benefit." } } }, "auth_ref": [ "r477", "r478", "r750" ] }, "pasg_AttheMarketFacilityAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://passagebio.com/20260721", "localname": "AttheMarketFacilityAgreementMember", "presentation": [ "http://passagebio.com/role/CommonStockFyDetails", "http://passagebio.com/role/RisksAndLiquidityFyDetails", "http://passagebio.com/role/RisksLiquidityAndGoingConcernQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Represents the member information pertaining to at-the-market (ATM) facility.", "label": "ATM Facility [Member]", "terseLabel": "ATM Facility" } } }, "auth_ref": [] }, "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax", "crdr": "credit", "calculation": { "http://passagebio.com/role/CashCashEquivalentsAndMarketableSecuritiesPortfolioOfMarketableSecuritiesFyDetails": { "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://passagebio.com/role/CashCashEquivalentsAndMarketableSecuritiesPortfolioOfMarketableSecuritiesFyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrealized gains", "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax", "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r219" ] }, "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax", "crdr": "debit", "calculation": { "http://passagebio.com/role/CashCashEquivalentsAndMarketableSecuritiesPortfolioOfMarketableSecuritiesFyDetails": { "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://passagebio.com/role/CashCashEquivalentsAndMarketableSecuritiesPortfolioOfMarketableSecuritiesFyDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Unrealized losses", "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax", "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r220" ] }, "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis", "crdr": "debit", "calculation": { "http://passagebio.com/role/CashCashEquivalentsAndMarketableSecuritiesPortfolioOfMarketableSecuritiesFyDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://passagebio.com/role/CashCashEquivalentsAndMarketableSecuritiesPortfolioOfMarketableSecuritiesFyDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Amortized cost", "label": "Debt Securities, Available-for-Sale, Amortized Cost", "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r216", "r254", "r583" ] }, "us-gaap_AvailableForSaleSecuritiesDebtSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AvailableForSaleSecuritiesDebtSecurities", "crdr": "debit", "calculation": { "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsRecurringBasisFyDetails": { "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0, "order": 2.0 }, "http://passagebio.com/role/CashCashEquivalentsAndMarketableSecuritiesPortfolioOfMarketableSecuritiesFyDetails": { "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://passagebio.com/role/CashCashEquivalentsAndMarketableSecuritiesPortfolioOfMarketableSecuritiesFyDetails", "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsRecurringBasisFyDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Fair value", "terseLabel": "Marketable securities", "label": "Debt Securities, Available-for-Sale", "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r217", "r254", "r477", "r496", "r497", "r498", "r499", "r574", "r703", "r750", "r755", "r762", "r831", "r893", "r894", "r895" ] }, "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrent", "crdr": "debit", "calculation": { "http://passagebio.com/role/BalanceSheetsFy": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://passagebio.com/role/BalanceSheetsFy", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesFyDetails", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Marketable securities", "label": "Debt Securities, Available-for-Sale, Current", "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current." } } }, "auth_ref": [ "r214", "r254" ] }, "us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract", "presentation": [ "http://passagebio.com/role/CashCashEquivalentsAndMarketableSecuritiesPortfolioOfMarketableSecuritiesFyDetails" ], "lang": { "en-us": { "role": { "label": "Debt Securities, Available-for-Sale, Fair Value to Amortized Cost, after Allowance for Credit Loss [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AwardTypeAxis", "presentation": [ "http://passagebio.com/role/SharebasedCompensationRestrictedStockUnitsFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationAssumptionsUsedInDeterminingFairValueEarlyExerciseOfStockOptionsQ1Details", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationRestrictedStockUnitsQ1Details" ], "lang": { "en-us": { "role": { "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r358", "r359", "r360", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r382", "r383", "r384", "r385", "r386" ] }, "pasg_BasisOfPresentationPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://passagebio.com/20260721", "localname": "BasisOfPresentationPolicyTextBlock", "presentation": [ "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesFyPolicies", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesQ1Policies" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of presentation.", "label": "Basis Of Presentation [Policy Text Block]", "terseLabel": "Basis of Presentation" } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://passagebio.com/role/BalanceSheetsFy": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://passagebio.com/role/BalanceSheetsFy", "http://passagebio.com/role/BalanceSheetsQ1", "http://passagebio.com/role/RisksLiquidityAndGoingConcernQ1Details", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and cash equivalents", "label": "Cash and Cash Equivalent", "documentation": "Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate." } } }, "auth_ref": [ "r22", "r109", "r704" ] }, "us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CashAndCashEquivalentsAtCarryingValueAbstract", "presentation": [ "http://passagebio.com/role/CashCashEquivalentsAndMarketableSecuritiesPortfolioOfCashAndCashEquivalentsFyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and cash equivalents", "label": "Cash and Cash Equivalent [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CashAndCashEquivalentsAxis", "presentation": [ "http://passagebio.com/role/CashCashEquivalentsAndMarketableSecuritiesPortfolioOfCashAndCashEquivalentsFyDetails", "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsRecurringBasisFyDetails" ], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents [Axis]", "documentation": "Information by type of cash and cash equivalent balance." } } }, "auth_ref": [ "r109" ] }, "us-gaap_CashAndCashEquivalentsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CashAndCashEquivalentsFairValueDisclosure", "crdr": "debit", "calculation": { "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsRecurringBasisFyDetails": { "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://passagebio.com/role/CashCashEquivalentsAndMarketableSecuritiesPortfolioOfCashAndCashEquivalentsFyDetails", "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsRecurringBasisFyDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Fair value", "terseLabel": "Cash equivalents", "label": "Cash and Cash Equivalents, Fair Value Disclosure", "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r497", "r498", "r499", "r891", "r892" ] }, "us-gaap_CashAndCashEquivalentsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CashAndCashEquivalentsLineItems", "presentation": [ "http://passagebio.com/role/CashCashEquivalentsAndMarketableSecuritiesPortfolioOfCashAndCashEquivalentsFyDetails", "http://passagebio.com/role/CashCashEquivalentsAndMarketableSecuritiesPortfolioOfMarketableSecuritiesFyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash, cash equivalents and marketable securities", "label": "Cash and Cash Equivalents [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CashAndCashEquivalentsPolicyTextBlock", "presentation": [ "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesFyPolicies", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesQ1Policies" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and Cash Equivalents", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value." } } }, "auth_ref": [ "r23" ] }, "pasg_CashCashEquivalentsAndMarketableSecuritiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://passagebio.com/20260721", "localname": "CashCashEquivalentsAndMarketableSecuritiesAbstract", "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Cash, Cash Equivalents, and Marketable Securities" } } }, "auth_ref": [] }, "us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CashCashEquivalentsAndMarketableSecuritiesTextBlock", "presentation": [ "http://passagebio.com/role/CashCashEquivalentsAndMarketableSecuritiesFy" ], "lang": { "en-us": { "role": { "terseLabel": "Cash, Cash Equivalents, and Marketable Securities", "label": "Cash, Cash Equivalent, and Marketable Security [Text Block]", "documentation": "The entire disclosure of cash, cash equivalent, and debt and equity securities, including realized and unrealized gain (loss)." } } }, "auth_ref": [ "r830" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "presentation": [ "http://passagebio.com/role/StatementsOfCashFlowsFy", "http://passagebio.com/role/StatementsOfCashFlowsQ1" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash and cash equivalents at beginning", "periodEndLabel": "Cash and cash equivalents at end", "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation", "documentation": "Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate." } } }, "auth_ref": [ "r22", "r64", "r138" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://passagebio.com/role/StatementsOfCashFlowsFy": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://passagebio.com/role/StatementsOfCashFlowsQ1": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://passagebio.com/role/StatementsOfCashFlowsFy", "http://passagebio.com/role/StatementsOfCashFlowsQ1" ], "lang": { "en-us": { "role": { "totalLabel": "Net increase (decrease) in cash and cash equivalents", "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation", "documentation": "Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate." } } }, "auth_ref": [ "r0", "r64" ] }, "us-gaap_CashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CashEquivalentsAtCarryingValue", "crdr": "debit", "presentation": [ "http://passagebio.com/role/CashCashEquivalentsAndMarketableSecuritiesPortfolioOfCashAndCashEquivalentsFyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cost or Amortized cost", "label": "Cash Equivalents, at Carrying Value", "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r806", "r923" ] }, "us-gaap_CertificatesOfDepositMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CertificatesOfDepositMember", "presentation": [ "http://passagebio.com/role/CashCashEquivalentsAndMarketableSecuritiesPortfolioOfMarketableSecuritiesFyDetails", "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsRecurringBasisFyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Certificates of deposit", "label": "Certificates of Deposit [Member]", "documentation": "Short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest. Certificates of deposit (CD) are typically Federal Deposit Insurance Corporation (FDIC) insured." } } }, "auth_ref": [ "r9", "r777", "r778", "r779", "r780" ] }, "us-gaap_ClassOfStockLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ClassOfStockLineItems", "presentation": [ "http://passagebio.com/role/CommonStockFyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock", "label": "Class of Stock [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r114", "r115", "r116", "r175", "r308", "r314", "r315", "r316", "r318", "r321", "r326", "r328", "r460", "r626", "r627", "r628", "r629", "r733", "r797", "r813", "r815" ] }, "pasg_CollaborationAgreementAmountPayablePerProductCandidateForRareMonogenicDisordersUponAchievementOfSpecificDevelopmentMilestone": { "xbrltype": "monetaryItemType", "nsuri": "http://passagebio.com/20260721", "localname": "CollaborationAgreementAmountPayablePerProductCandidateForRareMonogenicDisordersUponAchievementOfSpecificDevelopmentMilestone", "crdr": "credit", "presentation": [ "http://passagebio.com/role/CommitmentsAndContingenciesCollaborationAgreementsFyDetails", "http://passagebio.com/role/CommitmentsAndContingenciesCollaborationAgreementsQ1Details" ], "lang": { "en-us": { "role": { "documentation": "The amount of payable per product candidate for rare monogenic disorders upon achievement of specific development milestone payment on collaboration and license agreement.", "label": "Collaboration Agreement, Amount Payable Per Product Candidate for Rare Monogenic Disorders, Upon Achievement Of Specific Development Milestone", "terseLabel": "Amount payable per product candidate for rare, monogenic disorders" } } }, "auth_ref": [] }, "pasg_CollaborationAgreementAmountPayablePerProductCandidateUponAchievementOfSpecificDevelopmentMilestone": { "xbrltype": "monetaryItemType", "nsuri": "http://passagebio.com/20260721", "localname": "CollaborationAgreementAmountPayablePerProductCandidateUponAchievementOfSpecificDevelopmentMilestone", "crdr": "credit", "presentation": [ "http://passagebio.com/role/CommitmentsAndContingenciesCollaborationAgreementsFyDetails", "http://passagebio.com/role/CommitmentsAndContingenciesCollaborationAgreementsQ1Details" ], "lang": { "en-us": { "role": { "documentation": "The amount of payable per product candidate upon achievement of specific development milestone payment on collaboration and license agreement.", "label": "Collaboration Agreement Amount Payable Per Product Candidate Upon Achievement Of Specific Development Milestone", "terseLabel": "Amount payable per product candidate upon achievement of specific development milestone" } } }, "auth_ref": [] }, "pasg_CollaborationAgreementSalesMilestonePaymentsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://passagebio.com/20260721", "localname": "CollaborationAgreementSalesMilestonePaymentsPayable", "crdr": "credit", "presentation": [ "http://passagebio.com/role/CommitmentsAndContingenciesCollaborationAgreementsFyDetails", "http://passagebio.com/role/CommitmentsAndContingenciesCollaborationAgreementsQ1Details" ], "lang": { "en-us": { "role": { "documentation": "The amount of payable on sales milestone payment on collaboration and license agreement.", "label": "Collaboration Agreement Sales Milestone Payments Payable", "terseLabel": "Sales milestone payments" } } }, "auth_ref": [] }, "pasg_CollaborativeArrangementDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://passagebio.com/20260721", "localname": "CollaborativeArrangementDisclosureAbstract", "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Gemma License Agreement" } } }, "auth_ref": [] }, "us-gaap_CollaborativeArrangementDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CollaborativeArrangementDisclosureTextBlock", "presentation": [ "http://passagebio.com/role/GemmaLicenseAgreementFy", "http://passagebio.com/role/GemmaLicenseAgreementQ1" ], "lang": { "en-us": { "role": { "terseLabel": "Gemma License Agreement", "label": "Collaborative Arrangement Disclosure [Text Block]", "documentation": "The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants." } } }, "auth_ref": [ "r100", "r449", "r450" ] }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "presentation": [ "http://passagebio.com/role/CommitmentsAndContingenciesCollaborationAgreementsFyDetails", "http://passagebio.com/role/CommitmentsAndContingenciesCollaborationAgreementsQ1Details", "http://passagebio.com/role/GemmaLicenseAgreementFyDetails", "http://passagebio.com/role/GemmaLicenseAgreementQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and Contingencies", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r451" ] }, "us-gaap_CommercialPaperMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommercialPaperMember", "presentation": [ "http://passagebio.com/role/CashCashEquivalentsAndMarketableSecuritiesPortfolioOfCashAndCashEquivalentsFyDetails", "http://passagebio.com/role/CashCashEquivalentsAndMarketableSecuritiesPortfolioOfMarketableSecuritiesFyDetails", "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsRecurringBasisFyDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Commercial paper", "label": "Commercial Paper [Member]", "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds." } } }, "auth_ref": [ "r73", "r290", "r777", "r778", "r779", "r780" ] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommitmentsAndContingencies", "crdr": "credit", "calculation": { "http://passagebio.com/role/BalanceSheetsFy": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://passagebio.com/role/BalanceSheetsFy", "http://passagebio.com/role/BalanceSheetsQ1" ], "lang": { "en-us": { "role": { "label": "Commitments and contingencies (note 11)", "terseLabel": "Commitments and contingencies (note 10)", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r48", "r83", "r586", "r644" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Commitments and Contingencies." } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://passagebio.com/role/CommitmentsAndContingenciesFy", "http://passagebio.com/role/CommitmentsAndContingenciesQ1" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and Contingencies", "label": "Commitments and Contingencies Disclosure [Text Block]", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r72", "r283", "r284", "r698", "r839", "r841" ] }, "pasg_CommonStockAdditionalCapitalSharesReservedForFutureIssuance": { "xbrltype": "sharesItemType", "nsuri": "http://passagebio.com/20260721", "localname": "CommonStockAdditionalCapitalSharesReservedForFutureIssuance", "presentation": [ "http://passagebio.com/role/SharebasedCompensationEquityIncentivePlanEsppFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationEquityIncentivePlanEsppQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Additional number of common shares reserved for future issuance.", "label": "Common Stock, Additional Capital Shares Reserved for Future Issuance", "terseLabel": "Additional number of common shares reserved for future issuance" } } }, "auth_ref": [] }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "presentation": [ "http://passagebio.com/role/SharebasedCompensationEquityIncentivePlanEsppFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationEquityIncentivePlanEsppQ1Details" ], "lang": { "en-us": { "role": { "verboseLabel": "Shares available for future issuance", "label": "Common Stock, Capital Shares Reserved for Future Issuance", "documentation": "Aggregate number of common shares reserved for future issuance." } } }, "auth_ref": [ "r51" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommonStockMember", "presentation": [ "http://passagebio.com/role/StatementsOfStockholdersEquityFy", "http://passagebio.com/role/StatementsOfStockholdersEquityQ1" ], "lang": { "en-us": { "role": { "verboseLabel": "Common stock", "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r773", "r774", "r775", "r777", "r778", "r779", "r780", "r820", "r821", "r823", "r889", "r955", "r958" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://passagebio.com/role/BalanceSheetsFyParenthetical", "http://passagebio.com/role/BalanceSheetsQ1Parenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, par value (in dollars per share)", "label": "Common Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r51" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://passagebio.com/role/BalanceSheetsFyParenthetical", "http://passagebio.com/role/BalanceSheetsQ1Parenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares authorized", "label": "Common Stock, Shares Authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r51", "r645" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommonStockSharesIssued", "presentation": [ "http://passagebio.com/role/BalanceSheetsFyParenthetical", "http://passagebio.com/role/BalanceSheetsQ1Parenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares issued", "label": "Common Stock, Shares, Issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r51" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://passagebio.com/role/BalanceSheetsFyParenthetical", "http://passagebio.com/role/BalanceSheetsQ1Parenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares outstanding", "label": "Common Stock, Shares, Outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r11", "r51", "r645", "r663", "r958", "r959" ] }, "us-gaap_ComponentsOfDeferredTaxAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ComponentsOfDeferredTaxAssetsAbstract", "presentation": [ "http://passagebio.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesFyDetails" ], "lang": { "en-us": { "role": { "label": "Deferred tax assets:" } } }, "auth_ref": [] }, "us-gaap_ComprehensiveIncomeNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ComprehensiveIncomeNetOfTax", "crdr": "credit", "calculation": { "http://passagebio.com/role/StatementsOfOperationsAndComprehensiveLossFy": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://passagebio.com/role/StatementsOfOperationsAndComprehensiveLossFy", "http://passagebio.com/role/StatementsOfOperationsAndComprehensiveLossQ1" ], "lang": { "en-us": { "role": { "totalLabel": "Comprehensive loss", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r20", "r122", "r124", "r129", "r575", "r597", "r598" ] }, "us-gaap_ComprehensiveIncomeNetOfTaxAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ComprehensiveIncomeNetOfTaxAbstract", "presentation": [ "http://passagebio.com/role/StatementsOfOperationsAndComprehensiveLossFy", "http://passagebio.com/role/StatementsOfOperationsAndComprehensiveLossQ1" ], "lang": { "en-us": { "role": { "terseLabel": "Comprehensive loss:", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ComputerEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ComputerEquipmentMember", "presentation": [ "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesFyDetails", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Computer hardware", "label": "Computer Equipment [Member]", "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems." } } }, "auth_ref": [] }, "pasg_ComputerHardwareAndSoftwareMember": { "xbrltype": "domainItemType", "nsuri": "http://passagebio.com/20260721", "localname": "ComputerHardwareAndSoftwareMember", "presentation": [ "http://passagebio.com/role/PropertyAndEquipmentNetFyDetails", "http://passagebio.com/role/PropertyAndEquipmentNetQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to Computer Hardware and Software.", "label": "Computer hardware and software. [Member]", "terseLabel": "Computer hardware and software." } } }, "auth_ref": [] }, "us-gaap_ConcentrationRiskCreditRisk": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ConcentrationRiskCreditRisk", "presentation": [ "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesFyPolicies", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesQ1Policies" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration of Credit Risk", "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for credit risk. Includes, but is not limited to, policy for entering into master netting arrangement or similar agreement to mitigate credit risk of financial instrument." } } }, "auth_ref": [ "r500", "r501" ] }, "pasg_ContingentProceedsFromUponCompletionOfCertainBusinessMilestones": { "xbrltype": "monetaryItemType", "nsuri": "http://passagebio.com/20260721", "localname": "ContingentProceedsFromUponCompletionOfCertainBusinessMilestones", "crdr": "debit", "presentation": [ "http://passagebio.com/role/GemmaLicenseAgreementFyDetails", "http://passagebio.com/role/GemmaLicenseAgreementQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Contingent proceeds upon completing certain business milestones.", "label": "Contingent Proceeds From Upon Completion of certain business milestones", "terseLabel": "Contingent proceeds upon completing certain business milestones" } } }, "auth_ref": [] }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ContractWithCustomerLiabilityCurrent", "crdr": "credit", "calculation": { "http://passagebio.com/role/BalanceSheetsFy": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://passagebio.com/role/BalanceSheetsFy", "http://passagebio.com/role/BalanceSheetsQ1", "http://passagebio.com/role/GemmaLicenseAgreementFyDetails", "http://passagebio.com/role/GemmaLicenseAgreementQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Non-refundable sublicense and transition services payments", "verboseLabel": "Non-refundable sublicense payments received", "label": "Contract with Customer, Liability, Current", "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current." } } }, "auth_ref": [ "r330", "r331", "r332", "r341" ] }, "us-gaap_CorporateDebtSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CorporateDebtSecuritiesMember", "presentation": [ "http://passagebio.com/role/CashCashEquivalentsAndMarketableSecuritiesPortfolioOfMarketableSecuritiesFyDetails", "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsRecurringBasisFyDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Corporate debt securities", "label": "Corporate Debt Securities [Member]", "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment." } } }, "auth_ref": [ "r734", "r736", "r738", "r750", "r765", "r772", "r952" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredIncomeTaxLiabilitiesNet", "crdr": "credit", "calculation": { "http://passagebio.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesFyDetails": { "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://passagebio.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesFyDetails" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Total deferred tax liabilities", "label": "Deferred Income Tax Liabilities, Net", "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting." } } }, "auth_ref": [ "r409", "r410", "r585" ] }, "pasg_DeferredProceedsReceivableFromSaleOfEquipmentInOtherCurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://passagebio.com/20260721", "localname": "DeferredProceedsReceivableFromSaleOfEquipmentInOtherCurrentAssets", "crdr": "debit", "presentation": [ "http://passagebio.com/role/StatementsOfCashFlowsQ1" ], "lang": { "en-us": { "role": { "documentation": "The amount of deferred proceeds from sale of equipment in other current assets in non-cash investing or financing transactions.", "label": "Deferred Proceeds Receivable From Sale Of Equipment In Other Current Assets", "terseLabel": "Deferred proceeds from equipment sale in other current assets" } } }, "auth_ref": [] }, "pasg_DeferredTaxAssetsCapitalizedResearchAndDevelopment": { "xbrltype": "monetaryItemType", "nsuri": "http://passagebio.com/20260721", "localname": "DeferredTaxAssetsCapitalizedResearchAndDevelopment", "crdr": "debit", "calculation": { "http://passagebio.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesFyDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://passagebio.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesFyDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from capitalized research and development costs.", "label": "Deferred Tax Assets, Capitalized Research and Development", "terseLabel": "Capitalized research and development" } } }, "auth_ref": [] }, "pasg_DeferredTaxAssetsCollaborationAndLicenseAgreement": { "xbrltype": "monetaryItemType", "nsuri": "http://passagebio.com/20260721", "localname": "DeferredTaxAssetsCollaborationAndLicenseAgreement", "crdr": "debit", "calculation": { "http://passagebio.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesFyDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://passagebio.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesFyDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from collaboration and license agreement.", "label": "Deferred Tax Assets, Collaboration and License Agreement", "terseLabel": "Collaboration and license agreement" } } }, "auth_ref": [] }, "pasg_DeferredTaxAssetsDepreciationAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://passagebio.com/20260721", "localname": "DeferredTaxAssetsDepreciationAndAmortization", "crdr": "debit", "calculation": { "http://passagebio.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesFyDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://passagebio.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesFyDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from depreciation and amortization.", "label": "Deferred Tax Assets, Depreciation and Amortization", "terseLabel": "Depreciation and amortization" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredTaxAssetsGross", "crdr": "debit", "calculation": { "http://passagebio.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesFyDetails": { "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://passagebio.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesFyDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total gross deferred tax assets before valuation allowance", "label": "Deferred Tax Assets, Gross", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards." } } }, "auth_ref": [ "r424" ] }, "us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredTaxAssetsInProcessResearchAndDevelopment", "crdr": "debit", "calculation": { "http://passagebio.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesFyDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://passagebio.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesFyDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Research and development credits", "label": "Deferred Tax Asset, In-Process Research and Development", "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from in-process research and development cost acquired in business combination or from joint venture formation or both." } } }, "auth_ref": [ "r882" ] }, "us-gaap_DeferredTaxAssetsLiabilitiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredTaxAssetsLiabilitiesNet", "crdr": "debit", "calculation": { "http://passagebio.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesFyDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://passagebio.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesFyDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net deferred taxes", "label": "Deferred Tax Assets, Net", "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting." } } }, "auth_ref": [ "r880" ] }, "us-gaap_DeferredTaxAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredTaxAssetsNet", "crdr": "debit", "calculation": { "http://passagebio.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesFyDetails": { "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://passagebio.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesFyDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net deferred tax assets", "label": "Deferred Tax Assets, Net of Valuation Allowance", "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards." } } }, "auth_ref": [ "r880" ] }, "pasg_DeferredTaxAssetsOperatingLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://passagebio.com/20260721", "localname": "DeferredTaxAssetsOperatingLeaseLiabilities", "crdr": "debit", "calculation": { "http://passagebio.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesFyDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://passagebio.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesFyDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from operating lease liabilities.", "label": "Deferred Tax Assets Operating Lease Liabilities", "terseLabel": "Operating lease liabilities" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "crdr": "debit", "calculation": { "http://passagebio.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesFyDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://passagebio.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesFyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net operating loss carryforwards", "label": "Deferred Tax Assets, Operating Loss Carryforwards", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards." } } }, "auth_ref": [ "r882" ] }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost", "crdr": "debit", "calculation": { "http://passagebio.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesFyDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://passagebio.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesFyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based compensation", "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation." } } }, "auth_ref": [ "r882" ] }, "pasg_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilitiesAndOther": { "xbrltype": "monetaryItemType", "nsuri": "http://passagebio.com/20260721", "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilitiesAndOther", "crdr": "debit", "calculation": { "http://passagebio.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesFyDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://passagebio.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesFyDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities and other.", "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities and Other", "terseLabel": "Accrued expenses and other" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredTaxAssetsValuationAllowance", "crdr": "credit", "calculation": { "http://passagebio.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesFyDetails": { "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://passagebio.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesFyDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Valuation allowance", "label": "Deferred Tax Assets, Valuation Allowance", "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized." } } }, "auth_ref": [ "r425" ] }, "us-gaap_DeferredTaxLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredTaxLiabilitiesAbstract", "presentation": [ "http://passagebio.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesFyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred tax liabilities:", "label": "Deferred Tax Liabilities, Gross [Abstract]" } } }, "auth_ref": [] }, "pasg_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://passagebio.com/20260721", "localname": "DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets", "crdr": "credit", "calculation": { "http://passagebio.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesFyDetails": { "parentTag": "us-gaap_DeferredIncomeTaxLiabilitiesNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://passagebio.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesFyDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from operating lease right of use assets.", "label": "Deferred Tax Liabilities, Operating Lease Right of Use Assets", "negatedLabel": "Right of use assets - operating leases" } } }, "auth_ref": [] }, "us-gaap_DemandDepositsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DemandDepositsMember", "presentation": [ "http://passagebio.com/role/CashCashEquivalentsAndMarketableSecuritiesPortfolioOfCashAndCashEquivalentsFyDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Cash accounts in banking institutions", "label": "Demand Deposits [Member]", "documentation": "Accounts that may or may not bear interest and that depositor is entitled to withdraw at anytime without prior notice. Checking and negotiable order of withdrawal (NOW) accounts are the most common forms of demand deposits." } } }, "auth_ref": [] }, "us-gaap_Depreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "Depreciation", "crdr": "debit", "presentation": [ "http://passagebio.com/role/PropertyAndEquipmentNetNarrativeFyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation on equipment", "label": "Depreciation", "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation." } } }, "auth_ref": [ "r5", "r30", "r134", "r705", "r706", "r708", "r710" ] }, "us-gaap_DepreciationDepletionAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DepreciationDepletionAndAmortization", "crdr": "debit", "calculation": { "http://passagebio.com/role/StatementsOfCashFlowsFy": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 9.0 }, "http://passagebio.com/role/StatementsOfCashFlowsQ1": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://passagebio.com/role/PropertyAndEquipmentNetFyDetails", "http://passagebio.com/role/PropertyAndEquipmentNetQ1Details", "http://passagebio.com/role/StatementsOfCashFlowsFy", "http://passagebio.com/role/StatementsOfCashFlowsQ1" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation and amortization", "verboseLabel": "Depreciation and amortization expense", "label": "Depreciation, Depletion and Amortization", "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets." } } }, "auth_ref": [ "r5", "r135", "r173", "r190", "r207", "r705", "r722", "r723" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "presentation": [ "http://passagebio.com/role/SharebasedCompensationFy", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationQ1" ], "lang": { "en-us": { "role": { "terseLabel": "Stockholder's Equity and Share-Based Compensation", "verboseLabel": "Share-Based Compensation", "label": "Share-Based Payment Arrangement [Text Block]", "documentation": "The entire disclosure for share-based payment arrangement." } } }, "auth_ref": [ "r353", "r357", "r388", "r389", "r391", "r740" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "lang": { "en-us": { "role": { "label": "Share-Based Compensation" } } }, "auth_ref": [] }, "us-gaap_DisposalGroupClassificationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DisposalGroupClassificationAxis", "presentation": [ "http://passagebio.com/role/PropertyAndEquipmentNetNarrativeFyDetails" ], "lang": { "en-us": { "role": { "label": "Disposal Group Classification [Axis]", "documentation": "Information by disposal group classification." } } }, "auth_ref": [ "r105" ] }, "us-gaap_DisposalGroupClassificationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DisposalGroupClassificationDomain", "presentation": [ "http://passagebio.com/role/PropertyAndEquipmentNetNarrativeFyDetails" ], "lang": { "en-us": { "role": { "label": "Disposal Group Classification [Domain]", "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations." } } }, "auth_ref": [] }, "us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember", "presentation": [ "http://passagebio.com/role/PropertyAndEquipmentNetNarrativeFyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disposal group classified as held for sale or to be disposed of by sale", "label": "Disposal Group, Held-for-Sale or Disposed of by Sale, Not Discontinued Operations [Member]", "documentation": "Disposal group that either has been sold or is classified as held-for-sale. Excludes disposals classified as discontinued operations." } } }, "auth_ref": [ "r2", "r6", "r15" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentType", "presentation": [ "http://passagebio.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "us-gaap_DomesticCountryMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DomesticCountryMember", "presentation": [ "http://passagebio.com/role/IncomeTaxesNetOperatingLossesFyDetails" ], "lang": { "en-us": { "role": { "label": "Domestic Tax Jurisdiction [Member]", "documentation": "Designated federal jurisdiction entitled to levy and collect income tax in country of domicile. Includes, but is not limited to, national jurisdiction for non-U.S. jurisdiction." } } }, "auth_ref": [ "r413" ] }, "pasg_EarlyLeaseTerminationFee": { "xbrltype": "monetaryItemType", "nsuri": "http://passagebio.com/20260721", "localname": "EarlyLeaseTerminationFee", "crdr": "debit", "presentation": [ "http://passagebio.com/role/LeasesQ1Details", "http://passagebio.com/role/PropertyAndEquipmentNetNarrativeQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Amount of expense incurred during the period for early lease termination.", "label": "Early Lease Termination Fee", "terseLabel": "Payment for early lease termination" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EarningsPerShareAbstract", "presentation": [ "http://passagebio.com/role/StatementsOfOperationsAndComprehensiveLossFy", "http://passagebio.com/role/StatementsOfOperationsAndComprehensiveLossQ1" ], "lang": { "en-us": { "role": { "terseLabel": "Per share information:", "label": "Earnings Per Share [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EarningsPerShareBasic", "presentation": [ "http://passagebio.com/role/StatementsOfOperationsAndComprehensiveLossFy", "http://passagebio.com/role/StatementsOfOperationsAndComprehensiveLossQ1" ], "lang": { "en-us": { "role": { "terseLabel": "Net loss per share of common stock, basic", "label": "Earnings Per Share, Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r103", "r130", "r152", "r153", "r154", "r155", "r156", "r157", "r158", "r159", "r163", "r165", "r167", "r168", "r169", "r172", "r304", "r392", "r443", "r448", "r474", "r475", "r576", "r599", "r712" ] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EarningsPerShareDiluted", "presentation": [ "http://passagebio.com/role/StatementsOfOperationsAndComprehensiveLossFy", "http://passagebio.com/role/StatementsOfOperationsAndComprehensiveLossQ1" ], "lang": { "en-us": { "role": { "terseLabel": "Net loss per share of common stock, diluted", "label": "Earnings Per Share, Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r103", "r130", "r152", "r153", "r154", "r155", "r156", "r157", "r158", "r159", "r165", "r167", "r168", "r169", "r172", "r304", "r392", "r443", "r448", "r474", "r475", "r576", "r599", "r712" ] }, "us-gaap_EarningsPerSharePolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EarningsPerSharePolicyTextBlock", "presentation": [ "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesFyPolicies", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesQ1Policies" ], "lang": { "en-us": { "role": { "terseLabel": "Net Loss Per Share", "label": "Earnings Per Share, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements." } } }, "auth_ref": [ "r25", "r26", "r171" ] }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EffectiveIncomeTaxRateContinuingOperations", "calculation": { "http://passagebio.com/role/IncomeTaxesReconciliationOfFederalIncomeTaxRateToEffectiveTaxRateFyDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://passagebio.com/role/IncomeTaxesReconciliationOfFederalIncomeTaxRateToEffectiveTaxRateFyDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Effective tax rate", "label": "Effective Income Tax Rate Reconciliation, Percent", "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r413", "r742" ] }, "us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract", "presentation": [ "http://passagebio.com/role/IncomeTaxesReconciliationOfFederalIncomeTaxRateToEffectiveTaxRateFyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percent", "label": "Effective Income Tax Rate Reconciliation, Percent [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "calculation": { "http://passagebio.com/role/IncomeTaxesReconciliationOfFederalIncomeTaxRateToEffectiveTaxRateFyDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://passagebio.com/role/IncomeTaxesReconciliationOfFederalIncomeTaxRateToEffectiveTaxRateFyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "US federal statutory tax rate", "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent", "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)." } } }, "auth_ref": [ "r141", "r145", "r413", "r434", "r742" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance", "calculation": { "http://passagebio.com/role/IncomeTaxesReconciliationOfFederalIncomeTaxRateToEffectiveTaxRateFyDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://passagebio.com/role/IncomeTaxesReconciliationOfFederalIncomeTaxRateToEffectiveTaxRateFyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Changes in valuation allowances", "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets." } } }, "auth_ref": [ "r416", "r742", "r813", "r818", "r875" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther", "calculation": { "http://passagebio.com/role/IncomeTaxesReconciliationOfFederalIncomeTaxRateToEffectiveTaxRateFyDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://passagebio.com/role/IncomeTaxesReconciliationOfFederalIncomeTaxRateToEffectiveTaxRateFyDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Other", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses." } } }, "auth_ref": [ "r742", "r813", "r818", "r875", "r877" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost", "calculation": { "http://passagebio.com/role/IncomeTaxesReconciliationOfFederalIncomeTaxRateToEffectiveTaxRateFyDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://passagebio.com/role/IncomeTaxesReconciliationOfFederalIncomeTaxRateToEffectiveTaxRateFyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expiration of share-based payment awards", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent", "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement." } } }, "auth_ref": [ "r742", "r813", "r818", "r875", "r877" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount", "crdr": "debit", "calculation": { "http://passagebio.com/role/IncomeTaxesReconciliationOfFederalIncomeTaxRateToEffectiveTaxRateFyDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://passagebio.com/role/IncomeTaxesReconciliationOfFederalIncomeTaxRateToEffectiveTaxRateFyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based payment awards", "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Amount", "documentation": "Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement." } } }, "auth_ref": [ "r874", "r875", "r876" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent", "calculation": { "http://passagebio.com/role/IncomeTaxesReconciliationOfFederalIncomeTaxRateToEffectiveTaxRateFyDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://passagebio.com/role/IncomeTaxesReconciliationOfFederalIncomeTaxRateToEffectiveTaxRateFyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based payment awards", "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Percent", "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement." } } }, "auth_ref": [ "r874", "r875", "r876" ] }, "pasg_EffectiveIncomeTaxRateReconciliationTaxCreditOrphanDrugAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://passagebio.com/20260721", "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditOrphanDrugAmount", "crdr": "credit", "calculation": { "http://passagebio.com/role/IncomeTaxesReconciliationOfFederalIncomeTaxRateToEffectiveTaxRateFyDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://passagebio.com/role/IncomeTaxesReconciliationOfFederalIncomeTaxRateToEffectiveTaxRateFyDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to orphan drug tax credit.", "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Orphan Drug, Amount", "negatedLabel": "Orphan drug tax credits" } } }, "auth_ref": [] }, "pasg_EffectiveIncomeTaxRateReconciliationTaxCreditOrphanDrugPercent": { "xbrltype": "percentItemType", "nsuri": "http://passagebio.com/20260721", "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditOrphanDrugPercent", "calculation": { "http://passagebio.com/role/IncomeTaxesReconciliationOfFederalIncomeTaxRateToEffectiveTaxRateFyDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://passagebio.com/role/IncomeTaxesReconciliationOfFederalIncomeTaxRateToEffectiveTaxRateFyDetails" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to orphan drug tax credit.", "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Orphan Drug, Percent", "negatedLabel": "Orphan drug tax credits" } } }, "auth_ref": [] }, "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsAbstract", "presentation": [ "http://passagebio.com/role/IncomeTaxesReconciliationOfFederalIncomeTaxRateToEffectiveTaxRateFyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax credits", "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Percent [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsResearch", "calculation": { "http://passagebio.com/role/IncomeTaxesReconciliationOfFederalIncomeTaxRateToEffectiveTaxRateFyDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://passagebio.com/role/IncomeTaxesReconciliationOfFederalIncomeTaxRateToEffectiveTaxRateFyDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Research and development tax credits", "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit." } } }, "auth_ref": [ "r742", "r813", "r818", "r875", "r877" ] }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EmployeeRelatedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://passagebio.com/role/AccruedExpensesAndOtherCurrentLiabilitiesFyDetails": { "parentTag": "pasg_AccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://passagebio.com/role/AccruedExpensesAndOtherCurrentLiabilitiesFyDetails", "http://passagebio.com/role/AccruedExpensesAndOtherCurrentLiabilitiesQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation and related benefits", "label": "Employee-related Liabilities, Current", "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r44" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "presentation": [ "http://passagebio.com/role/SharebasedCompensationStockOptionActivityFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationRestrictedStockUnitsQ1Details", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationStockOptionActivityQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average period for recognition", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r390" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions", "crdr": "debit", "presentation": [ "http://passagebio.com/role/SharebasedCompensationRestrictedStockUnitsFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationRestrictedStockUnitsQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Total unrecognized expense", "label": "Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount", "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [ "r873" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "crdr": "debit", "presentation": [ "http://passagebio.com/role/SharebasedCompensationStockOptionActivityFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationStockOptionActivityQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecognized compensation expense related to unvested stock option awards", "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount", "documentation": "Amount of cost to be recognized for option under share-based payment arrangement." } } }, "auth_ref": [ "r873" ] }, "us-gaap_EmployeeSeveranceMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EmployeeSeveranceMember", "presentation": [ "http://passagebio.com/role/LeasesFyDetails", "http://passagebio.com/role/PropertyAndEquipmentNetNarrativeFyDetails", "http://passagebio.com/role/SeveranceFyDetails", "http://passagebio.com/role/SeveranceQ1Details" ], "lang": { "en-us": { "role": { "verboseLabel": "Workforce reduction", "terseLabel": "Employee Severance", "label": "Employee Severance [Member]", "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan." } } }, "auth_ref": [] }, "us-gaap_EmployeeStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EmployeeStockMember", "presentation": [ "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesFyDetails", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Employee stock purchase plan", "label": "Employee Stock [Member]", "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock." } } }, "auth_ref": [] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EmployeeStockOptionMember", "presentation": [ "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationAssumptionsUsedInDeterminingFairValueEarlyExerciseOfStockOptionsQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Employee Stock Option", "label": "Employee Stock Option [Member]", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [ "r847", "r848", "r849", "r850", "r851", "r852", "r853", "r854", "r855", "r856", "r857", "r858", "r859", "r860", "r861", "r862", "r863", "r864", "r865", "r866", "r867", "r868", "r869", "r870", "r871", "r872" ] }, "pasg_EmployeeStockPurchasePlanIssuancePercentageOfCommonStockOutstanding": { "xbrltype": "percentItemType", "nsuri": "http://passagebio.com/20260721", "localname": "EmployeeStockPurchasePlanIssuancePercentageOfCommonStockOutstanding", "presentation": [ "http://passagebio.com/role/SharebasedCompensationEquityIncentivePlanEsppFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationEquityIncentivePlanEsppQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Represents the percentage of total number of shares of the Company's common stock outstanding equal to which shares may be issued under Employee Stock Purchase Plan.", "label": "Employee Stock Purchase Plan Issuance, Percentage Of Common Stock Outstanding", "terseLabel": "Percentage of common stock outstanding" } } }, "auth_ref": [] }, "pasg_EmployeeStockPurchasePlanMaximumAmountOfCommonStockThatCanBePurchased": { "xbrltype": "monetaryItemType", "nsuri": "http://passagebio.com/20260721", "localname": "EmployeeStockPurchasePlanMaximumAmountOfCommonStockThatCanBePurchased", "crdr": "credit", "presentation": [ "http://passagebio.com/role/SharebasedCompensationEquityIncentivePlanEsppFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationEquityIncentivePlanEsppQ1Details" ], "lang": { "en-us": { "role": { "documentation": "The maximum amount of common stock that a participant may accrue rights to purchase for each calendar year in which such right is outstanding.", "label": "Employee Stock Purchase Plan, Maximum Amount Of Common Stock That Can Be Purchased", "terseLabel": "Maximum amount of common stock that can be purchased" } } }, "auth_ref": [] }, "pasg_EmployeeStockPurchasePlanMaximumEmployeeContributionPercentage": { "xbrltype": "percentItemType", "nsuri": "http://passagebio.com/20260721", "localname": "EmployeeStockPurchasePlanMaximumEmployeeContributionPercentage", "presentation": [ "http://passagebio.com/role/SharebasedCompensationEquityIncentivePlanEsppFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationEquityIncentivePlanEsppQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Represents the maximum contribution percentage on eligible compensation by eligible employees under Employee Stock Purchase Plan.", "label": "Employee Stock Purchase Plan, Maximum Employee Contribution Percentage", "terseLabel": "Percentage of maximum employee contribution" } } }, "auth_ref": [] }, "pasg_EmployeeStockPurchasePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://passagebio.com/20260721", "localname": "EmployeeStockPurchasePlanMember", "presentation": [ "http://passagebio.com/role/SharebasedCompensationEquityIncentivePlanEsppFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationEquityIncentivePlanEsppQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to Employee Stock Purchase Plan.", "label": "Employee Stock Purchase Plan [Member]", "terseLabel": "Employee stock purchase plan" } } }, "auth_ref": [] }, "pasg_EmployeeStockPurchasePlanPeriodTillWhichAutomaticIncreaseInRightsGranted": { "xbrltype": "durationItemType", "nsuri": "http://passagebio.com/20260721", "localname": "EmployeeStockPurchasePlanPeriodTillWhichAutomaticIncreaseInRightsGranted", "presentation": [ "http://passagebio.com/role/SharebasedCompensationEquityIncentivePlanEsppFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationEquityIncentivePlanEsppQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Represents the period till which there is automatic annual increase in rights granted under the employee stock purchase plan.", "label": "Employee Stock Purchase Plan, Period Till Which Automatic Increase In Rights Granted", "terseLabel": "Period till which there is automatic increase in rights granted under ESPP" } } }, "auth_ref": [] }, "pasg_EmployeeStockPurchasePlanStockPurchasePricePercentage": { "xbrltype": "percentItemType", "nsuri": "http://passagebio.com/20260721", "localname": "EmployeeStockPurchasePlanStockPurchasePricePercentage", "presentation": [ "http://passagebio.com/role/SharebasedCompensationEquityIncentivePlanEsppFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationEquityIncentivePlanEsppQ1Details" ], "lang": { "en-us": { "role": { "documentation": "The stock purchase price percentage on the lower of the fair market value of the Company's common stock on the first or last day of the respective offering period under the ESPP.", "label": "Employee Stock Purchase Plan, Stock Purchase Price Percentage", "terseLabel": "Percentage of stock purchase price" } } }, "auth_ref": [] }, "pasg_EmployeeStockPurchasePlanThresholdNumberOfSharesThatCanBePurchased": { "xbrltype": "sharesItemType", "nsuri": "http://passagebio.com/20260721", "localname": "EmployeeStockPurchasePlanThresholdNumberOfSharesThatCanBePurchased", "presentation": [ "http://passagebio.com/role/SharebasedCompensationEquityIncentivePlanEsppFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationEquityIncentivePlanEsppQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Threshold number of shares that can be purchased in any single offering period.", "label": "Employee Stock Purchase Plan, Threshold Number Of Shares That Can Be Purchased", "terseLabel": "Number of shares that can be purchased" } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityCentralIndexKey", "presentation": [ "http://passagebio.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r784" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://passagebio.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r784" ] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityFilerCategory", "presentation": [ "http://passagebio.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r784" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityRegistrantName", "presentation": [ "http://passagebio.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r784" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntitySmallBusiness", "presentation": [ "http://passagebio.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r784" ] }, "us-gaap_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EquityAbstract", "lang": { "en-us": { "role": { "label": "Common Stock." } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EquityComponentDomain", "presentation": [ "http://passagebio.com/role/StatementsOfStockholdersEquityFy", "http://passagebio.com/role/StatementsOfStockholdersEquityQ1" ], "lang": { "en-us": { "role": { "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r11", "r101", "r102", "r103", "r126", "r127", "r128", "r147", "r148", "r149", "r151", "r158", "r160", "r162", "r174", "r247", "r248", "r268", "r303", "r329", "r392", "r432", "r433", "r440", "r441", "r442", "r444", "r447", "r448", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r473", "r507", "r508", "r509", "r510", "r511", "r512", "r514", "r516", "r535", "r595", "r616", "r617", "r618", "r632", "r682" ] }, "pasg_EquityIncentivePlan2020Member": { "xbrltype": "domainItemType", "nsuri": "http://passagebio.com/20260721", "localname": "EquityIncentivePlan2020Member", "presentation": [ "http://passagebio.com/role/SharebasedCompensationEquityIncentivePlanEsppFyDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to 2020 Equity Incentive Plan.", "label": "Equity Incentive Plan 2020 [Member]", "terseLabel": "Equity Incentive Plan 2020" } } }, "auth_ref": [] }, "pasg_EquityIncentivePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://passagebio.com/20260721", "localname": "EquityIncentivePlanMember", "presentation": [ "http://passagebio.com/role/SharebasedCompensationEquityIncentivePlanEsppFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationEquityIncentivePlanEsppQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to Equity Incentive Plan.", "label": "Equity Incentive Plan [Member]", "terseLabel": "Equity Incentive Plan" } } }, "auth_ref": [] }, "pasg_EquityInducementPlan2021Member": { "xbrltype": "domainItemType", "nsuri": "http://passagebio.com/20260721", "localname": "EquityInducementPlan2021Member", "presentation": [ "http://passagebio.com/role/SharebasedCompensationEquityIncentivePlanEsppFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationEquityIncentivePlanEsppQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to 2021 Equity Inducement plan.", "label": "Equity Inducement Plan 2021 [Member]", "terseLabel": "Equity inducement plan 2021" } } }, "auth_ref": [] }, "pasg_EstimatedSeveranceAndRelatedCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://passagebio.com/20260721", "localname": "EstimatedSeveranceAndRelatedCosts", "crdr": "credit", "presentation": [ "http://passagebio.com/role/SubsequentEventsQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Amount of aggregate estimated and severance costs to be incurred as a part of restructuring plan.", "label": "Estimated Severance And Related Costs", "terseLabel": "Estimated severance and related costs" } } }, "auth_ref": [] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "presentation": [ "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsNonrecurringBasisFyDetails", "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsQ1Details", "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsRecurringBasisFyDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value of Financial Instruments and Non-Financial Instruments", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r477", "r478", "r488", "r750" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "presentation": [ "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsNonrecurringBasisFyDetails", "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsQ1Details", "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsRecurringBasisFyDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Recurring and Nonrecurring [Table]", "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis." } } }, "auth_ref": [ "r477", "r478", "r488", "r750" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "presentation": [ "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsFyTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of assets measured at fair value on a recurring basis", "label": "Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]", "documentation": "Tabular disclosure of financial instrument measured at fair value on recurring or nonrecurring basis. Includes, but is not limited to, instrument classified in shareholders' equity." } } }, "auth_ref": [ "r750", "r891", "r892", "r897" ] }, "us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueAssetsMeasuredOnNonrecurringBasisTextBlock", "presentation": [ "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsFyTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of non-financial instruments measured at fair value, on a nonrecurring basis", "label": "Fair Value Measurements, Nonrecurring [Table Text Block]", "documentation": "Tabular disclosure of assets and liabilities by class, including financial instruments measured at fair value that are classified in shareholders' equity, if any, that are measured at fair value on a nonrecurring basis in periods after initial recognition (for example, impaired assets). Disclosures may include, but are not limited to: (a) the fair value measurements recorded and the reasons for the measurements and (b) the level within the fair value hierarchy in which the fair value measurements are categorized in their entirety (levels 1, 2, 3)." } } }, "auth_ref": [ "r891", "r892" ] }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueByFairValueHierarchyLevelAxis", "presentation": [ "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsNonrecurringBasisFyDetails", "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsQ1Details", "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsRecurringBasisFyDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value Hierarchy and NAV [Axis]", "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r300", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r476", "r478", "r479", "r480", "r481", "r487", "r488", "r490", "r497", "r542", "r543", "r544", "r703", "r730", "r731", "r734", "r735", "r736", "r737", "r738", "r750", "r755", "r762" ] }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueByMeasurementFrequencyAxis", "presentation": [ "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsNonrecurringBasisFyDetails", "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsQ1Details", "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsRecurringBasisFyDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Frequency [Axis]", "documentation": "Information by measurement frequency." } } }, "auth_ref": [ "r477", "r478", "r479", "r481", "r750", "r894", "r898" ] }, "us-gaap_FairValueDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueDisclosuresAbstract", "lang": { "en-us": { "role": { "label": "Fair Value of Financial Instruments and Non-Financial Instruments" } } }, "auth_ref": [] }, "us-gaap_FairValueDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueDisclosuresTextBlock", "presentation": [ "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsFy", "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsQ1" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value of Financial Instruments and Non-Financial Instruments", "label": "Fair Value Disclosures [Text Block]", "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information." } } }, "auth_ref": [ "r479", "r483", "r485", "r486", "r487", "r490", "r491", "r492", "r493", "r494", "r573", "r750", "r756" ] }, "us-gaap_FairValueInputsLevel1Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueInputsLevel1Member", "presentation": [ "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsNonrecurringBasisFyDetails", "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsRecurringBasisFyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level 1", "label": "Fair Value, Inputs, Level 1 [Member]", "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date." } } }, "auth_ref": [ "r300", "r343", "r348", "r349", "r478", "r488", "r497", "r542", "r703", "r734", "r735", "r736", "r737", "r738", "r750", "r762" ] }, "us-gaap_FairValueInputsLevel2Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueInputsLevel2Member", "presentation": [ "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsNonrecurringBasisFyDetails", "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsRecurringBasisFyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level 2", "label": "Fair Value, Inputs, Level 2 [Member]", "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets." } } }, "auth_ref": [ "r300", "r343", "r348", "r349", "r351", "r478", "r479", "r488", "r497", "r543", "r703", "r730", "r731", "r734", "r735", "r736", "r737", "r738", "r750", "r762" ] }, "us-gaap_FairValueInputsLevel3Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueInputsLevel3Member", "presentation": [ "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsNonrecurringBasisFyDetails", "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsQ1Details", "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsRecurringBasisFyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level 3", "label": "Fair Value, Inputs, Level 3 [Member]", "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r300", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r478", "r479", "r480", "r481", "r488", "r497", "r544", "r703", "r730", "r731", "r734", "r735", "r736", "r737", "r738", "r750", "r755", "r762" ] }, "us-gaap_FairValueMeasurementFrequencyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueMeasurementFrequencyDomain", "presentation": [ "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsNonrecurringBasisFyDetails", "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsQ1Details", "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsRecurringBasisFyDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Frequency [Domain]", "documentation": "Measurement frequency." } } }, "auth_ref": [ "r477", "r478", "r479", "r481", "r750", "r894", "r898" ] }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueMeasurementsFairValueHierarchyDomain", "presentation": [ "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsNonrecurringBasisFyDetails", "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsQ1Details", "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsRecurringBasisFyDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value Hierarchy and NAV [Domain]", "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "auth_ref": [ "r300", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r476", "r478", "r479", "r480", "r481", "r487", "r488", "r490", "r497", "r542", "r543", "r544", "r703", "r730", "r731", "r734", "r735", "r736", "r737", "r738", "r750", "r755", "r762" ] }, "us-gaap_FairValueMeasurementsNonrecurringMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueMeasurementsNonrecurringMember", "presentation": [ "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsNonrecurringBasisFyDetails", "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Nonrecurring basis", "label": "Fair Value, Nonrecurring [Member]", "documentation": "Infrequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, not frequently measured at fair value." } } }, "auth_ref": [ "r477", "r478", "r479", "r481", "r750", "r894" ] }, "us-gaap_FairValueMeasurementsRecurringMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueMeasurementsRecurringMember", "presentation": [ "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsRecurringBasisFyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Recurring", "label": "Fair Value, Recurring [Member]", "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value." } } }, "auth_ref": [ "r750", "r891", "r892", "r893", "r894", "r895", "r898" ] }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueOfFinancialInstrumentsPolicy", "presentation": [ "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesFyPolicies", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesQ1Policies" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value of Financial Instruments", "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments." } } }, "auth_ref": [ "r899" ] }, "us-gaap_FinancialInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinancialInstrumentAxis", "presentation": [ "http://passagebio.com/role/CashCashEquivalentsAndMarketableSecuritiesPortfolioOfMarketableSecuritiesFyDetails", "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsRecurringBasisFyDetails" ], "lang": { "en-us": { "role": { "label": "Financial Instrument [Axis]", "documentation": "Information by type of financial instrument." } } }, "auth_ref": [ "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r249", "r250", "r251", "r252", "r253", "r255", "r256", "r257", "r302", "r326", "r460", "r471", "r495", "r502", "r505", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r546", "r547", "r548", "r549", "r550", "r551", "r552", "r553", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r582", "r596", "r728", "r750", "r753", "r755", "r756", "r757", "r758", "r759", "r760", "r761", "r765", "r799", "r800", "r801", "r802", "r803", "r804", "r805", "r833", "r834", "r835", "r836", "r890", "r893", "r894", "r895", "r896", "r898", "r900", "r901" ] }, "us-gaap_FurnitureAndFixturesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FurnitureAndFixturesMember", "presentation": [ "http://passagebio.com/role/PropertyAndEquipmentNetFyDetails", "http://passagebio.com/role/PropertyAndEquipmentNetQ1Details", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesFyDetails", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Furniture and fixtures", "label": "Furniture and Fixtures [Member]", "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases." } } }, "auth_ref": [] }, "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "GainLossOnSaleOfPropertyPlantEquipment", "crdr": "credit", "presentation": [ "http://passagebio.com/role/LeasesQ1Details", "http://passagebio.com/role/PropertyAndEquipmentNetNarrativeQ1Details", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesFyDetails", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Loss on disposal of property and equipment", "label": "Gain (Loss) on Disposition of Property Plant Equipment", "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property." } } }, "auth_ref": [ "r5" ] }, "pasg_GainLossOnSaleOfTaxCredits": { "xbrltype": "monetaryItemType", "nsuri": "http://passagebio.com/20260721", "localname": "GainLossOnSaleOfTaxCredits", "crdr": "credit", "presentation": [ "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesFyDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of gain (loss) on sale of tax credits.", "label": "Gain (Loss) on Sale of Tax Credits", "terseLabel": "Gain (loss) on sale of tax credits" } } }, "auth_ref": [] }, "us-gaap_GainLossOnTerminationOfLease": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "GainLossOnTerminationOfLease", "crdr": "credit", "calculation": { "http://passagebio.com/role/StatementsOfOperationsAndComprehensiveLossFy": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 4.0 }, "http://passagebio.com/role/StatementsOfCashFlowsQ1": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://passagebio.com/role/LeasesQ1Details", "http://passagebio.com/role/PropertyAndEquipmentNetNarrativeQ1Details", "http://passagebio.com/role/SegmentReportingQ1Details", "http://passagebio.com/role/StatementsOfCashFlowsQ1", "http://passagebio.com/role/StatementsOfOperationsAndComprehensiveLossFy", "http://passagebio.com/role/StatementsOfOperationsAndComprehensiveLossQ1" ], "lang": { "en-us": { "role": { "negatedLabel": "Net gain on lease termination", "terseLabel": "Net gain on lease termination", "label": "Gain (Loss) on Termination of Lease", "documentation": "Amount of gain (loss) on termination of lease before expiration of lease term." } } }, "auth_ref": [ "r517" ] }, "pasg_GainLossOnWriteOffOfOperatingLeases": { "xbrltype": "monetaryItemType", "nsuri": "http://passagebio.com/20260721", "localname": "GainLossOnWriteOffOfOperatingLeases", "crdr": "credit", "presentation": [ "http://passagebio.com/role/LeasesQ1Details", "http://passagebio.com/role/PropertyAndEquipmentNetNarrativeQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on write-off of assets and liabilities for operating leases.", "label": "Gain (Loss) On Write Off Of Operating Leases", "terseLabel": "Gain (loss) on write-off of operating leases" } } }, "auth_ref": [] }, "pasg_GeneralAndAdministrativeDepreciationAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://passagebio.com/20260721", "localname": "GeneralAndAdministrativeDepreciationAndAmortization", "crdr": "debit", "calculation": { "http://passagebio.com/role/SegmentReportingFyDetails": { "parentTag": "us-gaap_GeneralAndAdministrativeExpense", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://passagebio.com/role/SegmentReportingFyDetails", "http://passagebio.com/role/SegmentReportingQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Amount of expenses in the period for usage of depreciation and amortization attributable to managing and administering the affairs of an entity", "label": "General and Administrative, Depreciation and Amortization", "terseLabel": "Depreciation and amortization" } } }, "auth_ref": [] }, "us-gaap_GeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "GeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://passagebio.com/role/StatementsOfOperationsAndComprehensiveLossFy": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 1.0 }, "http://passagebio.com/role/SegmentReportingFyDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://passagebio.com/role/SegmentReportingFyDetails", "http://passagebio.com/role/SegmentReportingQ1Details", "http://passagebio.com/role/StatementsOfOperationsAndComprehensiveLossFy", "http://passagebio.com/role/StatementsOfOperationsAndComprehensiveLossQ1" ], "lang": { "en-us": { "role": { "terseLabel": "General and administrative", "totalLabel": "Total general and administrative expenses", "label": "General and Administrative Expense", "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line." } } }, "auth_ref": [ "r59", "r666" ] }, "us-gaap_GeneralAndAdministrativeExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "GeneralAndAdministrativeExpenseAbstract", "presentation": [ "http://passagebio.com/role/SegmentReportingFyDetails", "http://passagebio.com/role/SegmentReportingQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "General and administrative", "label": "General and Administrative Expense [Abstract]" } } }, "auth_ref": [] }, "us-gaap_GeneralAndAdministrativeExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "GeneralAndAdministrativeExpenseMember", "presentation": [ "http://passagebio.com/role/SeveranceFyDetails", "http://passagebio.com/role/SeveranceQ1Details", "http://passagebio.com/role/SharebasedCompensationSharebasedCompensationExpenseFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationSharebasedCompensationExpenseQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "General and administrative expense", "verboseLabel": "General and administrative", "label": "General and Administrative Expense [Member]", "documentation": "Primary financial statement caption encompassing general and administrative expense." } } }, "auth_ref": [ "r59" ] }, "pasg_GeneralAndAdministrativeLaborAndRelatedExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://passagebio.com/20260721", "localname": "GeneralAndAdministrativeLaborAndRelatedExpenses", "crdr": "debit", "calculation": { "http://passagebio.com/role/SegmentReportingFyDetails": { "parentTag": "us-gaap_GeneralAndAdministrativeExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://passagebio.com/role/SegmentReportingFyDetails", "http://passagebio.com/role/SegmentReportingQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit, excluding wages and other benefits incurred for employees in research and development phase of the medicines.", "label": "General And Administrative, Labor And Related Expenses", "verboseLabel": "Wages, benefits, and other payroll" } } }, "auth_ref": [] }, "pasg_GeneralAndAdministrativeShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://passagebio.com/20260721", "localname": "GeneralAndAdministrativeShareBasedCompensation", "crdr": "debit", "calculation": { "http://passagebio.com/role/SegmentReportingFyDetails": { "parentTag": "us-gaap_GeneralAndAdministrativeExpense", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://passagebio.com/role/SegmentReportingFyDetails", "http://passagebio.com/role/SegmentReportingQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Amount of expenses in the period for usage of share based compensation attributable to managing and administering the affairs of an entity.", "label": "General and Administrative, Share Based Compensation", "terseLabel": "Share-based compensation" } } }, "auth_ref": [] }, "pasg_GeneralAndAdministrativeThirdPartyCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://passagebio.com/20260721", "localname": "GeneralAndAdministrativeThirdPartyCosts", "crdr": "debit", "calculation": { "http://passagebio.com/role/SegmentReportingFyDetails": { "parentTag": "us-gaap_GeneralAndAdministrativeExpense", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://passagebio.com/role/SegmentReportingFyDetails", "http://passagebio.com/role/SegmentReportingQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Amount of expenses in the period for usage of third party costs attributable to managing and administering the affairs of an entity.", "label": "General and Administrative, Third Party Costs", "terseLabel": "Third-party costs" } } }, "auth_ref": [] }, "pasg_GeneticMedicinesSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://passagebio.com/20260721", "localname": "GeneticMedicinesSegmentMember", "presentation": [ "http://passagebio.com/role/SegmentReportingFyDetails", "http://passagebio.com/role/SegmentReportingQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to developing and advancing of genetic medicines.", "label": "Genetic Medicines Segment [Member]", "terseLabel": "Genetic Medicines Segment" } } }, "auth_ref": [] }, "us-gaap_ImpairmentOfLeasehold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ImpairmentOfLeasehold", "crdr": "debit", "presentation": [ "http://passagebio.com/role/LeasesFyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Impairment of leasehold improvements", "label": "Impairment of Leasehold", "documentation": "The adjustment to reduce the value of existing agreements that specify the lessee's rights to use the leased property. This expense is charged when the estimates of future profits generated by the leased property are reduced." } } }, "auth_ref": [ "r5", "r29" ] }, "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ImpairmentOfLongLivedAssetsHeldForUse", "crdr": "debit", "calculation": { "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsNonrecurringBasisFyDetails": { "parentTag": "us-gaap_AssetImpairmentCharges", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsNonrecurringBasisFyDetails", "http://passagebio.com/role/LeasesFyDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Property and equipment, net", "terseLabel": "Impairment expenses for property and equipment", "label": "Impairment, Long-Lived Asset, Held-for-Use", "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale)." } } }, "auth_ref": [ "r5", "r29", "r71", "r131", "r706", "r751" ] }, "us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ImpairmentOfLongLivedAssetsToBeDisposedOf", "crdr": "debit", "presentation": [ "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsQ1Details", "http://passagebio.com/role/PropertyAndEquipmentNetNarrativeFyDetails", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesFyDetails", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Impairment of property and equipment", "verboseLabel": "Impairment of long-lived assets", "label": "Impairment of Long-Lived Assets to be Disposed of", "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale." } } }, "auth_ref": [ "r5", "r69", "r752" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign", "crdr": "credit", "presentation": [ "http://passagebio.com/role/IncomeTaxesFyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign pre-tax income or losses", "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign", "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile." } } }, "auth_ref": [ "r141", "r144", "r412" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Statements of Operations and Comprehensive Loss" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeStatementLocationAxis", "presentation": [ "http://passagebio.com/role/SeveranceFyDetails", "http://passagebio.com/role/SeveranceQ1Details", "http://passagebio.com/role/SharebasedCompensationSharebasedCompensationExpenseFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationSharebasedCompensationExpenseQ1Details" ], "lang": { "en-us": { "role": { "label": "Statement of Income Location, Balance [Axis]", "documentation": "Information by location in statement of income where disaggregated amount is reported." } } }, "auth_ref": [ "r269", "r271", "r276", "r456", "r457", "r458", "r459", "r482", "r484", "r489", "r504", "r505", "r506", "r613", "r615", "r667", "r701", "r703", "r743", "r744", "r748", "r749", "r754", "r762", "r883", "r884", "r925" ] }, "us-gaap_IncomeStatementLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeStatementLocationDomain", "presentation": [ "http://passagebio.com/role/SeveranceFyDetails", "http://passagebio.com/role/SeveranceQ1Details", "http://passagebio.com/role/SharebasedCompensationSharebasedCompensationExpenseFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationSharebasedCompensationExpenseQ1Details" ], "lang": { "en-us": { "role": { "label": "Statement of Income Location, Balance [Domain]", "documentation": "Location in statement of income where disaggregated amount is reported." } } }, "auth_ref": [ "r271", "r276", "r456", "r457", "r458", "r459", "r482", "r484", "r489", "r504", "r505", "r506", "r613", "r615", "r667", "r701", "r703", "r743", "r744", "r748", "r749", "r754", "r762", "r883", "r884", "r925" ] }, "us-gaap_IncomeTaxAuthorityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeTaxAuthorityAxis", "presentation": [ "http://passagebio.com/role/IncomeTaxesNetOperatingLossesFyDetails" ], "lang": { "en-us": { "role": { "label": "Income Tax Jurisdiction [Axis]", "documentation": "Information by income tax jurisdiction." } } }, "auth_ref": [ "r137", "r413", "r414", "r420", "r429", "r742", "r881" ] }, "us-gaap_IncomeTaxAuthorityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeTaxAuthorityDomain", "presentation": [ "http://passagebio.com/role/IncomeTaxesNetOperatingLossesFyDetails" ], "lang": { "en-us": { "role": { "label": "Income Tax Jurisdiction [Domain]", "documentation": "Income tax jurisdiction." } } }, "auth_ref": [ "r137", "r413", "r414", "r420", "r429", "r742", "r881" ] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Income Taxes" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://passagebio.com/role/IncomeTaxesFy" ], "lang": { "en-us": { "role": { "terseLabel": "Income Taxes", "label": "Income Tax Disclosure [Text Block]", "documentation": "The entire disclosure for income tax." } } }, "auth_ref": [ "r141", "r145", "r406", "r413", "r417", "r418", "r419", "r421", "r427", "r435", "r437", "r438", "r439", "r581", "r623", "r631", "r742" ] }, "us-gaap_IncomeTaxExaminationDescription": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeTaxExaminationDescription", "presentation": [ "http://passagebio.com/role/IncomeTaxesNetOperatingLossesFyDetails" ], "lang": { "en-us": { "role": { "label": "Income Tax Examination, Description", "documentation": "A brief description of status of the tax examination, significant findings to date, and the entity's position with respect to the findings." } } }, "auth_ref": [ "r879" ] }, "us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeTaxExaminationPenaltiesAndInterestAccrued", "crdr": "credit", "presentation": [ "http://passagebio.com/role/IncomeTaxesNetOperatingLossesFyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued interest or penalties related to uncertain tax positions", "label": "Income Tax Examination, Penalties and Interest Accrued", "documentation": "The amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations." } } }, "auth_ref": [ "r878" ] }, "us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeTaxExaminationPenaltiesAndInterestExpense", "crdr": "debit", "presentation": [ "http://passagebio.com/role/IncomeTaxesNetOperatingLossesFyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income tax examination, penalties and interest expense", "label": "Income Tax Examination, Penalties and Interest Expense", "documentation": "The sum of the amounts of estimated penalties and interest recognized in the period arising from income tax examinations." } } }, "auth_ref": [ "r878" ] }, "us-gaap_IncomeTaxExaminationYearUnderExamination": { "xbrltype": "gYearListItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeTaxExaminationYearUnderExamination", "presentation": [ "http://passagebio.com/role/IncomeTaxesNetOperatingLossesFyDetails" ], "lang": { "en-us": { "role": { "label": "Income Tax Examination, Year under Examination", "documentation": "Tax year being audited in the income tax examination, in YYYY format." } } }, "auth_ref": [] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://passagebio.com/role/IncomeTaxesReconciliationOfFederalIncomeTaxRateToEffectiveTaxRateFyDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://passagebio.com/role/IncomeTaxesReconciliationOfFederalIncomeTaxRateToEffectiveTaxRateFyDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Effective tax rate", "label": "Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r91", "r98", "r141", "r161", "r162", "r173", "r193", "r207", "r411", "r413", "r436", "r600", "r707", "r709", "r711", "r742" ] }, "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract", "presentation": [ "http://passagebio.com/role/IncomeTaxesReconciliationOfFederalIncomeTaxRateToEffectiveTaxRateFyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount", "label": "Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeTaxPolicyTextBlock", "presentation": [ "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesFyPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Income Taxes", "label": "Income Tax, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements." } } }, "auth_ref": [ "r125", "r407", "r408", "r421", "r422", "r426", "r431", "r625" ] }, "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance", "crdr": "debit", "calculation": { "http://passagebio.com/role/IncomeTaxesReconciliationOfFederalIncomeTaxRateToEffectiveTaxRateFyDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://passagebio.com/role/IncomeTaxesReconciliationOfFederalIncomeTaxRateToEffectiveTaxRateFyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Changes in valuation allowances", "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets." } } }, "auth_ref": [ "r416", "r742", "r875" ] }, "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "crdr": "debit", "calculation": { "http://passagebio.com/role/IncomeTaxesReconciliationOfFederalIncomeTaxRateToEffectiveTaxRateFyDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://passagebio.com/role/IncomeTaxesReconciliationOfFederalIncomeTaxRateToEffectiveTaxRateFyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "US federal statutory tax rate", "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount", "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations." } } }, "auth_ref": [ "r413", "r742" ] }, "us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeTaxReconciliationNondeductibleExpenseOther", "crdr": "debit", "calculation": { "http://passagebio.com/role/IncomeTaxesReconciliationOfFederalIncomeTaxRateToEffectiveTaxRateFyDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://passagebio.com/role/IncomeTaxesReconciliationOfFederalIncomeTaxRateToEffectiveTaxRateFyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses." } } }, "auth_ref": [ "r742", "r875", "r877" ] }, "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost", "crdr": "debit", "calculation": { "http://passagebio.com/role/IncomeTaxesReconciliationOfFederalIncomeTaxRateToEffectiveTaxRateFyDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://passagebio.com/role/IncomeTaxesReconciliationOfFederalIncomeTaxRateToEffectiveTaxRateFyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expiration of share-based payment awards", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount", "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement." } } }, "auth_ref": [ "r742", "r875", "r877" ] }, "us-gaap_IncomeTaxReconciliationTaxCreditsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeTaxReconciliationTaxCreditsAbstract", "presentation": [ "http://passagebio.com/role/IncomeTaxesReconciliationOfFederalIncomeTaxRateToEffectiveTaxRateFyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax credits", "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Amount [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxReconciliationTaxCreditsResearch": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeTaxReconciliationTaxCreditsResearch", "crdr": "credit", "calculation": { "http://passagebio.com/role/IncomeTaxesReconciliationOfFederalIncomeTaxRateToEffectiveTaxRateFyDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://passagebio.com/role/IncomeTaxesReconciliationOfFederalIncomeTaxRateToEffectiveTaxRateFyDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Research and development tax credits", "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit." } } }, "auth_ref": [ "r742", "r875", "r877" ] }, "us-gaap_IncomeTaxesPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeTaxesPaidNet", "crdr": "credit", "presentation": [ "http://passagebio.com/role/IncomeTaxesFyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income tax payments", "label": "Income Taxes Paid, Net", "documentation": "Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax." } } }, "auth_ref": [ "r24", "r137", "r428", "r429" ] }, "us-gaap_IncreaseDecreaseInAccountsPayableTrade": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncreaseDecreaseInAccountsPayableTrade", "crdr": "debit", "calculation": { "http://passagebio.com/role/StatementsOfCashFlowsFy": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 }, "http://passagebio.com/role/StatementsOfCashFlowsQ1": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://passagebio.com/role/StatementsOfCashFlowsFy", "http://passagebio.com/role/StatementsOfCashFlowsQ1" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable", "label": "Increase (Decrease) in Accounts Payable, Trade", "documentation": "Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services." } } }, "auth_ref": [ "r4" ] }, "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities", "crdr": "debit", "calculation": { "http://passagebio.com/role/StatementsOfCashFlowsFy": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 6.0 }, "http://passagebio.com/role/StatementsOfCashFlowsQ1": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://passagebio.com/role/StatementsOfCashFlowsFy", "http://passagebio.com/role/StatementsOfCashFlowsQ1" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued expenses and other current liabilities", "label": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities", "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other." } } }, "auth_ref": [ "r811" ] }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncreaseDecreaseInContractWithCustomerLiability", "crdr": "debit", "calculation": { "http://passagebio.com/role/StatementsOfCashFlowsFy": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 5.0 }, "http://passagebio.com/role/StatementsOfCashFlowsQ1": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://passagebio.com/role/StatementsOfCashFlowsFy", "http://passagebio.com/role/StatementsOfCashFlowsQ1" ], "lang": { "en-us": { "role": { "terseLabel": "Non-refundable sublicense and transition services payments received", "label": "Increase (Decrease) in Contract with Customer, Liability", "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable." } } }, "auth_ref": [ "r571", "r811" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://passagebio.com/role/StatementsOfCashFlowsFy", "http://passagebio.com/role/StatementsOfCashFlowsQ1" ], "lang": { "en-us": { "role": { "terseLabel": "Changes in operating assets and liabilities:", "label": "Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "crdr": "credit", "calculation": { "http://passagebio.com/role/StatementsOfCashFlowsFy": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 3.0 }, "http://passagebio.com/role/StatementsOfCashFlowsQ1": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://passagebio.com/role/StatementsOfCashFlowsFy", "http://passagebio.com/role/StatementsOfCashFlowsQ1" ], "lang": { "en-us": { "role": { "negatedLabel": "Prepaid expenses and other current assets, and other assets", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other." } } }, "auth_ref": [ "r4" ] }, "pasg_IncreaseDecreaseInPrepaidResearchAndDevelopment": { "xbrltype": "monetaryItemType", "nsuri": "http://passagebio.com/20260721", "localname": "IncreaseDecreaseInPrepaidResearchAndDevelopment", "crdr": "credit", "calculation": { "http://passagebio.com/role/StatementsOfCashFlowsFy": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 4.0 }, "http://passagebio.com/role/StatementsOfCashFlowsQ1": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://passagebio.com/role/StatementsOfCashFlowsFy", "http://passagebio.com/role/StatementsOfCashFlowsQ1" ], "lang": { "en-us": { "role": { "documentation": "The amount of increase (decrease) in prepaid research and development.", "label": "Increase (Decrease) In Prepaid Research and Development", "negatedLabel": "Prepaid research and development" } } }, "auth_ref": [] }, "pasg_IncreaseDecreaseInRightOfUseAssetsAndOperatingLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://passagebio.com/20260721", "localname": "IncreaseDecreaseInRightOfUseAssetsAndOperatingLeaseLiabilities", "crdr": "credit", "calculation": { "http://passagebio.com/role/StatementsOfCashFlowsFy": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 1.0 }, "http://passagebio.com/role/StatementsOfCashFlowsQ1": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://passagebio.com/role/StatementsOfCashFlowsFy", "http://passagebio.com/role/StatementsOfCashFlowsQ1" ], "lang": { "en-us": { "role": { "documentation": "The amount of increase (decrease) during the period in the carrying value of right of use assets and operating lease liabilities.", "label": "Increase (Decrease) in Right of Use Assets and Operating Lease Liabilities", "negatedLabel": "Right of use assets and operating lease liabilities" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "presentation": [ "http://passagebio.com/role/StatementsOfStockholdersEquityFy", "http://passagebio.com/role/StatementsOfStockholdersEquityQ1" ], "lang": { "en-us": { "role": { "terseLabel": "Stockholders' equity", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "pasg_InterimFinancialStatementsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://passagebio.com/20260721", "localname": "InterimFinancialStatementsPolicyTextBlock", "presentation": [ "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesQ1Policies" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for interim financial statements.", "label": "Interim Financial Statements [Policy Text Block]", "terseLabel": "Interim Financial Statements" } } }, "auth_ref": [] }, "us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "InvestmentIncomeNetAmortizationOfDiscountAndPremium", "crdr": "credit", "presentation": [ "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesFyDetails", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization of premium and discount", "label": "Investment Income, Net, Amortization of Discount and Premium", "documentation": "Amount of accretion (amortization) of purchase discount (premium) on nonoperating securities." } } }, "auth_ref": [ "r61" ] }, "pasg_LaboratoryEquipmentAndCertainOtherAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://passagebio.com/20260721", "localname": "LaboratoryEquipmentAndCertainOtherAssetsMember", "presentation": [ "http://passagebio.com/role/PropertyAndEquipmentNetNarrativeFyDetails", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesFyDetails", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to laboratory equipment and certain other assets.", "label": "Laboratory Equipment And Certain Other Assets [Member]", "terseLabel": "Laboratory equipment and certain other assets" } } }, "auth_ref": [] }, "pasg_LaboratoryEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://passagebio.com/20260721", "localname": "LaboratoryEquipmentMember", "presentation": [ "http://passagebio.com/role/PropertyAndEquipmentNetFyDetails", "http://passagebio.com/role/PropertyAndEquipmentNetNarrativeFyDetails", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesFyDetails", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to Laboratory equipment.", "label": "Laboratory equipment [Member]", "terseLabel": "Laboratory equipment" } } }, "auth_ref": [] }, "us-gaap_LeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LeaseCost", "crdr": "debit", "calculation": { "http://passagebio.com/role/LeasesOperatingLeaseCostFyDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://passagebio.com/role/LeasesOperatingLeaseCostFyDetails", "http://passagebio.com/role/LeasesOperatingLeaseCostQ1Details" ], "lang": { "en-us": { "role": { "totalLabel": "Lease expense", "label": "Lease, Cost", "documentation": "Amount of lease cost recognized by lessee for lease contract." } } }, "auth_ref": [ "r524", "r763" ] }, "us-gaap_LeaseCostTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LeaseCostTableTextBlock", "presentation": [ "http://passagebio.com/role/LeasesFyTables", "http://passagebio.com/role/LeasesQ1Tables" ], "lang": { "en-us": { "role": { "verboseLabel": "Summary of operating leases", "label": "Lease, Cost [Table Text Block]", "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income." } } }, "auth_ref": [ "r910" ] }, "pasg_LeaseLiabilityForOperatingLeasePeriodDecreaseDueToLeaseTermination": { "xbrltype": "monetaryItemType", "nsuri": "http://passagebio.com/20260721", "localname": "LeaseLiabilityForOperatingLeasePeriodDecreaseDueToLeaseTermination", "crdr": "credit", "presentation": [ "http://passagebio.com/role/LeasesQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Lease Liability for Operating Lease, Period Decrease due to Lease Termination.", "label": "Lease Liability For Operating Lease, Period Decrease due to Lease Termination" } } }, "auth_ref": [] }, "us-gaap_LeaseholdsAndLeaseholdImprovementsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LeaseholdsAndLeaseholdImprovementsMember", "presentation": [ "http://passagebio.com/role/PropertyAndEquipmentNetFyDetails", "http://passagebio.com/role/PropertyAndEquipmentNetQ1Details", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesFyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Leasehold improvements", "label": "Leaseholds and Leasehold Improvements [Member]", "documentation": "Asset held by lessee under finance lease and addition or improvement to asset held under lease arrangement." } } }, "auth_ref": [ "r70" ] }, "us-gaap_LeasesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LeasesAbstract", "lang": { "en-us": { "role": { "label": "Leases" } } }, "auth_ref": [] }, "us-gaap_LesseeLeaseDescriptionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LesseeLeaseDescriptionLineItems", "presentation": [ "http://passagebio.com/role/LeasesFyDetails", "http://passagebio.com/role/LeasesQ1Details" ], "lang": { "en-us": { "role": { "label": "Lessee, Lease, Description [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r522", "r534" ] }, "us-gaap_LesseeLeaseDescriptionTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LesseeLeaseDescriptionTable", "presentation": [ "http://passagebio.com/role/LeasesFyDetails", "http://passagebio.com/role/LeasesQ1Details" ], "lang": { "en-us": { "role": { "label": "Lessee, Lease, Description [Table]", "documentation": "Disclosure of information about lessee's leases." } } }, "auth_ref": [ "r522", "r534" ] }, "us-gaap_LesseeLeasesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LesseeLeasesPolicyTextBlock", "presentation": [ "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesFyPolicies", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesQ1Policies" ], "lang": { "en-us": { "role": { "terseLabel": "Leasing", "label": "Lessee, Leases [Policy Text Block]", "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee." } } }, "auth_ref": [ "r521" ] }, "us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend": { "xbrltype": "booleanItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LesseeOperatingLeaseExistenceOfOptionToExtend", "presentation": [ "http://passagebio.com/role/LeasesFyDetails", "http://passagebio.com/role/LeasesQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Option to extend lease", "label": "Lessee, Operating Lease, Existence of Option to Extend [true false]", "documentation": "Indicates (true false) whether lessee has option to extend operating lease." } } }, "auth_ref": [ "r523" ] }, "us-gaap_LesseeOperatingLeaseExistenceOfOptionToTerminate": { "xbrltype": "booleanItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LesseeOperatingLeaseExistenceOfOptionToTerminate", "presentation": [ "http://passagebio.com/role/LeasesFyDetails", "http://passagebio.com/role/LeasesQ1Details" ], "lang": { "en-us": { "role": { "verboseLabel": "Option to terminate lease", "label": "Lessee, Operating Lease, Existence of Option to Terminate [true false]", "documentation": "Indicates (true false) whether lessee has option to terminate operating lease." } } }, "auth_ref": [ "r523" ] }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "presentation": [ "http://passagebio.com/role/LeasesFyTables", "http://passagebio.com/role/LeasesQ1Tables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of future minimum rental payments for operating leases", "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]", "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position." } } }, "auth_ref": [ "r911" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "crdr": "credit", "calculation": { "http://passagebio.com/role/LeasesFyDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://passagebio.com/role/LeasesFyDetailsCalc01": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://passagebio.com/role/LeasesQ1DetailsCalc01": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://passagebio.com/role/LeasesFyDetails", "http://passagebio.com/role/LeasesQ1Details" ], "lang": { "en-us": { "role": { "totalLabel": "Total undiscounted lease payments", "label": "Lessee, Operating Lease, Liability, to be Paid", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease." } } }, "auth_ref": [ "r532", "r814", "r819", "r921" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "crdr": "credit", "calculation": { "http://passagebio.com/role/LeasesFyDetailsCalc01": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://passagebio.com/role/LeasesFyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Thereafter", "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r532", "r814", "r819", "r921" ] }, "pasg_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://passagebio.com/20260721", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour", "crdr": "credit", "calculation": { "http://passagebio.com/role/LeasesQ1DetailsCalc01": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://passagebio.com/role/LeasesQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee Operating Lease Liability Payments Due After Year Four", "terseLabel": "Thereafter" } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "crdr": "credit", "calculation": { "http://passagebio.com/role/LeasesFyDetailsCalc01": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 1.0 }, "http://passagebio.com/role/LeasesQ1DetailsCalc01": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://passagebio.com/role/LeasesFyDetails", "http://passagebio.com/role/LeasesQ1Details" ], "lang": { "en-us": { "role": { "label": "2026", "verboseLabel": "2027", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r532", "r814", "r819", "r921" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "crdr": "credit", "calculation": { "http://passagebio.com/role/LeasesFyDetailsCalc01": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://passagebio.com/role/LeasesFyDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "2030", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r532", "r814", "r819", "r921" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "crdr": "credit", "calculation": { "http://passagebio.com/role/LeasesFyDetailsCalc01": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 4.0 }, "http://passagebio.com/role/LeasesQ1DetailsCalc01": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://passagebio.com/role/LeasesFyDetails", "http://passagebio.com/role/LeasesQ1Details" ], "lang": { "en-us": { "role": { "label": "2029", "verboseLabel": "2030", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r532", "r814", "r819", "r921" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "crdr": "credit", "calculation": { "http://passagebio.com/role/LeasesFyDetailsCalc01": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 3.0 }, "http://passagebio.com/role/LeasesQ1DetailsCalc01": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://passagebio.com/role/LeasesFyDetails", "http://passagebio.com/role/LeasesQ1Details" ], "lang": { "en-us": { "role": { "label": "2028", "verboseLabel": "2029", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r532", "r814", "r819", "r921" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "crdr": "credit", "calculation": { "http://passagebio.com/role/LeasesFyDetailsCalc01": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 2.0 }, "http://passagebio.com/role/LeasesQ1DetailsCalc01": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://passagebio.com/role/LeasesFyDetails", "http://passagebio.com/role/LeasesQ1Details" ], "lang": { "en-us": { "role": { "label": "2027", "verboseLabel": "2028", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r532", "r814", "r819", "r921" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "crdr": "credit", "calculation": { "http://passagebio.com/role/LeasesQ1DetailsCalc01": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://passagebio.com/role/LeasesQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "2026", "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year." } } }, "auth_ref": [ "r911" ] }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "crdr": "credit", "calculation": { "http://passagebio.com/role/LeasesFyDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://passagebio.com/role/LeasesFyDetails", "http://passagebio.com/role/LeasesQ1Details" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: imputed interest", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease." } } }, "auth_ref": [ "r532" ] }, "pasg_LesseeOperatingLeaseNoticePeriodForTerminationOfLease": { "xbrltype": "durationItemType", "nsuri": "http://passagebio.com/20260721", "localname": "LesseeOperatingLeaseNoticePeriodForTerminationOfLease", "presentation": [ "http://passagebio.com/role/LeasesFyDetails", "http://passagebio.com/role/LeasesQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Represents the notice period for termination of lease.", "label": "Lessee, Operating Lease, Notice Period for Termination of Lease", "terseLabel": "Notice Period for termination lease" } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LesseeOperatingLeaseRemainingLeaseTerm", "presentation": [ "http://passagebio.com/role/LeasesFyDetails", "http://passagebio.com/role/LeasesQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Renewal term of lease", "label": "Lessee, Operating Lease, Remaining Lease Term", "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r534", "r908" ] }, "us-gaap_LesseeOperatingLeaseTermOfContract": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LesseeOperatingLeaseTermOfContract", "presentation": [ "http://passagebio.com/role/LeasesFyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Term of Contract", "label": "Lessee, Operating Lease, Term of Contract", "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r909" ] }, "us-gaap_LesseeOperatingLeasesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LesseeOperatingLeasesTextBlock", "presentation": [ "http://passagebio.com/role/LeasesFy", "http://passagebio.com/role/LeasesQ1" ], "lang": { "en-us": { "role": { "terseLabel": "Leases", "label": "Lessee, Operating Leases [Text Block]", "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability." } } }, "auth_ref": [ "r515" ] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://passagebio.com/role/BalanceSheetsFy": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://passagebio.com/role/BalanceSheetsFy", "http://passagebio.com/role/BalanceSheetsQ1" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities", "label": "Liabilities", "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others." } } }, "auth_ref": [ "r17", "r43", "r44", "r45", "r46", "r47", "r48", "r49", "r141", "r142", "r143", "r246", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r453", "r454", "r455", "r503", "r643", "r716", "r732", "r783", "r842", "r912", "r913" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://passagebio.com/role/BalanceSheetsFy": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://passagebio.com/role/BalanceSheetsFy", "http://passagebio.com/role/BalanceSheetsQ1" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities and stockholders' equity", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r56", "r84", "r590", "r764", "r770", "r771", "r813", "r817", "r837", "r905" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://passagebio.com/role/BalanceSheetsFy", "http://passagebio.com/role/BalanceSheetsQ1" ], "lang": { "en-us": { "role": { "terseLabel": "Liabilities and stockholders' equity", "label": "Liabilities and Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://passagebio.com/role/BalanceSheetsFy": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://passagebio.com/role/BalanceSheetsFy", "http://passagebio.com/role/BalanceSheetsQ1" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r45", "r108", "r141", "r142", "r143", "r246", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r453", "r454", "r455", "r503", "r764", "r842", "r912", "r913" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://passagebio.com/role/BalanceSheetsFy", "http://passagebio.com/role/BalanceSheetsQ1" ], "lang": { "en-us": { "role": { "terseLabel": "Current liabilities:", "label": "Liabilities, Current [Abstract]" } } }, "auth_ref": [] }, "pasg_LicenseFeeDueAndReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://passagebio.com/20260721", "localname": "LicenseFeeDueAndReceivable", "crdr": "debit", "presentation": [ "http://passagebio.com/role/GemmaLicenseAgreementQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Amount of license fee due and receivable as of the balance sheet date under the license agreement.", "label": "License Fee Due And Receivable", "terseLabel": "Amount of license fee due and receivables" } } }, "auth_ref": [] }, "pasg_LocalTaxAuthoritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://passagebio.com/20260721", "localname": "LocalTaxAuthoritiesMember", "presentation": [ "http://passagebio.com/role/IncomeTaxesNetOperatingLossesFyDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to local tax authorities.", "label": "Local [Member]", "terseLabel": "Local" } } }, "auth_ref": [] }, "us-gaap_LongLivedAssetsHeldForSaleByAssetTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LongLivedAssetsHeldForSaleByAssetTypeAxis", "presentation": [ "http://passagebio.com/role/PropertyAndEquipmentNetNarrativeFyDetails", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesFyDetails" ], "lang": { "en-us": { "role": { "label": "Long-Lived Asset, Held-for-Sale, Type [Axis]", "documentation": "Information by long-lived asset held for sale." } } }, "auth_ref": [ "r8" ] }, "us-gaap_LongLivedAssetsHeldForSaleNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LongLivedAssetsHeldForSaleNameDomain", "presentation": [ "http://passagebio.com/role/PropertyAndEquipmentNetNarrativeFyDetails", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesFyDetails" ], "lang": { "en-us": { "role": { "label": "Long-Lived Assets Held-for-Sale, Name [Domain]", "documentation": "A name of the assets to be disposed." } } }, "auth_ref": [ "r8" ] }, "pasg_LongTermLicenseFeeDueAndReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://passagebio.com/20260721", "localname": "LongTermLicenseFeeDueAndReceivable", "crdr": "debit", "presentation": [ "http://passagebio.com/role/GemmaLicenseAgreementFyDetails", "http://passagebio.com/role/GemmaLicenseAgreementQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Amount of license fee due and receivable in long-term as of the balance sheet date under the license agreement.", "label": "Long-Term License Fee Due And Receivable", "terseLabel": "Long-term license fee due and receivables" } } }, "auth_ref": [] }, "us-gaap_LossContingencyAccrualAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LossContingencyAccrualAtCarryingValue", "crdr": "credit", "presentation": [ "http://passagebio.com/role/CommitmentsAndContingenciesCollaborationAgreementsFyDetails", "http://passagebio.com/role/CommitmentsAndContingenciesCollaborationAgreementsQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Amount of loss contingency", "label": "Loss Contingency Accrual", "documentation": "Amount of loss contingency liability." } } }, "auth_ref": [ "r285", "r798" ] }, "pasg_LossContingencySharesAgreedByDefendant": { "xbrltype": "sharesItemType", "nsuri": "http://passagebio.com/20260721", "localname": "LossContingencySharesAgreedByDefendant", "presentation": [ "http://passagebio.com/role/CommitmentsAndContingenciesCollaborationAgreementsFyDetails", "http://passagebio.com/role/CommitmentsAndContingenciesCollaborationAgreementsQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Number of shares agreed to be issued by defendant and subject to reverse stock split.", "label": "Loss Contingency, Shares Agreed by Defendant", "terseLabel": "Loss contingency, shares agreed by defendant" } } }, "auth_ref": [] }, "pasg_MarketStreetLeaseAgreement2005Member": { "xbrltype": "domainItemType", "nsuri": "http://passagebio.com/20260721", "localname": "MarketStreetLeaseAgreement2005Member", "presentation": [ "http://passagebio.com/role/SubsequentEventsQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Represents the member information pertaining to 2005 Market Street Lease Agreement.", "label": "Market Street Lease Agreement 2005 [Member]" } } }, "auth_ref": [] }, "pasg_MarketStreetSubleaseAgreement1835Member": { "xbrltype": "domainItemType", "nsuri": "http://passagebio.com/20260721", "localname": "MarketStreetSubleaseAgreement1835Member", "presentation": [ "http://passagebio.com/role/LeasesFyDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the member information pertaining to 1835 Market Street Sublease Agreement.", "label": "1835 Market Street Sublease Agreement [Member]", "terseLabel": "1835 market street sublease agreement" } } }, "auth_ref": [] }, "us-gaap_MarketableSecuritiesPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "MarketableSecuritiesPolicy", "presentation": [ "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesFyPolicies", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesQ1Policies" ], "lang": { "en-us": { "role": { "terseLabel": "Marketable Securities", "label": "Marketable Securities, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for investment classified as marketable security." } } }, "auth_ref": [ "r41" ] }, "us-gaap_MarketableSecuritiesUnrealizedGainLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "MarketableSecuritiesUnrealizedGainLoss", "crdr": "credit", "presentation": [ "http://passagebio.com/role/StatementsOfCashFlowsFy", "http://passagebio.com/role/StatementsOfCashFlowsQ1" ], "lang": { "en-us": { "role": { "terseLabel": "Unrealized gain (loss) on marketable securities", "label": "Marketable Security, Unrealized Gain (Loss)", "documentation": "Amount of unrealized gain (loss) on investment in marketable security." } } }, "auth_ref": [ "r60" ] }, "pasg_MaximumAdditionalAmountInDevelopmentAndCommercialMilestonePaymentsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://passagebio.com/20260721", "localname": "MaximumAdditionalAmountInDevelopmentAndCommercialMilestonePaymentsReceivable", "crdr": "debit", "presentation": [ "http://passagebio.com/role/GemmaLicenseAgreementFyDetails", "http://passagebio.com/role/GemmaLicenseAgreementQ1Details" ], "lang": { "en-us": { "role": { "documentation": "The maximum additional amount in development and commercial milestone payments receivable.", "label": "Maximum Additional Amount in Development And Commercial Milestone Payments Receivable", "terseLabel": "Maximum additional amount in development and commercial milestone payments receivable" } } }, "auth_ref": [] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "MaximumMember", "presentation": [ "http://passagebio.com/role/CommonStockFyDetails", "http://passagebio.com/role/LeasesFyDetails", "http://passagebio.com/role/LeasesQ1Details", "http://passagebio.com/role/RisksAndLiquidityFyDetails", "http://passagebio.com/role/RisksLiquidityAndGoingConcernQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum", "label": "Maximum [Member]" } } }, "auth_ref": [ "r180", "r286", "r287", "r288", "r289", "r352", "r383", "r384", "r385", "r403", "r481", "r570", "r612", "r614", "r622", "r635", "r636", "r687", "r688", "r689", "r690", "r691", "r694", "r695", "r696", "r697", "r699", "r700", "r727", "r733", "r739", "r743", "r745", "r746", "r755", "r756", "r760", "r761", "r768", "r844", "r914", "r915", "r916", "r917", "r918", "r919" ] }, "pasg_MergerAgreementTerminationPaymentAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://passagebio.com/20260721", "localname": "MergerAgreementTerminationPaymentAmount", "crdr": "credit", "presentation": [ "http://passagebio.com/role/SubsequentEventsQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Amount of cash payment required to be made by the registrant upon termination of a merger agreement.", "label": "Merger Agreement Termination Payment Amount", "terseLabel": "Termination payment amount" } } }, "auth_ref": [] }, "us-gaap_MoneyMarketFundsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "MoneyMarketFundsMember", "presentation": [ "http://passagebio.com/role/CashCashEquivalentsAndMarketableSecuritiesPortfolioOfCashAndCashEquivalentsFyDetails", "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsRecurringBasisFyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Money market funds", "label": "Money Market Funds [Member]", "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities." } } }, "auth_ref": [ "r845", "r846" ] }, "us-gaap_NatureOfOperations": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NatureOfOperations", "presentation": [ "http://passagebio.com/role/NatureOfOperationsFy", "http://passagebio.com/role/NatureOfOperationsQ1" ], "lang": { "en-us": { "role": { "terseLabel": "Nature of Operations", "label": "Nature of Operations [Text Block]", "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward." } } }, "auth_ref": [ "r92", "r177", "r713", "r714" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://passagebio.com/role/StatementsOfCashFlowsFy": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://passagebio.com/role/StatementsOfCashFlowsFy" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by (used in) financing activities", "label": "Cash Provided by (Used in) Financing Activity, Including Discontinued Operation", "documentation": "Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit." } } }, "auth_ref": [ "r136" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://passagebio.com/role/StatementsOfCashFlowsFy" ], "lang": { "en-us": { "role": { "verboseLabel": "Cash flows provided by (used in) financing activities:", "label": "Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://passagebio.com/role/StatementsOfCashFlowsQ1": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 }, "http://passagebio.com/role/StatementsOfCashFlowsFy": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://passagebio.com/role/StatementsOfCashFlowsFy", "http://passagebio.com/role/StatementsOfCashFlowsQ1" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by (used in) investing activities", "label": "Cash Provided by (Used in) Investing Activity, Including Discontinued Operation", "documentation": "Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets." } } }, "auth_ref": [ "r136" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://passagebio.com/role/StatementsOfCashFlowsFy", "http://passagebio.com/role/StatementsOfCashFlowsQ1" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows provided by (used in) investing activities:", "label": "Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://passagebio.com/role/StatementsOfCashFlowsQ1": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 }, "http://passagebio.com/role/StatementsOfCashFlowsFy": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://passagebio.com/role/StatementsOfCashFlowsFy", "http://passagebio.com/role/StatementsOfCashFlowsQ1" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by (used in) operating activities", "label": "Cash Provided by (Used in) Operating Activity, Including Discontinued Operation", "documentation": "Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity." } } }, "auth_ref": [ "r64", "r65", "r66" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://passagebio.com/role/StatementsOfCashFlowsFy", "http://passagebio.com/role/StatementsOfCashFlowsQ1" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows used in operating activities:", "label": "Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://passagebio.com/role/StatementsOfOperationsAndComprehensiveLossFy": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 1.0 }, "http://passagebio.com/role/StatementsOfCashFlowsFy": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 10.0 }, "http://passagebio.com/role/StatementsOfCashFlowsQ1": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://passagebio.com/role/RisksLiquidityAndGoingConcernQ1Details", "http://passagebio.com/role/SegmentReportingFyDetails", "http://passagebio.com/role/SegmentReportingQ1Details", "http://passagebio.com/role/StatementsOfCashFlowsFy", "http://passagebio.com/role/StatementsOfCashFlowsQ1", "http://passagebio.com/role/StatementsOfOperationsAndComprehensiveLossFy", "http://passagebio.com/role/StatementsOfOperationsAndComprehensiveLossQ1", "http://passagebio.com/role/StatementsOfStockholdersEquityFy", "http://passagebio.com/role/StatementsOfStockholdersEquityQ1" ], "lang": { "en-us": { "role": { "verboseLabel": "Net loss", "totalLabel": "Net loss", "negatedTotalLabel": "Net loss", "terseLabel": "Net Income (Loss)", "label": "Net Income (Loss)", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r58", "r66", "r85", "r103", "r106", "r121", "r123", "r128", "r141", "r142", "r143", "r146", "r150", "r154", "r155", "r156", "r157", "r158", "r161", "r162", "r166", "r246", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r304", "r307", "r309", "r312", "r392", "r443", "r448", "r475", "r503", "r594", "r664", "r680", "r681", "r707", "r709", "r711", "r781", "r842" ] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesFyPolicies", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesQ1Policies" ], "lang": { "en-us": { "role": { "label": "Recently Issued Accounting Pronouncements Not Yet Adopted and Recently Adopted Accounting Pronouncements", "terseLabel": "Recently Issued Accounting Pronouncements", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "pasg_NewLeaseAgreementOperatingLeaseNumberOfExtensions": { "xbrltype": "integerItemType", "nsuri": "http://passagebio.com/20260721", "localname": "NewLeaseAgreementOperatingLeaseNumberOfExtensions", "presentation": [ "http://passagebio.com/role/LeasesFyDetails", "http://passagebio.com/role/LeasesQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Represents the number of extensions available under the new lease arrangement.", "label": "New Lease Agreement, Operating Lease, Number Of Extensions", "terseLabel": "Number of extension terms" } } }, "auth_ref": [] }, "pasg_NewLeaseAgreementOperatingLeaseRenewalTerm": { "xbrltype": "durationItemType", "nsuri": "http://passagebio.com/20260721", "localname": "NewLeaseAgreementOperatingLeaseRenewalTerm", "presentation": [ "http://passagebio.com/role/LeasesFyDetails", "http://passagebio.com/role/LeasesQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Represents the renewal term under new lease agreement.", "label": "New Lease Agreement, Operating Lease, Renewal Term", "terseLabel": "Extended term of new lease agreement" } } }, "auth_ref": [] }, "pasg_NonRefundableAggregateFeesPayablePerProductIndication": { "xbrltype": "monetaryItemType", "nsuri": "http://passagebio.com/20260721", "localname": "NonRefundableAggregateFeesPayablePerProductIndication", "crdr": "credit", "presentation": [ "http://passagebio.com/role/CommitmentsAndContingenciesCollaborationAgreementsFyDetails", "http://passagebio.com/role/CommitmentsAndContingenciesCollaborationAgreementsQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Amount of aggregate non-refundable fees payable per product indication.", "label": "Non - Refundable Aggregate Fees Payable Per Product Indication", "terseLabel": "Non - Refundable aggregate fees payable" } } }, "auth_ref": [] }, "pasg_NonRefundableFeesPayablePerProductIndicationUponDevelopmentalMilestone": { "xbrltype": "monetaryItemType", "nsuri": "http://passagebio.com/20260721", "localname": "NonRefundableFeesPayablePerProductIndicationUponDevelopmentalMilestone", "crdr": "credit", "presentation": [ "http://passagebio.com/role/CommitmentsAndContingenciesCollaborationAgreementsFyDetails", "http://passagebio.com/role/CommitmentsAndContingenciesCollaborationAgreementsQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Amount of upfront fees payable per product indication upon developmental milestone.", "label": "Non - Refundable Fees Payable Per Product Indication Upon Developmental Milestone", "terseLabel": "Non - Refundable fees payable" } } }, "auth_ref": [] }, "pasg_NonRefundableUpfrontFeesPayablePerProductIndication": { "xbrltype": "monetaryItemType", "nsuri": "http://passagebio.com/20260721", "localname": "NonRefundableUpfrontFeesPayablePerProductIndication", "crdr": "credit", "presentation": [ "http://passagebio.com/role/CommitmentsAndContingenciesCollaborationAgreementsFyDetails", "http://passagebio.com/role/CommitmentsAndContingenciesCollaborationAgreementsQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Amount of upfront fees payable per product indication.", "label": "Non - Refundable Upfront Fees Payable Per Product Indication", "terseLabel": "Non - Refundable upfront fees payable" } } }, "auth_ref": [] }, "us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NonvestedRestrictedStockSharesActivityTableTextBlock", "presentation": [ "http://passagebio.com/role/SharebasedCompensationFyTables", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationQ1Tables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of activity related to restricted stock unit", "label": "Nonvested Restricted Stock Shares Activity [Table Text Block]", "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock shares." } } }, "auth_ref": [ "r16" ] }, "pasg_NumberOfEquityIncentivePlans": { "xbrltype": "integerItemType", "nsuri": "http://passagebio.com/20260721", "localname": "NumberOfEquityIncentivePlans", "presentation": [ "http://passagebio.com/role/SharebasedCompensationEquityIncentivePlanEsppFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationEquityIncentivePlanEsppQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Represents the number of equity incentive plans.", "label": "Number Of Equity Incentive Plans", "terseLabel": "Number of equity incentive plans" } } }, "auth_ref": [] }, "us-gaap_NumberOfReportableSegments": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NumberOfReportableSegments", "presentation": [ "http://passagebio.com/role/SegmentReportingFyDetails", "http://passagebio.com/role/SegmentReportingQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Number of reportable segments", "label": "Number of Reportable Segments", "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements." } } }, "auth_ref": [ "r718", "r726", "r825" ] }, "us-gaap_OfficeEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OfficeEquipmentMember", "presentation": [ "http://passagebio.com/role/PropertyAndEquipmentNetFyDetails", "http://passagebio.com/role/PropertyAndEquipmentNetQ1Details", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesFyDetails", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Office equipment", "label": "Office Equipment [Member]", "documentation": "Tangible personal property used in an office setting. Examples include, but are not limited to, computers, copiers and fax machine." } } }, "auth_ref": [] }, "us-gaap_OperatingExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OperatingExpensesAbstract", "presentation": [ "http://passagebio.com/role/StatementsOfOperationsAndComprehensiveLossFy", "http://passagebio.com/role/StatementsOfOperationsAndComprehensiveLossQ1" ], "lang": { "en-us": { "role": { "terseLabel": "Operating expenses:", "label": "Operating Expenses [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://passagebio.com/role/StatementsOfOperationsAndComprehensiveLossFy": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://passagebio.com/role/SegmentReportingFyDetails", "http://passagebio.com/role/SegmentReportingQ1Details", "http://passagebio.com/role/StatementsOfOperationsAndComprehensiveLossFy", "http://passagebio.com/role/StatementsOfOperationsAndComprehensiveLossQ1" ], "lang": { "en-us": { "role": { "totalLabel": "Loss from operations", "negatedTotalLabel": "Loss from operations", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r88", "r707", "r711", "r717", "r824", "r826", "r827", "r828", "r829" ] }, "us-gaap_OperatingLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OperatingLeaseCost", "crdr": "debit", "calculation": { "http://passagebio.com/role/LeasesOperatingLeaseCostFyDetails": { "parentTag": "us-gaap_LeaseCost", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://passagebio.com/role/LeasesOperatingLeaseCostFyDetails", "http://passagebio.com/role/LeasesOperatingLeaseCostQ1Details" ], "lang": { "en-us": { "role": { "label": "Operating lease cost", "terseLabel": "Operating lease expense", "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability." } } }, "auth_ref": [ "r525", "r763" ] }, "us-gaap_OperatingLeaseImpairmentLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OperatingLeaseImpairmentLoss", "crdr": "debit", "calculation": { "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsNonrecurringBasisFyDetails": { "parentTag": "us-gaap_AssetImpairmentCharges", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsNonrecurringBasisFyDetails", "http://passagebio.com/role/LeasesFyDetails", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesFyDetails", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Impairment expenses for right of use assets", "verboseLabel": "Right of use assets", "label": "Operating Lease, Impairment Loss", "documentation": "Amount of loss from impairment of right-of-use asset from operating lease." } } }, "auth_ref": [ "r907" ] }, "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract", "presentation": [ "http://passagebio.com/role/LeasesFyDetails", "http://passagebio.com/role/LeasesQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Future minimum lease payments", "label": "Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OperatingLeaseLiability", "crdr": "credit", "calculation": { "http://passagebio.com/role/LeasesFyDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://passagebio.com/role/LeasesFyDetails", "http://passagebio.com/role/LeasesQ1Details" ], "lang": { "en-us": { "role": { "verboseLabel": "Total lease liabilities", "label": "Operating Lease, Liability", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease." } } }, "auth_ref": [ "r519" ] }, "us-gaap_OperatingLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OperatingLeaseLiabilityCurrent", "crdr": "credit", "calculation": { "http://passagebio.com/role/BalanceSheetsFy": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://passagebio.com/role/BalanceSheetsFy", "http://passagebio.com/role/BalanceSheetsQ1" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease liabilities", "label": "Operating Lease, Liability, Current", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current." } } }, "auth_ref": [ "r519" ] }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OperatingLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://passagebio.com/role/BalanceSheetsFy": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://passagebio.com/role/BalanceSheetsFy", "http://passagebio.com/role/BalanceSheetsQ1" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease liabilities - noncurrent", "label": "Operating Lease, Liability, Noncurrent", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent." } } }, "auth_ref": [ "r519" ] }, "pasg_OperatingLeaseLiabilityRecognizedUponAdoptionOfStandard": { "xbrltype": "monetaryItemType", "nsuri": "http://passagebio.com/20260721", "localname": "OperatingLeaseLiabilityRecognizedUponAdoptionOfStandard", "crdr": "credit", "presentation": [ "http://passagebio.com/role/StatementsOfCashFlowsFy" ], "lang": { "en-us": { "role": { "documentation": "The amount of lease liabilities recognized upon adoption of standard.", "label": "Operating Lease Liability Recognized Upon Adoption of Standard", "terseLabel": "Operating lease liabilities recognized upon the commencement of sublease" } } }, "auth_ref": [] }, "us-gaap_OperatingLeasePaymentsUse": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OperatingLeasePaymentsUse", "crdr": "credit", "presentation": [ "http://passagebio.com/role/LeasesOperatingLeaseCostFyDetails", "http://passagebio.com/role/LeasesOperatingLeaseCostQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease payments", "label": "Operating Lease, Payments, Use", "documentation": "Amount of cash outflow from operating lease to bring another asset to condition and location necessary for its intended use." } } }, "auth_ref": [ "r520", "r528" ] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://passagebio.com/role/BalanceSheetsFy": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://passagebio.com/role/BalanceSheetsFy", "http://passagebio.com/role/BalanceSheetsQ1" ], "lang": { "en-us": { "role": { "verboseLabel": "Right of use assets - operating leases", "label": "Operating Lease, Right-of-Use Asset", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r518" ] }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "presentation": [ "http://passagebio.com/role/LeasesOperatingLeaseCostFyDetails", "http://passagebio.com/role/LeasesOperatingLeaseCostQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-average discount rate", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "documentation": "Weighted average discount rate for operating lease calculated at point in time." } } }, "auth_ref": [ "r531", "r763" ] }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "presentation": [ "http://passagebio.com/role/LeasesOperatingLeaseCostFyDetails", "http://passagebio.com/role/LeasesOperatingLeaseCostQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-average remaining lease term (years)", "label": "Operating Lease, Weighted Average Remaining Lease Term", "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r530", "r763" ] }, "pasg_OperatingLeasesForLaboratorySpaceMember": { "xbrltype": "domainItemType", "nsuri": "http://passagebio.com/20260721", "localname": "OperatingLeasesForLaboratorySpaceMember", "presentation": [ "http://passagebio.com/role/LeasesFyDetails", "http://passagebio.com/role/LeasesQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Represents the operating lease agreement for laboratory space.", "label": "Operating Leases For Laboratory Space [Member]", "terseLabel": "Operating leases for laboratory space" } } }, "auth_ref": [] }, "pasg_OperatingLeasesForOfficeSpaceMember": { "xbrltype": "domainItemType", "nsuri": "http://passagebio.com/20260721", "localname": "OperatingLeasesForOfficeSpaceMember", "presentation": [ "http://passagebio.com/role/LeasesFyDetails", "http://passagebio.com/role/LeasesQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Represents the operating lease agreement for office space.", "label": "Operating Leases For Office Space [Member]", "terseLabel": "Operating leases for office space" } } }, "auth_ref": [] }, "pasg_OperatingLossCarryforwardSubjectToExpiration": { "xbrltype": "monetaryItemType", "nsuri": "http://passagebio.com/20260721", "localname": "OperatingLossCarryforwardSubjectToExpiration", "crdr": "debit", "presentation": [ "http://passagebio.com/role/IncomeTaxesNetOperatingLossesFyDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward subject to expiry, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Operating Loss Carryforward Subject to Expiration", "verboseLabel": "Net operating loss carryforwards subject to expiration" } } }, "auth_ref": [] }, "us-gaap_OperatingLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OperatingLossCarryforwards", "crdr": "debit", "presentation": [ "http://passagebio.com/role/IncomeTaxesNetOperatingLossesFyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net operating loss carryforwards", "label": "Operating Loss Carryforwards", "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws." } } }, "auth_ref": [ "r430" ] }, "us-gaap_OperatingLossCarryforwardsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OperatingLossCarryforwardsLineItems", "presentation": [ "http://passagebio.com/role/IncomeTaxesNetOperatingLossesFyDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Income Taxes", "label": "Operating Loss Carryforwards [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r430" ] }, "us-gaap_OperatingLossCarryforwardsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OperatingLossCarryforwardsTable", "presentation": [ "http://passagebio.com/role/IncomeTaxesNetOperatingLossesFyDetails" ], "lang": { "en-us": { "role": { "label": "Operating Loss Carryforwards [Table]", "documentation": "Disclosure of information about operating loss carryforward. Includes, but is not limited to, tax authority, amount and expiration date of operating loss carryforward, and likelihood of utilization." } } }, "auth_ref": [ "r430" ] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "label": "Nature of Operations" } } }, "auth_ref": [] }, "pasg_OrphanDrugMember": { "xbrltype": "domainItemType", "nsuri": "http://passagebio.com/20260721", "localname": "OrphanDrugMember", "presentation": [ "http://passagebio.com/role/IncomeTaxesNetOperatingLossesFyDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to Orphan Drug.", "label": "Orphan Drug [Member]", "terseLabel": "Orphan drug" } } }, "auth_ref": [] }, "us-gaap_OtherAssetImpairmentCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherAssetImpairmentCharges", "crdr": "debit", "calculation": { "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsNonrecurringBasisFyDetails": { "parentTag": "us-gaap_AssetImpairmentCharges", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsNonrecurringBasisFyDetails", "http://passagebio.com/role/LeasesFyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other assets", "verboseLabel": "Impairment of certain other assets", "label": "Other Asset Impairment Charges", "documentation": "The charge against earnings resulting from the write down of long lived assets other than goodwill due to the difference between the carrying value and lower fair value." } } }, "auth_ref": [ "r812", "r838" ] }, "us-gaap_OtherAssetsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherAssetsFairValueDisclosure", "crdr": "debit", "calculation": { "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsNonrecurringBasisFyDetails": { "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsNonrecurringBasisFyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other assets", "label": "Other Assets, Fair Value Disclosure", "documentation": "Fair value portion of other assets." } } }, "auth_ref": [ "r891", "r892", "r896", "r900", "r901", "r902", "r904" ] }, "us-gaap_OtherAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherAssetsNoncurrent", "crdr": "debit", "calculation": { "http://passagebio.com/role/BalanceSheetsFy": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://passagebio.com/role/BalanceSheetsFy", "http://passagebio.com/role/BalanceSheetsQ1" ], "lang": { "en-us": { "role": { "terseLabel": "Other assets", "label": "Other Assets, Noncurrent", "documentation": "Amount of noncurrent assets classified as other." } } }, "auth_ref": [ "r112" ] }, "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax", "crdr": "credit", "calculation": { "http://passagebio.com/role/StatementsOfOperationsAndComprehensiveLossFy": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://passagebio.com/role/StatementsOfOperationsAndComprehensiveLossFy", "http://passagebio.com/role/StatementsOfOperationsAndComprehensiveLossQ1", "http://passagebio.com/role/StatementsOfStockholdersEquityFy", "http://passagebio.com/role/StatementsOfStockholdersEquityQ1" ], "lang": { "en-us": { "role": { "terseLabel": "Unrealized gain (loss) on marketable securities", "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax", "documentation": "Amount, before tax and adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale." } } }, "auth_ref": [ "r119", "r120", "r245" ] }, "pasg_OtherIncomeAndOtherExpensePolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://passagebio.com/20260721", "localname": "OtherIncomeAndOtherExpensePolicyPolicyTextBlock", "presentation": [ "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesFyPolicies", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesQ1Policies" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for other income or other expense items.", "label": "Other Income and Other Expense Policy [Policy Text Block]", "terseLabel": "Other Income (Expense), Net" } } }, "auth_ref": [] }, "us-gaap_OtherNoncashExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherNoncashExpense", "crdr": "debit", "calculation": { "http://passagebio.com/role/StatementsOfCashFlowsFy": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://passagebio.com/role/StatementsOfCashFlowsFy" ], "lang": { "en-us": { "role": { "terseLabel": "Other non-cash items", "label": "Other Noncash Expense", "documentation": "Amount of expense or loss included in net income that result in no cash flow, classified as other." } } }, "auth_ref": [ "r66" ] }, "us-gaap_OtherNonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherNonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://passagebio.com/role/StatementsOfOperationsAndComprehensiveLossFy": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://passagebio.com/role/SegmentReportingFyDetails", "http://passagebio.com/role/SegmentReportingQ1Details", "http://passagebio.com/role/StatementsOfOperationsAndComprehensiveLossFy", "http://passagebio.com/role/StatementsOfOperationsAndComprehensiveLossQ1", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesFyDetails", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Other income (expense), net", "negatedLabel": "Other (income) expense, net", "label": "Other Nonoperating Income (Expense)", "documentation": "Amount of income (expense) related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r62", "r747" ] }, "pasg_PayableDecreaseFromAmountsReceivedTransitionServicesPayments": { "xbrltype": "monetaryItemType", "nsuri": "http://passagebio.com/20260721", "localname": "PayableDecreaseFromAmountsReceivedTransitionServicesPayments", "crdr": "debit", "presentation": [ "http://passagebio.com/role/GemmaLicenseAgreementFyDetails", "http://passagebio.com/role/GemmaLicenseAgreementQ1Details" ], "lang": { "en-us": { "role": { "documentation": "The amount of decrease in payable due to amounts received under transition service payments.", "label": "Payable, Decrease from Amounts Received Transition Services Payments", "terseLabel": "Transition service payments" } } }, "auth_ref": [] }, "pasg_PaymentOfLeaseTerminationFee": { "xbrltype": "monetaryItemType", "nsuri": "http://passagebio.com/20260721", "localname": "PaymentOfLeaseTerminationFee", "crdr": "credit", "presentation": [ "http://passagebio.com/role/SubsequentEventsQ1Details" ], "lang": { "en-us": { "role": { "documentation": "The cash outflow related to the payment of lease termination fee.", "label": "Payment of Lease Termination Fee", "terseLabel": "Payment of lease termination fee" } } }, "auth_ref": [] }, "us-gaap_PaymentsOfStockIssuanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PaymentsOfStockIssuanceCosts", "crdr": "credit", "presentation": [ "http://passagebio.com/role/CommonStockFyDetails", "http://passagebio.com/role/RisksAndLiquidityFyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance cost", "label": "Payments of Stock Issuance Costs", "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security." } } }, "auth_ref": [ "r21" ] }, "us-gaap_PaymentsToAcquireMarketableSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PaymentsToAcquireMarketableSecurities", "crdr": "credit", "calculation": { "http://passagebio.com/role/StatementsOfCashFlowsFy": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://passagebio.com/role/StatementsOfCashFlowsFy" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchases of marketable securities", "label": "Payments to Acquire Marketable Securities", "documentation": "Amount of cash outflow for purchase of marketable security." } } }, "auth_ref": [ "r832" ] }, "us-gaap_PaymentsToAcquireProductiveAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PaymentsToAcquireProductiveAssets", "crdr": "credit", "calculation": { "http://passagebio.com/role/StatementsOfCashFlowsFy": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://passagebio.com/role/StatementsOfCashFlowsFy" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchases of property and equipment and other assets", "label": "Payments to Acquire Productive Assets", "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets." } } }, "auth_ref": [ "r90", "r885", "r886", "r887" ] }, "pasg_PercentageOfAnnualIncreaseInSubleaseRent": { "xbrltype": "percentItemType", "nsuri": "http://passagebio.com/20260721", "localname": "PercentageOfAnnualIncreaseInSubleaseRent", "presentation": [ "http://passagebio.com/role/LeasesFyDetails", "http://passagebio.com/role/LeasesQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Represents the percentage of annual increase in sublease rent.", "label": "Percentage of Annual Increase in Sublease Rent", "terseLabel": "Annual increase in sublease rent (as a percent)" } } }, "auth_ref": [] }, "pasg_PercentageOfTargetAnnualBonusAmounts": { "xbrltype": "percentItemType", "nsuri": "http://passagebio.com/20260721", "localname": "PercentageOfTargetAnnualBonusAmounts", "presentation": [ "http://passagebio.com/role/CommitmentsAndContingenciesCollaborationAgreementsFyDetails", "http://passagebio.com/role/CommitmentsAndContingenciesCollaborationAgreementsQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Represents the percentage of target annual bonus amounts.", "label": "Percentage of Target Annual Bonus Amounts", "terseLabel": "Target annual bonus" } } }, "auth_ref": [] }, "us-gaap_PlanNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PlanNameAxis", "presentation": [ "http://passagebio.com/role/SharebasedCompensationEquityIncentivePlanEsppFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationEquityIncentivePlanEsppQ1Details" ], "lang": { "en-us": { "role": { "label": "Plan Name [Axis]", "documentation": "Information by plan name for share-based payment arrangement." } } }, "auth_ref": [ "r847", "r848", "r849", "r850", "r851", "r852", "r853", "r854", "r855", "r856", "r857", "r858", "r859", "r860", "r861", "r862", "r863", "r864", "r865", "r866", "r867", "r868", "r869", "r870", "r871", "r872" ] }, "us-gaap_PlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PlanNameDomain", "presentation": [ "http://passagebio.com/role/SharebasedCompensationEquityIncentivePlanEsppFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationEquityIncentivePlanEsppQ1Details" ], "lang": { "en-us": { "role": { "label": "Plan Name [Domain]", "documentation": "Plan name for share-based payment arrangement." } } }, "auth_ref": [ "r847", "r848", "r849", "r850", "r851", "r852", "r853", "r854", "r855", "r856", "r857", "r858", "r859", "r860", "r861", "r862", "r863", "r864", "r865", "r866", "r867", "r868", "r869", "r870", "r871", "r872" ] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://passagebio.com/role/BalanceSheetsFyParenthetical", "http://passagebio.com/role/BalanceSheetsQ1Parenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, par value (in dollars per share)", "label": "Preferred Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r50", "r314" ] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://passagebio.com/role/BalanceSheetsFyParenthetical", "http://passagebio.com/role/BalanceSheetsQ1Parenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, shares authorized", "label": "Preferred Stock, Shares Authorized", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r50", "r645" ] }, "us-gaap_PreferredStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PreferredStockSharesIssued", "presentation": [ "http://passagebio.com/role/BalanceSheetsFyParenthetical", "http://passagebio.com/role/BalanceSheetsQ1Parenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, shares issued", "label": "Preferred Stock, Shares Issued", "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt." } } }, "auth_ref": [ "r50", "r314" ] }, "us-gaap_PreferredStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PreferredStockSharesOutstanding", "presentation": [ "http://passagebio.com/role/BalanceSheetsFyParenthetical", "http://passagebio.com/role/BalanceSheetsQ1Parenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, shares outstanding", "label": "Preferred Stock, Shares Outstanding", "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased." } } }, "auth_ref": [ "r50", "r645", "r663", "r958", "r959" ] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PreferredStockValue", "crdr": "credit", "calculation": { "http://passagebio.com/role/BalanceSheetsFy": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://passagebio.com/role/BalanceSheetsFy", "http://passagebio.com/role/BalanceSheetsQ1" ], "lang": { "en-us": { "role": { "label": "Preferred stock, $0.0001 par value: 10,000,000 shares authorized; no shares issued and outstanding at both December 31, 2025 and December 31, 2024", "terseLabel": "Preferred stock, $0.0001 par value: 10,000,000 shares authorized; no shares issued and outstanding at both March 31, 2026 and December 31, 2025", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r50", "r306", "r311", "r587", "r764" ] }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PrepaidExpenseAndOtherAssetsCurrent", "crdr": "debit", "calculation": { "http://passagebio.com/role/BalanceSheetsFy": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://passagebio.com/role/BalanceSheetsFy", "http://passagebio.com/role/BalanceSheetsQ1" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid expenses and other current assets", "label": "Prepaid Expense and Other Assets, Current", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r807" ] }, "pasg_PrepaidResearchAndDevelopmentAssetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://passagebio.com/20260721", "localname": "PrepaidResearchAndDevelopmentAssetCurrent", "crdr": "debit", "calculation": { "http://passagebio.com/role/BalanceSheetsFy": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://passagebio.com/role/BalanceSheetsFy", "http://passagebio.com/role/BalanceSheetsQ1" ], "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for current portion of prepaid research and development expense that provides economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid Research And Development Asset, Current", "terseLabel": "Prepaid research and development" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ProceedsFromIssuanceOfCommonStock", "crdr": "debit", "presentation": [ "http://passagebio.com/role/CommonStockFyDetails", "http://passagebio.com/role/RisksAndLiquidityFyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from issuance of common stock, net of offering costs", "label": "Proceeds from Issuance of Common Stock", "documentation": "The cash inflow from the additional capital contribution to the entity." } } }, "auth_ref": [ "r3" ] }, "us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ProceedsFromIssuanceOfConvertiblePreferredStock", "crdr": "debit", "calculation": { "http://passagebio.com/role/StatementsOfCashFlowsFy": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://passagebio.com/role/StatementsOfCashFlowsFy" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from issuance of common stock under the ATM Facility, net of offering costs", "label": "Proceeds from Issuance of Convertible Preferred Stock", "documentation": "The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock." } } }, "auth_ref": [ "r3" ] }, "pasg_ProceedsFromNonRefundableSublicensePayments": { "xbrltype": "monetaryItemType", "nsuri": "http://passagebio.com/20260721", "localname": "ProceedsFromNonRefundableSublicensePayments", "crdr": "debit", "presentation": [ "http://passagebio.com/role/GemmaLicenseAgreementFyDetails", "http://passagebio.com/role/GemmaLicenseAgreementQ1Details" ], "lang": { "en-us": { "role": { "documentation": "The cash inflow from non-refundable sublicense payments received.", "label": "Proceeds From Non-Refundable Sublicense Payments", "terseLabel": "Payment received" } } }, "auth_ref": [] }, "pasg_ProceedsFromNonRefundableTransitionServicesPayments": { "xbrltype": "monetaryItemType", "nsuri": "http://passagebio.com/20260721", "localname": "ProceedsFromNonRefundableTransitionServicesPayments", "crdr": "debit", "presentation": [ "http://passagebio.com/role/GemmaLicenseAgreementFyDetails", "http://passagebio.com/role/GemmaLicenseAgreementQ1Details" ], "lang": { "en-us": { "role": { "documentation": "The cash inflow from non-refundable transition service payments received by the company.", "label": "Proceeds From Non Refundable Transition Services Payments", "terseLabel": "Amount of transition services payments" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities", "crdr": "debit", "calculation": { "http://passagebio.com/role/StatementsOfCashFlowsQ1": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 2.0 }, "http://passagebio.com/role/StatementsOfCashFlowsFy": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://passagebio.com/role/StatementsOfCashFlowsFy", "http://passagebio.com/role/StatementsOfCashFlowsQ1" ], "lang": { "en-us": { "role": { "terseLabel": "Sales or maturities of marketable securities", "label": "Proceeds from Sale and Maturity of Marketable Securities", "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period." } } }, "auth_ref": [] }, "us-gaap_ProceedsFromSaleOfProductiveAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ProceedsFromSaleOfProductiveAssets", "crdr": "debit", "calculation": { "http://passagebio.com/role/StatementsOfCashFlowsQ1": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 1.0 }, "http://passagebio.com/role/StatementsOfCashFlowsFy": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://passagebio.com/role/StatementsOfCashFlowsFy", "http://passagebio.com/role/StatementsOfCashFlowsQ1" ], "lang": { "en-us": { "role": { "terseLabel": "Sales of property and equipment and other assets", "label": "Proceeds from Sale of Productive Assets", "documentation": "The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets." } } }, "auth_ref": [ "r63" ] }, "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment", "crdr": "debit", "calculation": { "http://passagebio.com/role/StatementsOfCashFlowsFy": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://passagebio.com/role/PropertyAndEquipmentNetNarrativeFyDetails", "http://passagebio.com/role/StatementsOfCashFlowsFy", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesFyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Sale of property and equipment and other assets", "label": "Proceeds from Sale of Property, Plant, and Equipment", "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r63" ] }, "pasg_ProceedsFromShortTermLicenseFee": { "xbrltype": "monetaryItemType", "nsuri": "http://passagebio.com/20260721", "localname": "ProceedsFromShortTermLicenseFee", "crdr": "debit", "presentation": [ "http://passagebio.com/role/GemmaLicenseAgreementQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from short term license.", "label": "Proceeds From Short Term License Fee", "terseLabel": "Proceeds from short term license fee" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromStockOptionsExercised": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ProceedsFromStockOptionsExercised", "crdr": "debit", "calculation": { "http://passagebio.com/role/StatementsOfCashFlowsFy": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://passagebio.com/role/StatementsOfCashFlowsFy" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from the exercise of stock options", "label": "Proceeds from Stock Options Exercised", "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement." } } }, "auth_ref": [ "r3", "r14" ] }, "us-gaap_ProceedsFromStockPlans": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ProceedsFromStockPlans", "crdr": "debit", "calculation": { "http://passagebio.com/role/StatementsOfCashFlowsFy": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://passagebio.com/role/StatementsOfCashFlowsFy" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from the issuance of common stock under employee stock purchase plan", "label": "Proceeds from Stock Plans", "documentation": "The cash inflow associated with the amount received from the stock plan during the period." } } }, "auth_ref": [ "r3" ] }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PropertyPlantAndEquipmentAbstract", "lang": { "en-us": { "role": { "label": "Property and Equipment, Net" } } }, "auth_ref": [] }, "pasg_PropertyPlantAndEquipmentAndCertainOtherAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://passagebio.com/20260721", "localname": "PropertyPlantAndEquipmentAndCertainOtherAssetsMember", "presentation": [ "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesFyDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to property, plant and equipment and certain other assets.", "label": "Property Plant And Equipment And Certain Other Assets [Member]", "terseLabel": "Property and equipment and certain other assets" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PropertyPlantAndEquipmentByTypeAxis", "presentation": [ "http://passagebio.com/role/LeasesFyDetails", "http://passagebio.com/role/LeasesQ1Details", "http://passagebio.com/role/PropertyAndEquipmentNetFyDetails", "http://passagebio.com/role/PropertyAndEquipmentNetQ1Details", "http://passagebio.com/role/SubsequentEventsQ1Details", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesFyDetails", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesQ1Details" ], "lang": { "en-us": { "role": { "label": "Long-Lived Tangible Asset [Axis]", "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r7", "r533" ] }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "presentation": [ "http://passagebio.com/role/PropertyAndEquipmentNetFy", "http://passagebio.com/role/PropertyAndEquipmentNetQ1" ], "lang": { "en-us": { "role": { "verboseLabel": "Property and Equipment, Net", "label": "Property, Plant and Equipment Disclosure [Text Block]", "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r68", "r95", "r96", "r97" ] }, "us-gaap_PropertyPlantAndEquipmentFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PropertyPlantAndEquipmentFairValueDisclosure", "crdr": "debit", "calculation": { "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsNonrecurringBasisFyDetails": { "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsNonrecurringBasisFyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property and equipment, net", "label": "Property, Plant, and Equipment, Fair Value Disclosure", "documentation": "Fair value portion of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r751", "r891", "r892", "r896", "r903" ] }, "us-gaap_PropertyPlantAndEquipmentGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PropertyPlantAndEquipmentGross", "crdr": "debit", "calculation": { "http://passagebio.com/role/PropertyAndEquipmentNetFyDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://passagebio.com/role/PropertyAndEquipmentNetFyDetails", "http://passagebio.com/role/PropertyAndEquipmentNetQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Total property and equipment", "label": "Property, Plant and Equipment, Gross", "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r70", "r110", "r593" ] }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PropertyPlantAndEquipmentLineItems", "presentation": [ "http://passagebio.com/role/PropertyAndEquipmentNetFyDetails", "http://passagebio.com/role/PropertyAndEquipmentNetNarrativeFyDetails", "http://passagebio.com/role/PropertyAndEquipmentNetQ1Details" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Line Items]", "terseLabel": "Property and Equipment, Net", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r533" ] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://passagebio.com/role/BalanceSheetsFy": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 }, "http://passagebio.com/role/PropertyAndEquipmentNetFyDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://passagebio.com/role/BalanceSheetsFy", "http://passagebio.com/role/BalanceSheetsQ1", "http://passagebio.com/role/PropertyAndEquipmentNetFyDetails", "http://passagebio.com/role/PropertyAndEquipmentNetQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Property and equipment, net", "totalLabel": "Total, property plant and equipment net", "label": "Property, Plant and Equipment, Net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r7", "r533", "r580", "r593", "r764" ] }, "us-gaap_PropertyPlantAndEquipmentOtherTypesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PropertyPlantAndEquipmentOtherTypesMember", "presentation": [ "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesFyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Assets", "label": "Property, Plant and Equipment, Other Types [Member]", "documentation": "Long-lived, physical assets used to produce goods and services and not intended for resale, classified as other." } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "presentation": [ "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesFyPolicies", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesQ1Policies" ], "lang": { "en-us": { "role": { "terseLabel": "Property and Equipment, Net", "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r7", "r95", "r96", "r591" ] }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PropertyPlantAndEquipmentTextBlock", "presentation": [ "http://passagebio.com/role/PropertyAndEquipmentNetFyTables", "http://passagebio.com/role/PropertyAndEquipmentNetQ1Tables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of property and equipment, net", "label": "Property, Plant and Equipment [Table Text Block]", "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r7" ] }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PropertyPlantAndEquipmentTypeDomain", "presentation": [ "http://passagebio.com/role/LeasesFyDetails", "http://passagebio.com/role/LeasesQ1Details", "http://passagebio.com/role/PropertyAndEquipmentNetFyDetails", "http://passagebio.com/role/PropertyAndEquipmentNetQ1Details", "http://passagebio.com/role/SubsequentEventsQ1Details", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesFyDetails", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesQ1Details" ], "lang": { "en-us": { "role": { "label": "Long-Lived Tangible Asset [Domain]", "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "auth_ref": [ "r70", "r533" ] }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PropertyPlantAndEquipmentUsefulLife", "presentation": [ "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesFyDetails", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Useful life", "label": "Property, Plant and Equipment, Useful Life", "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment." } } }, "auth_ref": [] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "RangeAxis", "presentation": [ "http://passagebio.com/role/CommonStockFyDetails", "http://passagebio.com/role/LeasesFyDetails", "http://passagebio.com/role/LeasesQ1Details", "http://passagebio.com/role/RisksAndLiquidityFyDetails", "http://passagebio.com/role/RisksLiquidityAndGoingConcernQ1Details" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [ "r180", "r286", "r287", "r288", "r289", "r342", "r352", "r383", "r384", "r385", "r391", "r403", "r481", "r545", "r554", "r570", "r612", "r614", "r622", "r635", "r636", "r687", "r688", "r689", "r690", "r691", "r694", "r695", "r696", "r697", "r699", "r700", "r727", "r733", "r739", "r743", "r745", "r746", "r755", "r756", "r760", "r761", "r768", "r775", "r840", "r844", "r894", "r915", "r916", "r917", "r918", "r919" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "RangeMember", "presentation": [ "http://passagebio.com/role/CommonStockFyDetails", "http://passagebio.com/role/LeasesFyDetails", "http://passagebio.com/role/LeasesQ1Details", "http://passagebio.com/role/RisksAndLiquidityFyDetails", "http://passagebio.com/role/RisksLiquidityAndGoingConcernQ1Details" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]" } } }, "auth_ref": [ "r180", "r286", "r287", "r288", "r289", "r342", "r352", "r383", "r384", "r385", "r391", "r403", "r481", "r545", "r554", "r570", "r612", "r614", "r622", "r635", "r636", "r687", "r688", "r689", "r690", "r691", "r694", "r695", "r696", "r697", "r699", "r700", "r727", "r733", "r739", "r743", "r745", "r746", "r755", "r756", "r760", "r761", "r768", "r775", "r840", "r844", "r894", "r915", "r916", "r917", "r918", "r919" ] }, "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable", "presentation": [ "http://passagebio.com/role/SegmentReportingFyDetails", "http://passagebio.com/role/SegmentReportingQ1Details" ], "lang": { "en-us": { "role": { "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]", "documentation": "Disclosure of information about the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment." } } }, "auth_ref": [ "r27", "r28" ] }, "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "presentation": [ "http://passagebio.com/role/SegmentReportingFyTables", "http://passagebio.com/role/SegmentReportingQ1Tables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of reconciliation of reported segment net loss to the statement of operations", "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]", "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment." } } }, "auth_ref": [ "r27", "r28" ] }, "pasg_RemainingCapacityOfValueOfSharesAvailableToBeSold": { "xbrltype": "monetaryItemType", "nsuri": "http://passagebio.com/20260721", "localname": "RemainingCapacityOfValueOfSharesAvailableToBeSold", "crdr": "credit", "presentation": [ "http://passagebio.com/role/RisksLiquidityAndGoingConcernQ1Details" ], "lang": { "en-us": { "role": { "documentation": "The remaining capacity of value of shares available to be sold.", "label": "Remaining Capacity of Value of Shares Available to Be Sold", "terseLabel": "Remaining capacity available to be sold" } } }, "auth_ref": [] }, "pasg_ResearchAndDevelopmentDepreciationAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://passagebio.com/20260721", "localname": "ResearchAndDevelopmentDepreciationAndAmortization", "crdr": "debit", "calculation": { "http://passagebio.com/role/SegmentReportingFyDetails": { "parentTag": "us-gaap_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://passagebio.com/role/SegmentReportingFyDetails", "http://passagebio.com/role/SegmentReportingQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Amount of expenses in the period for usage of depreciation and amortization attributable specifically to research and development division.", "label": "Research and Development, Depreciation and Amortization", "terseLabel": "Depreciation and amortization" } } }, "auth_ref": [] }, "us-gaap_ResearchAndDevelopmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ResearchAndDevelopmentExpense", "crdr": "debit", "calculation": { "http://passagebio.com/role/StatementsOfOperationsAndComprehensiveLossFy": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 3.0 }, "http://passagebio.com/role/SegmentReportingFyDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://passagebio.com/role/SegmentReportingFyDetails", "http://passagebio.com/role/SegmentReportingQ1Details", "http://passagebio.com/role/StatementsOfOperationsAndComprehensiveLossFy", "http://passagebio.com/role/StatementsOfOperationsAndComprehensiveLossQ1" ], "lang": { "en-us": { "role": { "terseLabel": "Research and development", "totalLabel": "Total research and development expenses", "label": "Research and Development Expense", "documentation": "Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity." } } }, "auth_ref": [ "r405", "r701", "r707", "r708", "r722", "r920" ] }, "us-gaap_ResearchAndDevelopmentExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ResearchAndDevelopmentExpenseAbstract", "presentation": [ "http://passagebio.com/role/SegmentReportingFyDetails", "http://passagebio.com/role/SegmentReportingQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Research and development", "label": "Research and Development Expense [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ResearchAndDevelopmentExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ResearchAndDevelopmentExpenseMember", "presentation": [ "http://passagebio.com/role/SeveranceFyDetails", "http://passagebio.com/role/SeveranceQ1Details", "http://passagebio.com/role/SharebasedCompensationSharebasedCompensationExpenseFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationSharebasedCompensationExpenseQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Research and development", "label": "Research and Development Expense [Member]", "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included." } } }, "auth_ref": [] }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ResearchAndDevelopmentExpensePolicy", "presentation": [ "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesFyPolicies", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesQ1Policies" ], "lang": { "en-us": { "role": { "terseLabel": "Research and Development", "label": "Research and Development Expense, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process." } } }, "auth_ref": [ "r404" ] }, "pasg_ResearchAndDevelopmentLaborAndRelatedExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://passagebio.com/20260721", "localname": "ResearchAndDevelopmentLaborAndRelatedExpenses", "crdr": "debit", "calculation": { "http://passagebio.com/role/SegmentReportingFyDetails": { "parentTag": "us-gaap_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://passagebio.com/role/SegmentReportingFyDetails", "http://passagebio.com/role/SegmentReportingQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit directly attributable to research and development phase of the medicines.", "label": "Research And Development, Labor And Related Expenses", "verboseLabel": "Wages, benefits, and other payroll" } } }, "auth_ref": [] }, "pasg_ResearchAndDevelopmentShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://passagebio.com/20260721", "localname": "ResearchAndDevelopmentShareBasedCompensation", "crdr": "debit", "calculation": { "http://passagebio.com/role/SegmentReportingFyDetails": { "parentTag": "us-gaap_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://passagebio.com/role/SegmentReportingFyDetails", "http://passagebio.com/role/SegmentReportingQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Amount of expenses in the period for usage of share based compensation attributable specifically to research and development division.", "label": "Research and Development, Share Based Compensation", "terseLabel": "Share-based compensation" } } }, "auth_ref": [] }, "pasg_ResearchAndDevelopmentThirdPartyCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://passagebio.com/20260721", "localname": "ResearchAndDevelopmentThirdPartyCosts", "crdr": "debit", "calculation": { "http://passagebio.com/role/SegmentReportingFyDetails": { "parentTag": "us-gaap_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://passagebio.com/role/SegmentReportingFyDetails", "http://passagebio.com/role/SegmentReportingQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Amount of expenses in the period for usage of third party costs attributable specifically to research and development division.", "label": "Research and Development, Third Party Costs", "terseLabel": "Third-party costs" } } }, "auth_ref": [] }, "us-gaap_ResearchMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ResearchMember", "presentation": [ "http://passagebio.com/role/IncomeTaxesNetOperatingLossesFyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Research tax credits", "label": "Research Tax Credit Carryforward [Member]", "documentation": "Research tax credit carryforwards arising from certain qualifying expenditures incurred to develop new products and processes." } } }, "auth_ref": [ "r881" ] }, "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember", "presentation": [ "http://passagebio.com/role/CashCashEquivalentsAndMarketableSecuritiesPortfolioOfCashAndCashEquivalentsFyDetails", "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsRecurringBasisFyDetails" ], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents [Domain]", "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r109" ] }, "us-gaap_RestrictedStockUnitsRSUMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RestrictedStockUnitsRSUMember", "presentation": [ "http://passagebio.com/role/SharebasedCompensationRestrictedStockUnitsFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationRestrictedStockUnitsQ1Details", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesFyDetails", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Unvested restricted stock units", "label": "Restricted Stock Units (RSUs) [Member]", "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met." } } }, "auth_ref": [ "r847", "r848", "r849", "r850", "r851", "r852", "r853", "r854", "r855", "r856", "r857", "r858", "r859", "r860", "r861", "r862", "r863", "r864", "r865", "r866", "r867", "r868", "r869", "r870", "r871", "r872" ] }, "us-gaap_RestructuringAndRelatedActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RestructuringAndRelatedActivitiesAbstract", "lang": { "en-us": { "role": { "label": "Severance" } } }, "auth_ref": [] }, "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock", "presentation": [ "http://passagebio.com/role/SeveranceFy", "http://passagebio.com/role/SeveranceQ1" ], "lang": { "en-us": { "role": { "terseLabel": "Severance", "label": "Restructuring and Related Activities Disclosure [Text Block]", "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled." } } }, "auth_ref": [ "r272", "r273", "r275", "r278", "r282" ] }, "us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent", "presentation": [ "http://passagebio.com/role/LeasesFyDetails", "http://passagebio.com/role/PropertyAndEquipmentNetNarrativeFyDetails", "http://passagebio.com/role/SeveranceFyDetails", "http://passagebio.com/role/SeveranceQ1Details" ], "lang": { "en-us": { "role": { "verboseLabel": "Workforce reduction", "terseLabel": "Number of positions eliminated, period percent", "label": "Restructuring and Related Cost, Number of Positions Eliminated, Period Percent", "documentation": "The number of positions eliminated during the period as a percentage of total positions eliminated during the period in connection with the restructuring plan(s)." } } }, "auth_ref": [] }, "us-gaap_RestructuringCostAndReserveAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RestructuringCostAndReserveAxis", "presentation": [ "http://passagebio.com/role/LeasesFyDetails", "http://passagebio.com/role/PropertyAndEquipmentNetNarrativeFyDetails", "http://passagebio.com/role/SeveranceFyDetails", "http://passagebio.com/role/SeveranceQ1Details" ], "lang": { "en-us": { "role": { "label": "Restructuring Type [Axis]", "documentation": "Information by type of restructuring cost." } } }, "auth_ref": [ "r132", "r133", "r274", "r275", "r279", "r280", "r708" ] }, "us-gaap_RestructuringCostAndReserveLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RestructuringCostAndReserveLineItems", "presentation": [ "http://passagebio.com/role/SeveranceFyDetails", "http://passagebio.com/role/SeveranceQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Severance", "label": "Restructuring Cost and Reserve [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r274", "r275", "r276", "r277", "r279", "r280", "r281" ] }, "pasg_RestructuringPlanReductionInWorkforcePercentage": { "xbrltype": "percentItemType", "nsuri": "http://passagebio.com/20260721", "localname": "RestructuringPlanReductionInWorkforcePercentage", "presentation": [ "http://passagebio.com/role/SubsequentEventsQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Percentage of reduction in workforce as a part of restructuring plan.", "label": "Restructuring Plan, Reduction In Workforce, Percentage", "terseLabel": "Reduction in workforce" } } }, "auth_ref": [] }, "us-gaap_RestructuringReserve": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RestructuringReserve", "crdr": "credit", "presentation": [ "http://passagebio.com/role/SeveranceFyDetails", "http://passagebio.com/role/SeveranceQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Unpaid severance", "label": "Restructuring Reserve", "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan." } } }, "auth_ref": [ "r275", "r280" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://passagebio.com/role/BalanceSheetsFy": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://passagebio.com/role/BalanceSheetsFy", "http://passagebio.com/role/BalanceSheetsQ1", "http://passagebio.com/role/RisksAndLiquidityFyDetails", "http://passagebio.com/role/RisksLiquidityAndGoingConcernQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated deficit", "label": "Retained Earnings (Accumulated Deficit)", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r53", "r77", "r589", "r619", "r621", "r630", "r646", "r764" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RetainedEarningsMember", "presentation": [ "http://passagebio.com/role/StatementsOfStockholdersEquityFy", "http://passagebio.com/role/StatementsOfStockholdersEquityQ1" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated deficit", "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r101", "r102", "r103", "r147", "r148", "r149", "r151", "r158", "r160", "r162", "r247", "r248", "r268", "r303", "r392", "r432", "r433", "r440", "r441", "r442", "r444", "r447", "r448", "r461", "r463", "r464", "r466", "r473", "r514", "r516", "r616", "r618", "r632", "r958" ] }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "presentation": [ "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesFyPolicies", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesQ1Policies" ], "lang": { "en-us": { "role": { "verboseLabel": "License and Other Revenue", "label": "Revenue from Contract with Customer [Policy Text Block]", "documentation": "Disclosure of accounting policy for revenue from contract with customer." } } }, "auth_ref": [ "r99", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r702" ] }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "crdr": "debit", "presentation": [ "http://passagebio.com/role/StatementsOfCashFlowsFy" ], "lang": { "en-us": { "role": { "negatedLabel": "Right of use assets recognized upon the commencement of sublease", "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability", "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability." } } }, "auth_ref": [ "r529", "r763" ] }, "pasg_RightOfUseAssetsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://passagebio.com/20260721", "localname": "RightOfUseAssetsFairValueDisclosure", "crdr": "debit", "calculation": { "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsNonrecurringBasisFyDetails": { "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsNonrecurringBasisFyDetails" ], "lang": { "en-us": { "role": { "documentation": "Fair value portion of right of use assets.", "label": "Right of use Assets, Fair Value Disclosure", "terseLabel": "Right of use assets" } } }, "auth_ref": [] }, "pasg_RightOfUsePeriodDecreaseDueToLeaseTermination": { "xbrltype": "monetaryItemType", "nsuri": "http://passagebio.com/20260721", "localname": "RightOfUsePeriodDecreaseDueToLeaseTermination", "crdr": "credit", "presentation": [ "http://passagebio.com/role/LeasesQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Right of Use period decrease due to lease termination.", "label": "Right of Use Period Decrease due to Lease Termination" } } }, "auth_ref": [] }, "pasg_RisksAndLiquidityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://passagebio.com/20260721", "localname": "RisksAndLiquidityAbstract", "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Risks and Liquidity" } } }, "auth_ref": [] }, "pasg_RisksAndLiquidityLineItems": { "xbrltype": "stringItemType", "nsuri": "http://passagebio.com/20260721", "localname": "RisksAndLiquidityLineItems", "presentation": [ "http://passagebio.com/role/RisksAndLiquidityFyDetails", "http://passagebio.com/role/RisksLiquidityAndGoingConcernQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Risks And Liquidity [Line Items]", "terseLabel": "Risks, Liquidity, and Going Concern" } } }, "auth_ref": [] }, "pasg_RisksAndLiquidityTable": { "xbrltype": "stringItemType", "nsuri": "http://passagebio.com/20260721", "localname": "RisksAndLiquidityTable", "presentation": [ "http://passagebio.com/role/RisksAndLiquidityFyDetails", "http://passagebio.com/role/RisksLiquidityAndGoingConcernQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Schedule of information pertaining to risk and liquidity.", "label": "Risks And Liquidity [Table]" } } }, "auth_ref": [] }, "pasg_RisksAndLiquidityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://passagebio.com/20260721", "localname": "RisksAndLiquidityTextBlock", "presentation": [ "http://passagebio.com/role/RisksAndLiquidityFy", "http://passagebio.com/role/RisksLiquidityAndGoingConcernQ1" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of information pertaining to risk and liquidity.", "label": "Risks And Liquidity [Text Block]", "verboseLabel": "Risks and Liquidity", "terseLabel": "Risks, Liquidity, and Going Concern" } } }, "auth_ref": [] }, "pasg_RisksLiquidityAndGoingConcernAbstract": { "xbrltype": "stringItemType", "nsuri": "http://passagebio.com/20260721", "localname": "RisksLiquidityAndGoingConcernAbstract", "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Risks, Liquidity, and Going Concern [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SaleOfStockNameOfTransactionDomain", "presentation": [ "http://passagebio.com/role/CommonStockFyDetails", "http://passagebio.com/role/RisksAndLiquidityFyDetails", "http://passagebio.com/role/RisksLiquidityAndGoingConcernQ1Details" ], "lang": { "en-us": { "role": { "label": "Sale of Stock [Domain]", "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement." } } }, "auth_ref": [] }, "pasg_ScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://passagebio.com/20260721", "localname": "ScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesTableTextBlock", "presentation": [ "http://passagebio.com/role/AccruedExpensesAndOtherCurrentLiabilitiesFyTables", "http://passagebio.com/role/AccruedExpensesAndOtherCurrentLiabilitiesQ1Tables" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information pertaining to accrued expenses and other current liabilities.", "label": "Schedule Of Accrued Liabilities And Other Current Liabilities [Table Text Block]", "terseLabel": "Schedule of accrued liabilities and other current liabilities" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "presentation": [ "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesFyDetails", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesQ1Details" ], "lang": { "en-us": { "role": { "label": "Antidilutive Security, Excluded EPS Calculation [Table]", "documentation": "Disclosure of information about security that could potentially dilute basic earnings per share (EPS) in future that was not included in calculation of diluted EPS." } } }, "auth_ref": [ "r170" ] }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "presentation": [ "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesFyTables", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesQ1Tables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of antidilutive securities excluded from computation of earnings per share", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]", "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities." } } }, "auth_ref": [ "r25" ] }, "us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock", "presentation": [ "http://passagebio.com/role/CashCashEquivalentsAndMarketableSecuritiesFyTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of details regarding the Company's portfolio of marketable securities", "label": "Schedule of Available-for-Sale Securities Reconciliation [Table Text Block]", "documentation": "Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfCashAndCashEquivalentsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfCashAndCashEquivalentsTable", "presentation": [ "http://passagebio.com/role/CashCashEquivalentsAndMarketableSecuritiesPortfolioOfCashAndCashEquivalentsFyDetails", "http://passagebio.com/role/CashCashEquivalentsAndMarketableSecuritiesPortfolioOfMarketableSecuritiesFyDetails" ], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalent [Table]", "documentation": "Disclosure of information about cash and cash equivalent by type. Excludes restricted cash and cash equivalent." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock", "presentation": [ "http://passagebio.com/role/CashCashEquivalentsAndMarketableSecuritiesFyTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of details regarding the Company's portfolio of cash and cash equivalents", "label": "Schedule of Cash and Cash Equivalents [Table Text Block]", "documentation": "Tabular disclosure of the components of cash and cash equivalents." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable", "presentation": [ "http://passagebio.com/role/CommitmentsAndContingenciesCollaborationAgreementsFyDetails", "http://passagebio.com/role/CommitmentsAndContingenciesCollaborationAgreementsQ1Details", "http://passagebio.com/role/GemmaLicenseAgreementFyDetails", "http://passagebio.com/role/GemmaLicenseAgreementQ1Details" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]", "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r451" ] }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "presentation": [ "http://passagebio.com/role/IncomeTaxesFyTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of deferred tax assets and liabilities", "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]", "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets." } } }, "auth_ref": [ "r880" ] }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "presentation": [ "http://passagebio.com/role/IncomeTaxesFyTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of effective income tax rate reconciliation", "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations." } } }, "auth_ref": [ "r415", "r742", "r875" ] }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "presentation": [ "http://passagebio.com/role/SharebasedCompensationFyTables", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationQ1Tables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of share-based compensation expense category", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]", "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement." } } }, "auth_ref": [ "r40" ] }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "presentation": [ "http://passagebio.com/role/PropertyAndEquipmentNetFyDetails", "http://passagebio.com/role/PropertyAndEquipmentNetNarrativeFyDetails", "http://passagebio.com/role/PropertyAndEquipmentNetQ1Details" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Table]", "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r7", "r533" ] }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfRestructuringAndRelatedCostsTable", "presentation": [ "http://passagebio.com/role/SeveranceFyDetails", "http://passagebio.com/role/SeveranceQ1Details" ], "lang": { "en-us": { "role": { "label": "Restructuring Cost [Table]", "documentation": "Disclosure of information about restructuring cost. Includes, but is not limited to, expected cost, cost incurred, statement of income caption that includes restructuring cost recognized, and amount of restructuring reserve." } } }, "auth_ref": [ "r274", "r275", "r276", "r277", "r279", "r280", "r281" ] }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "presentation": [ "http://passagebio.com/role/SharebasedCompensationEquityIncentivePlanEsppFyDetails", "http://passagebio.com/role/SharebasedCompensationRestrictedStockUnitsFyDetails", "http://passagebio.com/role/SharebasedCompensationSharebasedCompensationExpenseFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationAssumptionsUsedInDeterminingFairValueEarlyExerciseOfStockOptionsQ1Details", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationEquityIncentivePlanEsppQ1Details", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationRestrictedStockUnitsQ1Details", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationSharebasedCompensationExpenseQ1Details" ], "lang": { "en-us": { "role": { "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "documentation": "Disclosure of information about share-based payment arrangement." } } }, "auth_ref": [ "r354", "r356", "r358", "r359", "r360", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r381", "r382", "r383", "r384", "r385", "r386", "r391" ] }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "presentation": [ "http://passagebio.com/role/SharebasedCompensationFyTables", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationQ1Tables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of stock option activity plan", "label": "Schedule of stock option activity plan", "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value." } } }, "auth_ref": [ "r12", "r13", "r79" ] }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "presentation": [ "http://passagebio.com/role/SharebasedCompensationFyTables", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationQ1Tables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of weighted average assumptions applied to options", "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]", "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions." } } }, "auth_ref": [ "r81" ] }, "us-gaap_ScheduleOfStockByClassTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfStockByClassTable", "presentation": [ "http://passagebio.com/role/CommonStockFyDetails" ], "lang": { "en-us": { "role": { "label": "Stock, Class of Stock [Table]", "documentation": "Disclosure of information about stock by class. Includes, but is not limited to, common, convertible, and preferred stocks." } } }, "auth_ref": [ "r32", "r33", "r34", "r35", "r36", "r37", "r75", "r76", "r77", "r114", "r115", "r116", "r175", "r314", "r315", "r316", "r318", "r321", "r326", "r328", "r460", "r626", "r627", "r628", "r629", "r733", "r797", "r813", "r815" ] }, "us-gaap_SegmentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SegmentDomain", "presentation": [ "http://passagebio.com/role/SegmentReportingFyDetails", "http://passagebio.com/role/SegmentReportingQ1Details" ], "lang": { "en-us": { "role": { "label": "Segments [Domain]", "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r86", "r87", "r88", "r89", "r173", "r182", "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r194", "r195", "r196", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r207", "r208", "r209", "r212", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r277", "r281", "r445", "r446", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r719", "r722", "r723", "r729", "r769", "r924", "r926", "r927", "r928", "r929", "r930", "r931", "r932", "r933", "r934", "r935", "r936", "r937", "r938", "r939", "r940", "r941", "r942", "r943", "r944", "r945", "r946", "r947", "r948", "r949", "r950", "r951", "r953", "r954" ] }, "us-gaap_SegmentReportingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SegmentReportingAbstract", "lang": { "en-us": { "role": { "label": "Segment Reporting" } } }, "auth_ref": [] }, "us-gaap_SegmentReportingDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SegmentReportingDisclosureTextBlock", "presentation": [ "http://passagebio.com/role/SegmentReportingFy", "http://passagebio.com/role/SegmentReportingQ1" ], "lang": { "en-us": { "role": { "terseLabel": "Segment Reporting", "label": "Segment Reporting Disclosure [Text Block]", "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments." } } }, "auth_ref": [ "r89", "r173", "r181", "r182", "r183", "r184", "r185", "r197", "r199", "r200", "r205", "r206", "r207", "r208", "r209", "r210", "r211", "r212", "r718", "r720", "r721", "r722", "r724", "r725", "r726" ] }, "us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems", "presentation": [ "http://passagebio.com/role/SegmentReportingFyDetails", "http://passagebio.com/role/SegmentReportingQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Segment Reporting", "label": "Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_SeveranceCosts1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SeveranceCosts1", "crdr": "debit", "presentation": [ "http://passagebio.com/role/SeveranceFyDetails", "http://passagebio.com/role/SeveranceQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Severance and termination-related expenses", "label": "Severance Costs", "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation." } } }, "auth_ref": [ "r5" ] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://passagebio.com/role/StatementsOfCashFlowsFy": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 8.0 }, "http://passagebio.com/role/StatementsOfCashFlowsQ1": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://passagebio.com/role/StatementsOfCashFlowsFy", "http://passagebio.com/role/StatementsOfCashFlowsQ1" ], "lang": { "en-us": { "role": { "terseLabel": "Sharebased compensation", "label": "Share-Based Payment Arrangement, Noncash Expense", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r4" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "presentation": [ "http://passagebio.com/role/SharebasedCompensationEquityIncentivePlanEsppFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationEquityIncentivePlanEsppQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Vesting period", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period", "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition." } } }, "auth_ref": [ "r740" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "presentation": [ "http://passagebio.com/role/SharebasedCompensationRestrictedStockUnitsFyDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Forfeited", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period." } } }, "auth_ref": [ "r375" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "presentation": [ "http://passagebio.com/role/SharebasedCompensationRestrictedStockUnitsFyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Forfeited, Weighted average grant date fair value", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event." } } }, "auth_ref": [ "r375" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "presentation": [ "http://passagebio.com/role/SharebasedCompensationRestrictedStockUnitsFyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Granted", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period", "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r373" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://passagebio.com/role/SharebasedCompensationRestrictedStockUnitsFyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Granted, Weighted average grant date fair value", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r373" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "presentation": [ "http://passagebio.com/role/SharebasedCompensationRestrictedStockUnitsFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationRestrictedStockUnitsQ1Details" ], "lang": { "en-us": { "role": { "periodEndLabel": "Unvested balance, Ending", "periodStartLabel": "Unvested balance, Beginning", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date." } } }, "auth_ref": [ "r370", "r371" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "presentation": [ "http://passagebio.com/role/SharebasedCompensationRestrictedStockUnitsFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationRestrictedStockUnitsQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Unvested balance, Weighted average grant date fair value, Beginning", "periodEndLabel": "Unvested balance, Weighted average grant date fair value, Ending", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [ "r370", "r371" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms", "presentation": [ "http://passagebio.com/role/SharebasedCompensationRestrictedStockUnitsFyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-average remaining contractual term", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms", "documentation": "Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r80" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "presentation": [ "http://passagebio.com/role/SharebasedCompensationRestrictedStockUnitsFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationRestrictedStockUnitsQ1Details" ], "lang": { "en-us": { "role": { "negatedLabel": "Vested", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period." } } }, "auth_ref": [ "r374" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://passagebio.com/role/SharebasedCompensationRestrictedStockUnitsFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationRestrictedStockUnitsQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Vested, Weighted average grant date fair value", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement." } } }, "auth_ref": [ "r374" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract", "presentation": [ "http://passagebio.com/role/SharebasedCompensationAssumptionsUsedInDeterminingFairValueEarlyExerciseOfStockOptionsFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationAssumptionsUsedInDeterminingFairValueEarlyExerciseOfStockOptionsQ1Details" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "presentation": [ "http://passagebio.com/role/SharebasedCompensationAssumptionsUsedInDeterminingFairValueEarlyExerciseOfStockOptionsFyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected dividend yield", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term." } } }, "auth_ref": [ "r384" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "presentation": [ "http://passagebio.com/role/SharebasedCompensationAssumptionsUsedInDeterminingFairValueEarlyExerciseOfStockOptionsFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationAssumptionsUsedInDeterminingFairValueEarlyExerciseOfStockOptionsQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Expected volatility", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period." } } }, "auth_ref": [ "r383" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "presentation": [ "http://passagebio.com/role/SharebasedCompensationAssumptionsUsedInDeterminingFairValueEarlyExerciseOfStockOptionsFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationAssumptionsUsedInDeterminingFairValueEarlyExerciseOfStockOptionsQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Risk-free interest rate", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares." } } }, "auth_ref": [ "r385" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "presentation": [ "http://passagebio.com/role/SharebasedCompensationEquityIncentivePlanEsppFyDetails", "http://passagebio.com/role/SharebasedCompensationRestrictedStockUnitsFyDetails", "http://passagebio.com/role/SharebasedCompensationSharebasedCompensationExpenseFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationAssumptionsUsedInDeterminingFairValueEarlyExerciseOfStockOptionsQ1Details", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationEquityIncentivePlanEsppQ1Details", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationRestrictedStockUnitsQ1Details", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationSharebasedCompensationExpenseQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Share-Based Compensation", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r354", "r356", "r358", "r359", "r360", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r381", "r382", "r383", "r384", "r385", "r386", "r391" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "presentation": [ "http://passagebio.com/role/SharebasedCompensationEquityIncentivePlanEsppFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationEquityIncentivePlanEsppQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Shares authorized", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized", "documentation": "Number of shares authorized for issuance under share-based payment arrangement." } } }, "auth_ref": [ "r741" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "presentation": [ "http://passagebio.com/role/SharebasedCompensationEquityIncentivePlanEsppFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationEquityIncentivePlanEsppQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Shares available for future grant", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant", "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable." } } }, "auth_ref": [ "r38" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract", "presentation": [ "http://passagebio.com/role/SharebasedCompensationStockOptionActivityFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationStockOptionActivityQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average remaining contractual term (years)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "presentation": [ "http://passagebio.com/role/SharebasedCompensationStockOptionActivityFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationStockOptionActivityQ1Details" ], "lang": { "en-us": { "role": { "verboseLabel": "Vested and exercisable at December 31, 2025", "terseLabel": "Vested and exercisable at March 31, 2026", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number", "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan." } } }, "auth_ref": [ "r364" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "presentation": [ "http://passagebio.com/role/SharebasedCompensationStockOptionActivityFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationStockOptionActivityQ1Details" ], "lang": { "en-us": { "role": { "verboseLabel": "Vested and exercisable at December 31, 2025", "terseLabel": "Vested and exercisable at March 31, 2026", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan." } } }, "auth_ref": [ "r364" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod", "presentation": [ "http://passagebio.com/role/SharebasedCompensationStockOptionActivityFyDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Expired", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period", "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements." } } }, "auth_ref": [ "r369" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "presentation": [ "http://passagebio.com/role/SharebasedCompensationStockOptionActivityFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationStockOptionActivityQ1Details" ], "lang": { "en-us": { "role": { "negatedLabel": "Forfeited", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period", "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan." } } }, "auth_ref": [ "r368" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "presentation": [ "http://passagebio.com/role/SharebasedCompensationStockOptionActivityFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationStockOptionActivityQ1Details" ], "lang": { "en-us": { "role": { "verboseLabel": "Granted", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross", "documentation": "Gross number of share options (or share units) granted during the period." } } }, "auth_ref": [ "r366" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://passagebio.com/role/SharebasedCompensationStockOptionActivityFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationStockOptionActivityQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average grant date fair value of options granted", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value", "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology." } } }, "auth_ref": [ "r376" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "crdr": "debit", "presentation": [ "http://passagebio.com/role/SharebasedCompensationStockOptionActivityFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationStockOptionActivityQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate intrinsic value of options outstanding", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value", "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding." } } }, "auth_ref": [ "r38" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "presentation": [ "http://passagebio.com/role/SharebasedCompensationStockOptionActivityFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationStockOptionActivityQ1Details" ], "lang": { "en-us": { "role": { "periodEndLabel": "Outstanding, Ending of period", "periodStartLabel": "Outstanding, Beginning of period", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "documentation": "Number of options outstanding, including both vested and non-vested options." } } }, "auth_ref": [ "r362", "r363" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward", "presentation": [ "http://passagebio.com/role/SharebasedCompensationStockOptionActivityFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationStockOptionActivityQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Number of shares", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "presentation": [ "http://passagebio.com/role/SharebasedCompensationStockOptionActivityFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationStockOptionActivityQ1Details" ], "lang": { "en-us": { "role": { "periodEndLabel": "Outstanding, Ending of period", "periodStartLabel": "Outstanding, Beginning of period", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan." } } }, "auth_ref": [ "r362", "r363" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward", "presentation": [ "http://passagebio.com/role/SharebasedCompensationStockOptionActivityFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationStockOptionActivityQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average exercise price per share", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber", "presentation": [ "http://passagebio.com/role/SharebasedCompensationStockOptionActivityFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationStockOptionActivityQ1Details" ], "lang": { "en-us": { "role": { "verboseLabel": "Vested or expected to vest at December 31, 2025", "terseLabel": "Vested or expected to vest at March 31, 2026", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number", "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r378" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice", "presentation": [ "http://passagebio.com/role/SharebasedCompensationStockOptionActivityFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationStockOptionActivityQ1Details" ], "lang": { "en-us": { "role": { "verboseLabel": "Vested or expected to vest at December 31, 2025", "terseLabel": "Vested or expected to vest at March 31, 2026", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price", "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r378" ] }, "pasg_ShareBasedCompensationArrangementByShareBasedPaymentAwardTerm": { "xbrltype": "durationItemType", "nsuri": "http://passagebio.com/20260721", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardTerm", "presentation": [ "http://passagebio.com/role/SharebasedCompensationEquityIncentivePlanEsppFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationEquityIncentivePlanEsppQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Duration from date of grant (issuance of an option) to when option auto expires.", "label": "Share-based Compensation Arrangement By Share-based Payment Award Term", "terseLabel": "Term of award" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://passagebio.com/role/SharebasedCompensationRestrictedStockUnitsFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationAssumptionsUsedInDeterminingFairValueEarlyExerciseOfStockOptionsQ1Details", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationRestrictedStockUnitsQ1Details" ], "lang": { "en-us": { "role": { "label": "Award Type [Domain]", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r358", "r359", "r360", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r382", "r383", "r384", "r385", "r386" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://passagebio.com/role/SharebasedCompensationStockOptionActivityFyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expired", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price", "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired." } } }, "auth_ref": [ "r369" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "presentation": [ "http://passagebio.com/role/SharebasedCompensationStockOptionActivityFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationStockOptionActivityQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Forfeited", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price", "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated." } } }, "auth_ref": [ "r368" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://passagebio.com/role/SharebasedCompensationStockOptionActivityFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationStockOptionActivityQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Granted", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options." } } }, "auth_ref": [ "r366" ] }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "presentation": [ "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesFyPolicies", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesQ1Policies" ], "lang": { "en-us": { "role": { "terseLabel": "Share-Based Compensation", "label": "Share-Based Payment Arrangement [Policy Text Block]", "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost." } } }, "auth_ref": [ "r353", "r361", "r380", "r381", "r382", "r383", "r386", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401" ] }, "pasg_ShareBasedPaymentArrangementPercentageOfOutstandingCommonSharesAsAutomaticIncrease": { "xbrltype": "percentItemType", "nsuri": "http://passagebio.com/20260721", "localname": "ShareBasedPaymentArrangementPercentageOfOutstandingCommonSharesAsAutomaticIncrease", "presentation": [ "http://passagebio.com/role/SharebasedCompensationEquityIncentivePlanEsppFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationEquityIncentivePlanEsppQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Represents the percentage of outstanding common shares to be taken as automatic annual increase in rights granted under the share based payment arrangement", "label": "Share Based Payment Arrangement, Percentage Of Outstanding Common Shares As Automatic Increase", "terseLabel": "Percent of the total number of shares of the Company's common stock outstanding" } } }, "auth_ref": [] }, "pasg_ShareBasedPaymentArrangementPeriodTillWhichAutomaticIncreaseInRightsGranted": { "xbrltype": "durationItemType", "nsuri": "http://passagebio.com/20260721", "localname": "ShareBasedPaymentArrangementPeriodTillWhichAutomaticIncreaseInRightsGranted", "presentation": [ "http://passagebio.com/role/SharebasedCompensationEquityIncentivePlanEsppFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationEquityIncentivePlanEsppQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Represents the period till which there is automatic annual increase in rights granted under the share based payment arrangement.", "label": "Share Based Payment Arrangement, Period Till Which Automatic Increase In Rights Granted", "terseLabel": "Period till which there is automatic increase in rights granted under the Plan" } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "presentation": [ "http://passagebio.com/role/SharebasedCompensationAssumptionsUsedInDeterminingFairValueEarlyExerciseOfStockOptionsFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationAssumptionsUsedInDeterminingFairValueEarlyExerciseOfStockOptionsQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Expected term", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term", "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r382" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "crdr": "debit", "presentation": [ "http://passagebio.com/role/SharebasedCompensationStockOptionActivityFyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate intrinsic value of options exercisable", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value", "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable." } } }, "auth_ref": [ "r38" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "presentation": [ "http://passagebio.com/role/SharebasedCompensationStockOptionActivityFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationStockOptionActivityQ1Details" ], "lang": { "en-us": { "role": { "label": "Vested and exercisable at December 31, 2025", "terseLabel": "Vested and exercisable at March 31, 2026", "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r38" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward", "presentation": [ "http://passagebio.com/role/SharebasedCompensationRestrictedStockUnitsFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationRestrictedStockUnitsQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Number of shares", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract", "presentation": [ "http://passagebio.com/role/SharebasedCompensationRestrictedStockUnitsFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationRestrictedStockUnitsQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average grant date fair value", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "presentation": [ "http://passagebio.com/role/SharebasedCompensationStockOptionActivityFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationStockOptionActivityQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r80" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1", "presentation": [ "http://passagebio.com/role/SharebasedCompensationStockOptionActivityFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationStockOptionActivityQ1Details" ], "lang": { "en-us": { "role": { "label": "Vested or expected to vest at December 31, 2025", "terseLabel": "Vested or expected to vest at March 31, 2026", "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r378" ] }, "us-gaap_SharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SharesOutstanding", "presentation": [ "http://passagebio.com/role/StatementsOfStockholdersEquityFy", "http://passagebio.com/role/StatementsOfStockholdersEquityQ1" ], "lang": { "en-us": { "role": { "periodEndLabel": "Balance at end of period (in shares)", "periodStartLabel": "Balance at Beginning of period (in shares)", "label": "Shares, Outstanding", "documentation": "Number of shares issued which are neither cancelled nor held in the treasury." } } }, "auth_ref": [] }, "pasg_ShortTermLicenseFeeDueAndReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://passagebio.com/20260721", "localname": "ShortTermLicenseFeeDueAndReceivable", "crdr": "debit", "presentation": [ "http://passagebio.com/role/GemmaLicenseAgreementFyDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of license fee due and receivable in short-term as of the balance sheet date under the license agreement.", "label": "Short-Term License Fee Due And Receivable", "terseLabel": "Short-term license fee due and receivables" } } }, "auth_ref": [] }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SignificantAccountingPoliciesTextBlock", "presentation": [ "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesFy", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesQ1" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Significant Accounting Policies", "label": "Significant Accounting Policies [Text Block]", "documentation": "The entire disclosure for all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r139", "r140" ] }, "us-gaap_StateAndLocalJurisdictionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StateAndLocalJurisdictionMember", "presentation": [ "http://passagebio.com/role/IncomeTaxesNetOperatingLossesFyDetails" ], "lang": { "en-us": { "role": { "label": "State and Local Jurisdiction [Member]", "documentation": "Designated state or local jurisdiction entitled to levy and collect income tax." } } }, "auth_ref": [ "r413" ] }, "pasg_StateTaxAuthorityMember": { "xbrltype": "domainItemType", "nsuri": "http://passagebio.com/20260721", "localname": "StateTaxAuthorityMember", "presentation": [ "http://passagebio.com/role/IncomeTaxesNetOperatingLossesFyDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to state tax authorities.", "label": "State [Member]", "terseLabel": "State" } } }, "auth_ref": [] }, "us-gaap_StatementBusinessSegmentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StatementBusinessSegmentsAxis", "presentation": [ "http://passagebio.com/role/SegmentReportingFyDetails", "http://passagebio.com/role/SegmentReportingQ1Details" ], "lang": { "en-us": { "role": { "label": "Segments [Axis]", "documentation": "Information by business segments." } } }, "auth_ref": [ "r86", "r87", "r88", "r89", "r104", "r173", "r182", "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r194", "r195", "r196", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r207", "r208", "r209", "r212", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r270", "r277", "r281", "r445", "r446", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r719", "r722", "r723", "r729", "r769", "r924", "r926", "r927", "r928", "r929", "r930", "r931", "r932", "r933", "r934", "r935", "r936", "r937", "r938", "r939", "r940", "r941", "r942", "r943", "r944", "r945", "r946", "r947", "r948", "r949", "r950", "r951", "r953", "r954" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://passagebio.com/role/StatementsOfStockholdersEquityFy", "http://passagebio.com/role/StatementsOfStockholdersEquityQ1" ], "lang": { "en-us": { "role": { "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r11", "r51", "r54", "r55", "r101", "r102", "r103", "r126", "r127", "r128", "r147", "r148", "r149", "r151", "r158", "r160", "r162", "r174", "r247", "r248", "r268", "r303", "r329", "r392", "r432", "r433", "r440", "r441", "r442", "r444", "r447", "r448", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r473", "r507", "r508", "r509", "r510", "r511", "r512", "r514", "r516", "r535", "r595", "r616", "r617", "r618", "r632", "r682" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StatementLineItems", "presentation": [ "http://passagebio.com/role/StatementsOfStockholdersEquityFy", "http://passagebio.com/role/StatementsOfStockholdersEquityQ1" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r147", "r148", "r149", "r174", "r305", "r306", "r308", "r310", "r516", "r572", "r624", "r633", "r634", "r637", "r638", "r639", "r640", "r641", "r642", "r645", "r648", "r649", "r650", "r651", "r652", "r653", "r654", "r655", "r656", "r658", "r659", "r660", "r661", "r662", "r665", "r666", "r668", "r669", "r670", "r671", "r672", "r673", "r674", "r675", "r676", "r677", "r678", "r679", "r682", "r709", "r711", "r776", "r957" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statements of Cash Flows" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Balance Sheets" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "label": "Statements of Stockholders' Equity" } } }, "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StatementTable", "presentation": [ "http://passagebio.com/role/StatementsOfStockholdersEquityFy", "http://passagebio.com/role/StatementsOfStockholdersEquityQ1" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "documentation": "Presentation of information about comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity." } } }, "auth_ref": [ "r147", "r148", "r149", "r174", "r213", "r305", "r306", "r308", "r310", "r516", "r572", "r624", "r633", "r634", "r637", "r638", "r639", "r640", "r641", "r642", "r645", "r648", "r649", "r650", "r651", "r652", "r653", "r654", "r655", "r656", "r658", "r659", "r660", "r661", "r662", "r665", "r666", "r668", "r669", "r670", "r671", "r672", "r673", "r674", "r675", "r676", "r677", "r678", "r679", "r682", "r709", "r711", "r776", "r957" ] }, "pasg_StockIssuedDuringPeriodSettlementOfLitigation": { "xbrltype": "sharesItemType", "nsuri": "http://passagebio.com/20260721", "localname": "StockIssuedDuringPeriodSettlementOfLitigation", "presentation": [ "http://passagebio.com/role/CommitmentsAndContingenciesCollaborationAgreementsFyDetails", "http://passagebio.com/role/CommitmentsAndContingenciesCollaborationAgreementsQ1Details" ], "lang": { "en-us": { "role": { "documentation": "The number of stock issued during period for settlement of litigation.", "label": "Stock Issued During Period, Settlement of Litigation", "terseLabel": "Common stock" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans", "presentation": [ "http://passagebio.com/role/StatementsOfStockholdersEquityFy" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of shares in connection with employee stock purchase plan (in shares)", "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans", "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan." } } }, "auth_ref": [ "r11", "r50", "r51", "r77" ] }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockIssuedDuringPeriodSharesNewIssues", "presentation": [ "http://passagebio.com/role/CommonStockFyDetails", "http://passagebio.com/role/RisksAndLiquidityFyDetails", "http://passagebio.com/role/StatementsOfStockholdersEquityFy" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued", "verboseLabel": "Issuance of common stock under the ATM Facility, net of offering costs (in shares)", "label": "Stock Issued During Period, Shares, New Issues", "documentation": "Number of new stock issued during the period." } } }, "auth_ref": [ "r11", "r50", "r51", "r77", "r626", "r682", "r692" ] }, "us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockIssuedDuringPeriodSharesReverseStockSplits", "presentation": [ "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesFyDetails", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Stock issued during period, Reverse stock splits", "label": "Stock Issued During Period, Shares, Reverse Stock Splits", "documentation": "Reduction in the number of shares during the period as a result of a reverse stock split." } } }, "auth_ref": [ "r11" ] }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "presentation": [ "http://passagebio.com/role/StatementsOfStockholdersEquityFy", "http://passagebio.com/role/StatementsOfStockholdersEquityQ1" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise of stock options and vesting of restricted stock units (in shares)", "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture", "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r11", "r50", "r51", "r77" ] }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "presentation": [ "http://passagebio.com/role/SharebasedCompensationStockOptionActivityFyDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Exercised", "verboseLabel": "Exercise of stock options (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period", "documentation": "Number of share options (or share units) exercised during the current period." } } }, "auth_ref": [ "r11", "r50", "r51", "r77", "r367" ] }, "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan", "crdr": "credit", "presentation": [ "http://passagebio.com/role/StatementsOfStockholdersEquityFy" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of shares in connection with employee stock purchase plan", "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan", "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan." } } }, "auth_ref": [ "r11", "r50", "r51", "r77" ] }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockIssuedDuringPeriodValueNewIssues", "crdr": "credit", "presentation": [ "http://passagebio.com/role/CommonStockFyDetails", "http://passagebio.com/role/RisksAndLiquidityFyDetails", "http://passagebio.com/role/RisksLiquidityAndGoingConcernQ1Details", "http://passagebio.com/role/StatementsOfStockholdersEquityFy" ], "lang": { "en-us": { "role": { "terseLabel": "Sale of common stock, net of issuance costs", "verboseLabel": "Issuance of common stock under the ATM Facility, net of offering costs", "label": "Stock Issued During Period, Value, New Issues", "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering." } } }, "auth_ref": [ "r11", "r50", "r51", "r77", "r632", "r682", "r692", "r782" ] }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "crdr": "credit", "presentation": [ "http://passagebio.com/role/StatementsOfStockholdersEquityFy" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise of stock options and vesting of restricted stock units", "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture", "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r39", "r50", "r51", "r77" ] }, "pasg_StockOptionsIncludingSharesSubjectToRepurchaseMember": { "xbrltype": "domainItemType", "nsuri": "http://passagebio.com/20260721", "localname": "StockOptionsIncludingSharesSubjectToRepurchaseMember", "presentation": [ "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesFyDetails", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to stock options (including shares subject to repurchase).", "label": "Stock options (including shares subject to repurchase) [Member]", "verboseLabel": "Stock options" } } }, "auth_ref": [] }, "pasg_StockholderSEquityAndShareBasedCompensationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://passagebio.com/20260721", "localname": "StockholderSEquityAndShareBasedCompensationAbstract", "lang": { "en-us": { "role": { "label": "Stockholder's Equity and Share-Based Compensation [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://passagebio.com/role/BalanceSheetsFy": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://passagebio.com/role/BalanceSheetsFy", "http://passagebio.com/role/BalanceSheetsQ1", "http://passagebio.com/role/StatementsOfStockholdersEquityFy", "http://passagebio.com/role/StatementsOfStockholdersEquityQ1" ], "lang": { "en-us": { "role": { "totalLabel": "Total stockholders' equity", "periodStartLabel": "Balance at Beginning of period", "periodEndLabel": "Balance at end of period", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r51", "r54", "r55", "r67", "r647", "r663", "r683", "r684", "r764", "r783", "r813", "r816", "r817", "r837", "r905", "r958" ] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockholdersEquityAbstract", "presentation": [ "http://passagebio.com/role/BalanceSheetsFy", "http://passagebio.com/role/BalanceSheetsQ1" ], "lang": { "en-us": { "role": { "verboseLabel": "Stockholders' equity:", "label": "Equity, Attributable to Parent [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://passagebio.com/role/CommonStockFy" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock", "label": "Equity [Text Block]", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r74", "r313", "r315", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r327", "r329", "r460", "r472", "r685", "r686", "r693" ] }, "us-gaap_StockholdersEquityNoteStockSplitConversionRatio1": { "xbrltype": "pureItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockholdersEquityNoteStockSplitConversionRatio1", "presentation": [ "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesFyDetails", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Stock split", "label": "Stockholders' Equity Note, Stock Split, Conversion Ratio", "documentation": "Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one." } } }, "auth_ref": [ "r78" ] }, "pasg_SubleaseAgreementBMember": { "xbrltype": "domainItemType", "nsuri": "http://passagebio.com/20260721", "localname": "SubleaseAgreementBMember", "presentation": [ "http://passagebio.com/role/LeasesFyDetails", "http://passagebio.com/role/LeasesQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to Sublease Agreement B.", "label": "Sublease Agreement B [Member]", "terseLabel": "Sublease Agreement B" } } }, "auth_ref": [] }, "pasg_SubleaseAgreementCMember": { "xbrltype": "domainItemType", "nsuri": "http://passagebio.com/20260721", "localname": "SubleaseAgreementCMember", "presentation": [ "http://passagebio.com/role/LeasesFyDetails", "http://passagebio.com/role/LeasesQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to Sublease Agreement C.", "label": "Sublease Agreement C [Member]", "terseLabel": "Sublease Agreement C" } } }, "auth_ref": [] }, "pasg_SubleaseAgreementaMember": { "xbrltype": "domainItemType", "nsuri": "http://passagebio.com/20260721", "localname": "SubleaseAgreementaMember", "presentation": [ "http://passagebio.com/role/LeasesFyDetails", "http://passagebio.com/role/LeasesQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to Sublease Agreement A.", "label": "Sublease Agreement A [Member]", "terseLabel": "Sublease Agreement A" } } }, "auth_ref": [] }, "us-gaap_SubleaseIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SubleaseIncome", "crdr": "credit", "presentation": [ "http://passagebio.com/role/LeasesFyDetails", "http://passagebio.com/role/LeasesQ1Details", "http://passagebio.com/role/LeasesSubleaseIncomeFyDetails", "http://passagebio.com/role/LeasesSubleaseIncomeQ1Details", "http://passagebio.com/role/SubsequentEventsFyDetails", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesFyDetails", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Sublease Income", "verboseLabel": "Sublease rental income", "label": "Sublease Income", "documentation": "Amount of sublease income excluding finance and operating lease expense." } } }, "auth_ref": [ "r527", "r763" ] }, "us-gaap_SubsequentEventLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SubsequentEventLineItems", "presentation": [ "http://passagebio.com/role/SubsequentEventsQ1Details" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Events", "label": "Subsequent Event [Line Items]", "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event." } } }, "auth_ref": [ "r513", "r537" ] }, "us-gaap_SubsequentEventMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SubsequentEventMember", "presentation": [ "http://passagebio.com/role/PropertyAndEquipmentNetNarrativeFyDetails", "http://passagebio.com/role/SharebasedCompensationEquityIncentivePlanEsppFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationEquityIncentivePlanEsppQ1Details", "http://passagebio.com/role/SubsequentEventsQ1Details", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesFyDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Member]", "terseLabel": "Subsequent event", "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r513", "r537" ] }, "us-gaap_SubsequentEventTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SubsequentEventTable", "presentation": [ "http://passagebio.com/role/SubsequentEventsQ1Details" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Table]", "documentation": "Disclosure of information about significant event or transaction occurring between statement of financial position date and date when financial statements were issued." } } }, "auth_ref": [ "r513", "r537" ] }, "us-gaap_SubsequentEventTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SubsequentEventTypeAxis", "presentation": [ "http://passagebio.com/role/PropertyAndEquipmentNetNarrativeFyDetails", "http://passagebio.com/role/SharebasedCompensationEquityIncentivePlanEsppFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationEquityIncentivePlanEsppQ1Details", "http://passagebio.com/role/SubsequentEventsQ1Details", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesFyDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event Type [Axis]", "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r513", "r537" ] }, "us-gaap_SubsequentEventTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SubsequentEventTypeDomain", "presentation": [ "http://passagebio.com/role/PropertyAndEquipmentNetNarrativeFyDetails", "http://passagebio.com/role/SharebasedCompensationEquityIncentivePlanEsppFyDetails", "http://passagebio.com/role/StockholderSEquityAndSharebasedCompensationEquityIncentivePlanEsppQ1Details", "http://passagebio.com/role/SubsequentEventsQ1Details", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesFyDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event Type [Domain]", "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r513", "r537" ] }, "us-gaap_SubsequentEventsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SubsequentEventsAbstract", "lang": { "en-us": { "role": { "label": "Subsequent Events." } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://passagebio.com/role/SubsequentEventsFy", "http://passagebio.com/role/SubsequentEventsQ1" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Events", "label": "Subsequent Events [Text Block]", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r536", "r538" ] }, "us-gaap_SubsidiarySaleOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SubsidiarySaleOfStockAxis", "presentation": [ "http://passagebio.com/role/CommonStockFyDetails", "http://passagebio.com/role/RisksAndLiquidityFyDetails", "http://passagebio.com/role/RisksLiquidityAndGoingConcernQ1Details" ], "lang": { "en-us": { "role": { "label": "Sale of Stock [Axis]", "documentation": "Information by type of sale of the entity's stock." } } }, "auth_ref": [] }, "us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SummaryOfOperatingLossCarryforwardsTextBlock", "presentation": [ "http://passagebio.com/role/IncomeTaxesFyTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of net operating loss carryforwards", "label": "Summary of Operating Loss Carryforwards [Table Text Block]", "documentation": "Tabular disclosure of pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization." } } }, "auth_ref": [ "r881" ] }, "us-gaap_SupplementalCashFlowInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SupplementalCashFlowInformationAbstract", "presentation": [ "http://passagebio.com/role/StatementsOfCashFlowsFy", "http://passagebio.com/role/StatementsOfCashFlowsQ1" ], "lang": { "en-us": { "role": { "terseLabel": "Supplemental disclosure of noncash activities:", "label": "Supplemental Cash Flow Information [Abstract]" } } }, "auth_ref": [] }, "us-gaap_TaxCreditCarryforwardAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "TaxCreditCarryforwardAmount", "crdr": "debit", "presentation": [ "http://passagebio.com/role/IncomeTaxesNetOperatingLossesFyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Research tax credits", "label": "Tax Credit Carryforward, Amount", "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws." } } }, "auth_ref": [ "r430" ] }, "us-gaap_TaxCreditCarryforwardAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "TaxCreditCarryforwardAxis", "presentation": [ "http://passagebio.com/role/IncomeTaxesNetOperatingLossesFyDetails" ], "lang": { "en-us": { "role": { "label": "Tax Credit Carryforward [Axis]", "documentation": "Information by specific tax credit related to an unused tax credit." } } }, "auth_ref": [ "r430" ] }, "us-gaap_TaxCreditCarryforwardNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "TaxCreditCarryforwardNameDomain", "presentation": [ "http://passagebio.com/role/IncomeTaxesNetOperatingLossesFyDetails" ], "lang": { "en-us": { "role": { "label": "Tax Credit Carryforward, Name [Domain]", "documentation": "The name of the tax credit carryforward." } } }, "auth_ref": [ "r430" ] }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "presentation": [ "http://passagebio.com/role/CashCashEquivalentsAndMarketableSecuritiesPortfolioOfMarketableSecuritiesFyDetails", "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsRecurringBasisFyDetails" ], "lang": { "en-us": { "role": { "label": "Financial Instruments [Domain]", "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms." } } }, "auth_ref": [ "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r302", "r326", "r460", "r471", "r495", "r502", "r505", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r546", "r547", "r548", "r549", "r550", "r551", "r552", "r553", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r582", "r596", "r750", "r753", "r755", "r756", "r757", "r758", "r759", "r760", "r761", "r765", "r799", "r800", "r801", "r802", "r803", "r804", "r805", "r833", "r834", "r835", "r836", "r890", "r893", "r894", "r895", "r896", "r898", "r900", "r901" ] }, "us-gaap_TypeOfArrangementAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "TypeOfArrangementAxis", "presentation": [ "http://passagebio.com/role/CommitmentsAndContingenciesCollaborationAgreementsFyDetails", "http://passagebio.com/role/CommitmentsAndContingenciesCollaborationAgreementsQ1Details", "http://passagebio.com/role/GemmaLicenseAgreementFyDetails", "http://passagebio.com/role/GemmaLicenseAgreementQ1Details" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]", "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r451" ] }, "us-gaap_TypeOfRestructuringDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "TypeOfRestructuringDomain", "presentation": [ "http://passagebio.com/role/LeasesFyDetails", "http://passagebio.com/role/PropertyAndEquipmentNetNarrativeFyDetails", "http://passagebio.com/role/SeveranceFyDetails", "http://passagebio.com/role/SeveranceQ1Details" ], "lang": { "en-us": { "role": { "label": "Type of Restructuring [Domain]", "documentation": "Identification of the types of restructuring costs." } } }, "auth_ref": [ "r132", "r133", "r274", "r275", "r279", "r280", "r708" ] }, "country_US": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2025", "localname": "US", "presentation": [ "http://passagebio.com/role/IncomeTaxesNetOperatingLossesFyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Federal", "label": "UNITED STATES" } } }, "auth_ref": [] }, "us-gaap_USGovernmentDebtSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "USGovernmentDebtSecuritiesMember", "presentation": [ "http://passagebio.com/role/CashCashEquivalentsAndMarketableSecuritiesPortfolioOfMarketableSecuritiesFyDetails", "http://passagebio.com/role/FairValueOfFinancialInstrumentsAndNonfinancialInstrumentsRecurringBasisFyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "U.S. government securities", "label": "US Government Debt Securities [Member]", "documentation": "Debt securities issued by the United States government." } } }, "auth_ref": [ "r922" ] }, "pasg_UpfrontLicenseFeeReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://passagebio.com/20260721", "localname": "UpfrontLicenseFeeReceivable", "crdr": "debit", "presentation": [ "http://passagebio.com/role/GemmaLicenseAgreementFyDetails", "http://passagebio.com/role/GemmaLicenseAgreementQ1Details" ], "lang": { "en-us": { "role": { "documentation": "Amount of upfront license fee that is receivable under the license arrangement.", "label": "Upfront License Fee Receivable", "terseLabel": "Upfront license fee receivable" } } }, "auth_ref": [] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "UseOfEstimates", "presentation": [ "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesFyPolicies", "http://passagebio.com/role/SummaryOfSignificantAccountingPoliciesQ1Policies" ], "lang": { "en-us": { "role": { "terseLabel": "Use of Estimates", "label": "Use of Estimates, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r93", "r94", "r176", "r178", "r179", "r180", "r577", "r579", "r715" ] }, "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount", "crdr": "credit", "presentation": [ "http://passagebio.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesFyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Valuation allowance increased", "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount", "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset." } } }, "auth_ref": [ "r423" ] }, "us-gaap_VariableLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "VariableLeaseCost", "crdr": "debit", "calculation": { "http://passagebio.com/role/LeasesOperatingLeaseCostFyDetails": { "parentTag": "us-gaap_LeaseCost", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://passagebio.com/role/LeasesOperatingLeaseCostFyDetails", "http://passagebio.com/role/LeasesOperatingLeaseCostQ1Details" ], "lang": { "en-us": { "role": { "label": "Variable lease cost", "terseLabel": "Variable lease expense", "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases." } } }, "auth_ref": [ "r526", "r763" ] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "presentation": [ "http://passagebio.com/role/StatementsOfOperationsAndComprehensiveLossFy", "http://passagebio.com/role/StatementsOfOperationsAndComprehensiveLossQ1" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average common shares outstanding, diluted", "label": "Weighted Average Number of Shares Outstanding, Diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r164", "r169" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "presentation": [ "http://passagebio.com/role/StatementsOfOperationsAndComprehensiveLossFy", "http://passagebio.com/role/StatementsOfOperationsAndComprehensiveLossQ1" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average common shares outstanding, basic", "label": "Weighted Average Number of Shares Outstanding, Basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r163", "r169" ] } } }, "ny20077915x1_ex107.htm": { "dts": { "inline": { "local": [ "ny20077915x1_ex107.htm" ] }, "schema": { "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd", "https://xbrl.sec.gov/dei/2025/dei-2025.xsd", "https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd" ] } }, "keyStandard": 21, "keyCustom": 0, "axisStandard": 1, "axisCustom": 0, "memberStandard": 1, "memberCustom": 0, "hidden": { "total": 4, "http://xbrl.sec.gov/dei/2025": 1, "http://xbrl.sec.gov/ffd/2025": 3 }, "contextCount": 4, "entityCount": 1, "segmentCount": 1, "elementCount": 107, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/ffd/2025": 33, "http://xbrl.sec.gov/dei/2025": 2 }, "report": { "R104": { "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable", "longName": "995210 - Document - Submission", "shortName": "Submission", "isDefault": "true", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Cover", "order": "104", "firstAnchor": { "contextRef": "c0", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_ex107.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_ex107.htm", "first": true, "unique": true } }, "R105": { "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable", "longName": "995211 - Document - Offerings", "shortName": "Offerings", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Cover", "order": "105", "firstAnchor": { "contextRef": "c1", "name": "ffd:PrevslyPdFlg", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_ex107.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c1", "name": "ffd:PrevslyPdFlg", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_ex107.htm", "first": true, "unique": true } }, "R106": { "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable", "longName": "995215 - Document - Fees Summary", "shortName": "Fees Summary", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Cover", "order": "106", "firstAnchor": { "contextRef": "c0", "name": "ffd:TtlOfferingAmt", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_ex107.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "ffd:TtlOfferingAmt", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20077915x1_ex107.htm", "first": true, "unique": true } } }, "tag": { "ffd_AggtRedRpPricFsclYr": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "AggtRedRpPricFsclYr", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/securities424iTable" ], "lang": { "en-us": { "role": { "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year", "terseLabel": "Aggregate Redeemed or Repurchased, FY" } } }, "auth_ref": [ "r785" ] }, "ffd_AggtRedRpPricPrrFsclYr": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "AggtRedRpPricPrrFsclYr", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/securities424iTable" ], "lang": { "en-us": { "role": { "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year", "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY" } } }, "auth_ref": [ "r785" ] }, "ffd_AggtSalesPricFsclYr": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "AggtSalesPricFsclYr", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/securities424iTable" ], "lang": { "en-us": { "role": { "label": "Aggregate Sales Price, Fiscal Year", "terseLabel": "Aggregate Sales Price" } } }, "auth_ref": [ "r785" ] }, "ffd_AmtRedCdts": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "AmtRedCdts", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/securities424iTable" ], "lang": { "en-us": { "role": { "label": "Amount of Redemption Credits", "terseLabel": "Redemption Credits" } } }, "auth_ref": [ "r785" ] }, "ffd_AmtSctiesRcvd": { "xbrltype": "nonNegativeDecimal2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "AmtSctiesRcvd", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Amount of Securities Received", "terseLabel": "Amount of Securities Received", "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)" } } }, "auth_ref": [ "r790" ] }, "ffd_AmtSctiesRegd": { "xbrltype": "nonNegativeDecimal2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "AmtSctiesRegd", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Amount of Securities Registered", "terseLabel": "Amount Registered", "documentation": "The amount of securities being registered." } } }, "auth_ref": [ "r785" ] }, "ffd_CeasedOprsDt": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "CeasedOprsDt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Ceased Operations Date", "terseLabel": "Ceased Operations Date" } } }, "auth_ref": [] }, "ffd_CfwdFormTp": { "xbrltype": "formTypeItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "CfwdFormTp", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Carry Forward Form Type", "terseLabel": "Carry Forward Form Type", "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)." } } }, "auth_ref": [ "r786" ] }, "ffd_CfwdPrevslyPdFee": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "CfwdPrevslyPdFee", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Carry Forward Previously Paid Fee", "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward", "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)." } } }, "auth_ref": [ "r786" ] }, "ffd_CfwdPrrFctvDt": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "CfwdPrrFctvDt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Carry Forward Prior Effective Date", "terseLabel": "Carry Forward Initial Effective Date", "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)." } } }, "auth_ref": [ "r786" ] }, "ffd_CfwdPrrFileNb": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "CfwdPrrFileNb", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Carry Forward File Number", "terseLabel": "Carry Forward File Number", "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used." } } }, "auth_ref": [ "r786" ] }, "ffd_CmbndPrspctsItemAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "CmbndPrspctsItemAxis", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable" ], "lang": { "en-us": { "role": { "label": "Combined Prospectus Item [Axis]", "terseLabel": "Combined Prospectus", "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission." } } }, "auth_ref": [ "r785" ] }, "ffd_CmbndPrspctsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "CmbndPrspctsLineItems", "lang": { "en-us": { "role": { "label": "Combined Prospectus [Line Items]", "terseLabel": "Combined Prospectus:" } } }, "auth_ref": [ "r785" ] }, "ffd_CmbndPrspctsTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "CmbndPrspctsTable", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable" ], "lang": { "en-us": { "role": { "label": "Combined Prospectus [Table]", "terseLabel": "Combined Prospectus Table" } } }, "auth_ref": [ "r785" ] }, "ffd_CombinedProspectusTableNa": { "xbrltype": "naItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "CombinedProspectusTableNa", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Combined Prospectus Table [N/A]", "terseLabel": "Combined Prospectus Table N/A" } } }, "auth_ref": [] }, "ffd_CshPdByRegistrantInTx": { "xbrltype": "nonNegative100TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "CshPdByRegistrantInTx", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Cash Paid by Registrant in Transaction", "terseLabel": "Cash Consideration Paid", "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)." } } }, "auth_ref": [ "r796" ] }, "ffd_CshRcvdByRegistrantInTx": { "xbrltype": "nonNegative100TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "CshRcvdByRegistrantInTx", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Cash Received by Registrant in Transaction", "terseLabel": "Cash Consideration Received", "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)." } } }, "auth_ref": [ "r796" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityCentralIndexKey", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "terseLabel": "Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r784" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityRegistrantName", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "terseLabel": "Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r784" ] }, "ffd_FeeAmt": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "FeeAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable", "http://xbrl.sec.gov/ffd/role/document/securities424iTable" ], "lang": { "en-us": { "role": { "label": "Fee Amount", "terseLabel": "Amount of Registration Fee", "documentation": "Total amount of registration fee (amount due after offsets)." } } }, "auth_ref": [ "r785" ] }, "ffd_FeeExhibitTp": { "xbrltype": "feeExhibitTypeItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "FeeExhibitTp", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Fee Exhibit Type", "terseLabel": "Fee Exhibit Type" } } }, "auth_ref": [] }, "ffd_FeeIntrstAmt": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "FeeIntrstAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable" ], "lang": { "en-us": { "role": { "label": "Fee Interest Amount", "terseLabel": "Interest Amount" } } }, "auth_ref": [ "r785" ] }, "ffd_FeeNote": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "FeeNote", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/securities424iTable" ], "lang": { "en-us": { "role": { "label": "Fee Note", "terseLabel": "Fee Note" } } }, "auth_ref": [ "r785" ] }, "ffd_FeeNoteMaxAggtOfferingPric": { "xbrltype": "nonNegative100TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "FeeNoteMaxAggtOfferingPric", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Fee Note Maximum Aggregate Offering Price", "terseLabel": "Fee Note MAOP" } } }, "auth_ref": [ "r785" ] }, "ffd_FeeRate": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "FeeRate", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable", "http://xbrl.sec.gov/ffd/role/document/securities424iTable" ], "lang": { "en-us": { "role": { "label": "Fee Rate", "terseLabel": "Fee Rate", "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission." } } }, "auth_ref": [ "r785" ] }, "ffd_FeesOthrRuleFlg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "FeesOthrRuleFlg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Fees, Other Rule [Flag]", "terseLabel": "Other Rule", "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due." } } }, "auth_ref": [ "r785" ] }, "ffd_FeesSummaryLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "FeesSummaryLineItems", "lang": { "en-us": { "role": { "label": "Fees Summary [Line Items]", "terseLabel": "Fees Summary:" } } }, "auth_ref": [ "r785" ] }, "ffd_FnlPrspctsFlg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "FnlPrspctsFlg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable" ], "lang": { "en-us": { "role": { "label": "Final Prospectus [Flag]", "terseLabel": "Final Prospectus" } } }, "auth_ref": [ "r785" ] }, "ffd_FormTp": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "FormTp", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Form Type", "terseLabel": "Form Type" } } }, "auth_ref": [] }, "ffd_GnlInstrIIhiFlg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "GnlInstrIIhiFlg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "General Instruction II.H,I [Flag]", "terseLabel": "General Instruction II.H,I" } } }, "auth_ref": [] }, "ffd_IssrBizAdrCity": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "IssrBizAdrCity", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Issuer Business Address, City", "terseLabel": "City" } } }, "auth_ref": [] }, "ffd_IssrBizAdrStatOrCtryCd": { "xbrltype": "stateOrCountryCodeItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "IssrBizAdrStatOrCtryCd", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Issuer Business Address, State or Country Code", "terseLabel": "State or Country Code" } } }, "auth_ref": [] }, "ffd_IssrBizAdrStrt1": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "IssrBizAdrStrt1", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Issuer Business Address, Street 1", "terseLabel": "Street 1" } } }, "auth_ref": [] }, "ffd_IssrBizAdrStrt2": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "IssrBizAdrStrt2", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Issuer Business Address, Street 2", "terseLabel": "Street 2" } } }, "auth_ref": [] }, "ffd_IssrBizAdrZipCd": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "IssrBizAdrZipCd", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Issuer Business Address, Zip Code", "terseLabel": "Zip Code" } } }, "auth_ref": [] }, "ffd_IssrNm": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "IssrNm", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Issuer Name", "terseLabel": "Issuer Name" } } }, "auth_ref": [] }, "ffd_MaxAggtOfferingPric": { "xbrltype": "nonNegative100TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "MaxAggtOfferingPric", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Maximum Aggregate Offering Price", "terseLabel": "Maximum Aggregate Offering Price", "documentation": "The maximum aggregate offering price for the offering that is being registered." } } }, "auth_ref": [ "r785" ] }, "ffd_MaxOfferingPricPerScty": { "xbrltype": "nonNegativeDecimal4lItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "MaxOfferingPricPerScty", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Maximum Offering Price per Security", "terseLabel": "Proposed Maximum Offering Price per Unit", "documentation": "The maximum offering price per share/unit being registered." } } }, "auth_ref": [ "r785" ] }, "ffd_NetFeeAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "NetFeeAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable" ], "lang": { "en-us": { "role": { "label": "Net Fee Amount", "terseLabel": "Net Fee" } } }, "auth_ref": [ "r785" ] }, "ffd_NetSalesAmt": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "NetSalesAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/securities424iTable" ], "lang": { "en-us": { "role": { "label": "Net Sales Amount", "terseLabel": "Net Sales" } } }, "auth_ref": [ "r785" ] }, "ffd_NrrtvDsclsr": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "NrrtvDsclsr", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable" ], "lang": { "en-us": { "role": { "label": "Narrative Disclosure", "terseLabel": "Narrative Disclosure" } } }, "auth_ref": [ "r785" ] }, "ffd_NrrtvMaxAggtAmt": { "xbrltype": "nonNegativeDecimal2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "NrrtvMaxAggtAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable" ], "lang": { "en-us": { "role": { "label": "Narrative Disclosure, Maximum Aggregate Offering Amount", "terseLabel": "Narrative - Max Aggregate Offering Amount" } } }, "auth_ref": [ "r785" ] }, "ffd_NrrtvMaxAggtOfferingPric": { "xbrltype": "nonNegative100TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "NrrtvMaxAggtOfferingPric", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable" ], "lang": { "en-us": { "role": { "label": "Narrative Disclosure, Maximum Aggregate Offering Price", "terseLabel": "Narrative - Max Aggregate Offering Price" } } }, "auth_ref": [ "r785" ] }, "ffd_OfferingAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "OfferingAxis", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Offering [Axis]", "terseLabel": "Offering", "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission." } } }, "auth_ref": [] }, "ffd_OfferingLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "OfferingLineItems", "lang": { "en-us": { "role": { "label": "Offering [Line Items]", "terseLabel": "Offering:" } } }, "auth_ref": [] }, "ffd_OfferingNote": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "OfferingNote", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Offering Note", "terseLabel": "Offering Note" } } }, "auth_ref": [ "r785" ] }, "ffd_OfferingSctyTitl": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "OfferingSctyTitl", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable", "http://xbrl.sec.gov/ffd/role/document/securities424iTable" ], "lang": { "en-us": { "role": { "label": "Offering Security Title", "terseLabel": "Security Class Title", "documentation": "The title of the class of securities being registered (for each class being registered)." } } }, "auth_ref": [ "r785" ] }, "ffd_OfferingSctyTp": { "xbrltype": "securityTypeItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "OfferingSctyTp", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Offering Security Type", "terseLabel": "Security Type", "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\"" } } }, "auth_ref": [ "r785" ] }, "ffd_OfferingTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "OfferingTable", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Offering [Table]", "terseLabel": "Offering:" } } }, "auth_ref": [] }, "ffd_OfferingTableNa": { "xbrltype": "naItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "OfferingTableNa", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Offering Table [N/A]", "terseLabel": "Offering Table N/A" } } }, "auth_ref": [] }, "ffd_OffsetAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "OffsetAxis", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset [Axis]", "terseLabel": "Offset", "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission." } } }, "auth_ref": [ "r785" ] }, "ffd_OffsetClmInitlFilgDt": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "OffsetClmInitlFilgDt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset Claim Initial Filing Date", "terseLabel": "Initial Filing Date", "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ." } } }, "auth_ref": [ "r789", "r792" ] }, "ffd_OffsetClmdAmt": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "OffsetClmdAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset Claimed Amount", "terseLabel": "Fee Offset Claimed", "documentation": "The amount of offsetting fees being claimed." } } }, "auth_ref": [ "r789", "r792" ] }, "ffd_OffsetClmdInd": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "OffsetClmdInd", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset Claimed Indicator", "terseLabel": "Offset Claimed" } } }, "auth_ref": [ "r785" ] }, "ffd_OffsetExpltnForClmdAmt": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "OffsetExpltnForClmdAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset Explanation for Claimed Amount", "terseLabel": "Explanation for Claimed Amount" } } }, "auth_ref": [ "r785" ] }, "ffd_OffsetLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "OffsetLineItems", "lang": { "en-us": { "role": { "terseLabel": "Offset:", "label": "Offset [Line Items]" } } }, "auth_ref": [ "r785" ] }, "ffd_OffsetNote": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "OffsetNote", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset Note", "terseLabel": "Offset Note" } } }, "auth_ref": [ "r785" ] }, "ffd_OffsetPrrFeeAmt": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "OffsetPrrFeeAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset Prior Fee Amount", "terseLabel": "Fee Paid with Fee Offset Source", "documentation": "The fee previously paid from which an offset is being derived." } } }, "auth_ref": [ "r789", "r792" ] }, "ffd_OffsetPrrFileNb": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "OffsetPrrFileNb", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset Prior File Number", "terseLabel": "File Number", "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used." } } }, "auth_ref": [ "r789", "r792" ] }, "ffd_OffsetPrrFilerNm": { "xbrltype": "filerNameItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "OffsetPrrFilerNm", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset Prior Filer Name", "terseLabel": "Registrant or Filer Name", "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid." } } }, "auth_ref": [ "r789", "r792" ] }, "ffd_OffsetPrrFormTp": { "xbrltype": "formTypeItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "OffsetPrrFormTp", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset Prior Form Type", "terseLabel": "Form or Filing Type", "documentation": "The Form Type of the offset filing." } } }, "auth_ref": [ "r789", "r792" ] }, "ffd_OffsetPrrNbOfUnsoldScties": { "xbrltype": "nonNegativeIntegerItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "OffsetPrrNbOfUnsoldScties", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset Prior Unsold Number of Securities", "terseLabel": "Unsold Securities Associated with Fee Offset Claimed", "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset." } } }, "auth_ref": [ "r789", "r792" ] }, "ffd_OffsetPrrSctyTitl": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "OffsetPrrSctyTitl", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset Prior Security Title", "terseLabel": "Security Title Associated with Fee Offset Claimed", "documentation": "The title of the class of securities from which offset fees were derived." } } }, "auth_ref": [ "r789", "r792" ] }, "ffd_OffsetPrrSctyTp": { "xbrltype": "securityTypeItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "OffsetPrrSctyTp", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset Prior Security Type", "terseLabel": "Security Type Associated with Fee Offset Claimed", "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\"" } } }, "auth_ref": [ "r789", "r792" ] }, "ffd_OffsetPrrUnsoldOfferingAmt": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "OffsetPrrUnsoldOfferingAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset Prior Unsold Offering Amount", "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed", "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset." } } }, "auth_ref": [ "r789", "r792" ] }, "ffd_OffsetSrcFilgDt": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "OffsetSrcFilgDt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset Source Filing Date", "terseLabel": "Filing Date", "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset." } } }, "auth_ref": [ "r789", "r792" ] }, "ffd_OffsetTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "OffsetTable", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "terseLabel": "Offset Payment:", "label": "Offset [Table]" } } }, "auth_ref": [ "r785" ] }, "ffd_OffsetTableNa": { "xbrltype": "naItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "OffsetTableNa", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Offset Table [N/A]", "terseLabel": "Offset Table N/A" } } }, "auth_ref": [] }, "ffd_PrevslyPdFlg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "PrevslyPdFlg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable", "http://xbrl.sec.gov/ffd/role/document/securities424iTable" ], "lang": { "en-us": { "role": { "label": "Fee Previously Paid [Flag]", "terseLabel": "Fee Previously Paid" } } }, "auth_ref": [] }, "ffd_RegnFileNb": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "RegnFileNb", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Registration File Number", "terseLabel": "Registration File Number" } } }, "auth_ref": [] }, "ffd_RptgFsclYrEndDt": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "RptgFsclYrEndDt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Reporting Fiscal Year End Date", "terseLabel": "Reporting FY End Date" } } }, "auth_ref": [] }, "ffd_Rule011Flg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "Rule011Flg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Rule 0-11 [Flag]", "terseLabel": "Rule 0-11" } } }, "auth_ref": [] }, "ffd_Rule011a2OffsetFlg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "Rule011a2OffsetFlg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 0-11(a)(2) Offset", "label": "Rule 0-11(a)(2) Offset [Flag]" } } }, "auth_ref": [] }, "ffd_Rule415a6Flg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "Rule415a6Flg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Rule 415(a)(6) [Flag]", "terseLabel": "Rule 415(a)(6)", "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward." } } }, "auth_ref": [ "r786" ] }, "ffd_Rule429AggtOfferingAmt": { "xbrltype": "nonNegative100TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "Rule429AggtOfferingAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable" ], "lang": { "en-us": { "role": { "label": "Rule 429 Aggregate Offering Amount", "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered", "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement." } } }, "auth_ref": [ "r787" ] }, "ffd_Rule429CmbndPrspctsFlg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "Rule429CmbndPrspctsFlg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable" ], "lang": { "en-us": { "role": { "label": "Rule 429 Combined Prospectus [Flag]", "terseLabel": "Rule 429", "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429." } } }, "auth_ref": [ "r787" ] }, "ffd_Rule429EarlierFileNb": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "Rule429EarlierFileNb", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable" ], "lang": { "en-us": { "role": { "label": "Rule 429 Earlier File Number", "terseLabel": "File Number", "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429." } } }, "auth_ref": [ "r787" ] }, "ffd_Rule429EarlierFormTp": { "xbrltype": "formTypeItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "Rule429EarlierFormTp", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable" ], "lang": { "en-us": { "role": { "label": "Rule 429 Earlier Form Type", "terseLabel": "Form Type", "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)." } } }, "auth_ref": [ "r787" ] }, "ffd_Rule429InitlFctvDt": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "Rule429InitlFctvDt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable" ], "lang": { "en-us": { "role": { "label": "Rule 429 Initial Effective Date", "terseLabel": "Initial Effective Date", "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429." } } }, "auth_ref": [ "r787" ] }, "ffd_Rule429NbOfUnsoldScties": { "xbrltype": "nonNegativeDecimal2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "Rule429NbOfUnsoldScties", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable" ], "lang": { "en-us": { "role": { "label": "Rule 429 Number Of Unsold Securities", "terseLabel": "Amount of Securities Previously Registered", "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429." } } }, "auth_ref": [ "r787" ] }, "ffd_Rule429PrspctsNote": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "Rule429PrspctsNote", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable" ], "lang": { "en-us": { "role": { "label": "Rule 429 Prospectus Note", "terseLabel": "Combined Prospectus Note" } } }, "auth_ref": [ "r785" ] }, "ffd_Rule429SctyTitl": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "Rule429SctyTitl", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable" ], "lang": { "en-us": { "role": { "label": "Rule 429 Security Title", "terseLabel": "Security Class Title" } } }, "auth_ref": [ "r785" ] }, "ffd_Rule429SctyTp": { "xbrltype": "securityTypeItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "Rule429SctyTp", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable" ], "lang": { "en-us": { "role": { "label": "Rule 429 Security Type", "terseLabel": "Security Type" } } }, "auth_ref": [ "r785" ] }, "ffd_Rule457aFlg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "Rule457aFlg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Rule 457(a) [Flag]", "terseLabel": "Rule 457(a)", "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due." } } }, "auth_ref": [ "r788" ] }, "ffd_Rule457bOffsetFlg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "Rule457bOffsetFlg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Rule 457(b) Offset [Flag]", "terseLabel": "Rule 457(b) Offset", "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)." } } }, "auth_ref": [ "r789" ] }, "ffd_Rule457fFlg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "Rule457fFlg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Rule 457(f) [Flag]", "terseLabel": "Rule 457(f)", "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due." } } }, "auth_ref": [ "r790" ] }, "ffd_Rule457oFlg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "Rule457oFlg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Rule 457(o) [Flag]", "terseLabel": "Rule 457(o)", "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due." } } }, "auth_ref": [ "r791" ] }, "ffd_Rule457pOffsetFlg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "Rule457pOffsetFlg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Rule 457(p) Offset [Flag]", "terseLabel": "Rule 457(p) Offset", "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)." } } }, "auth_ref": [ "r792" ] }, "ffd_Rule457rFlg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "Rule457rFlg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Rule 457(r) [Flag]", "terseLabel": "Rule 457(r)" } } }, "auth_ref": [ "r793" ] }, "ffd_Rule457sFlg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "Rule457sFlg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Rule 457(s) Flag", "terseLabel": "Rule 457(s)" } } }, "auth_ref": [ "r794" ] }, "ffd_Rule457uFlg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "Rule457uFlg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Rule 457(u) [Flag]", "terseLabel": "Rule 457(u)", "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due." } } }, "auth_ref": [ "r795" ] }, "ffd_Scties424iAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "Scties424iAxis", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/securities424iTable" ], "lang": { "en-us": { "role": { "label": "Securities, 424I [Axis]", "terseLabel": "Securities, 424I" } } }, "auth_ref": [ "r785" ] }, "ffd_Scties424iLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "Scties424iLineItems", "lang": { "en-us": { "role": { "label": "Securities, 424I [Line Items]", "terseLabel": "Securities, 424I:" } } }, "auth_ref": [ "r785" ] }, "ffd_Scties424iTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "Scties424iTable", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/securities424iTable" ], "lang": { "en-us": { "role": { "label": "Securities, 424I [Table]", "terseLabel": "Securities, 424I Table" } } }, "auth_ref": [ "r785" ] }, "ffd_Securities424iTableNa": { "xbrltype": "naItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "Securities424iNa", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Securities 424I [N/A]", "terseLabel": "Securities 424I N/A" } } }, "auth_ref": [] }, "ffd_SubmissionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "SubmissionLineItems", "lang": { "en-us": { "role": { "label": "Submission [Line Items]", "terseLabel": "Items" } } }, "auth_ref": [] }, "ffd_SubmissnTp": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "SubmissnTp", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Submission Type", "terseLabel": "Submission Type" } } }, "auth_ref": [] }, "ffd_TermntnCmpltnWdrwl": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "TermntnCmpltnWdrwl", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Termination / Completion / Withdrawal Statement", "terseLabel": "Termination / Withdrawal Statement" } } }, "auth_ref": [] }, "ffd_TtlFeeAmt": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "TtlFeeAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable" ], "lang": { "en-us": { "role": { "label": "Total Fee Amount", "terseLabel": "Total Fee Amount" } } }, "auth_ref": [ "r785" ] }, "ffd_TtlFeeAndIntrstAmt": { "xbrltype": "nonNegativeDecimal2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "TtlFeeAndIntrstAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable" ], "lang": { "en-us": { "role": { "label": "Total Fee and Interest Amount", "terseLabel": "Total Fee and Interest Amount" } } }, "auth_ref": [ "r785" ] }, "ffd_TtlOfferingAmt": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "TtlOfferingAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable" ], "lang": { "en-us": { "role": { "label": "Total Offering Amount", "terseLabel": "Total Offering" } } }, "auth_ref": [ "r785" ] }, "ffd_TtlOffsetAmt": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "TtlOffsetAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable" ], "lang": { "en-us": { "role": { "label": "Total Offset Amount", "terseLabel": "Total Offset Amount" } } }, "auth_ref": [ "r785" ] }, "ffd_TtlPrevslyPdAmt": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "TtlPrevslyPdAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable" ], "lang": { "en-us": { "role": { "label": "Total Previously Paid Amount", "terseLabel": "Previously Paid Amount" } } }, "auth_ref": [ "r785" ] }, "ffd_TtlTxValtn": { "xbrltype": "nonNegative100TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "TtlTxValtn", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable" ], "lang": { "en-us": { "role": { "label": "Total Transaction Valuation", "terseLabel": "Total Transaction Valuation" } } }, "auth_ref": [ "r785" ] }, "ffd_TxValtn": { "xbrltype": "nonNegative100TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "TxValtn", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Transaction Valuation", "terseLabel": "Transaction Valuation" } } }, "auth_ref": [] }, "ffd_ValSctiesRcvd": { "xbrltype": "nonNegative100TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "ValSctiesRcvd", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Value of Securities Received", "terseLabel": "Value of Securities Received", "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)" } } }, "auth_ref": [ "r790" ] }, "ffd_ValSctiesRcvdPerShr": { "xbrltype": "nonNegativeDecimal4lItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "ValSctiesRcvdPerShr", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Value of Securities Received, Per Share", "terseLabel": "Value of Securities Received, Per Share", "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation." } } }, "auth_ref": [ "r790" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-14" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-5" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "20", "Topic": "205", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "405", "Topic": "942", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478353/942-405-50-1" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2A" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Subparagraph": "(c)", "Paragraph": "2", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-5" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-4" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481142/505-10-45-2" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-10" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-4" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-5" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "320", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-5" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(7)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/360/tableOfContent" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-15" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-2" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/440/tableOfContent" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481573/470-10-45-12A" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/505/tableOfContent" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SAB Topic 4.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-4" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(e)(1)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(f)(2)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r90": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13" }, "r91": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2" }, "r92": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r93": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r94": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r95": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-1" }, "r96": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-6" }, "r97": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-7" }, "r98": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r99": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org/606/tableOfContent" }, "r100": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "808", "Publisher": "FASB", "URI": "https://asc.fasb.org/808/tableOfContent" }, "r101": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6" }, "r102": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "9", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9" }, "r103": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "9", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9" }, "r104": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1" }, "r105": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5C" }, "r106": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7" }, "r107": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r108": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5" }, "r109": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r110": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r111": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r112": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r113": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r114": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r115": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r116": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r117": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r118": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r119": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r120": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11" }, "r121": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A" }, "r122": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A" }, "r123": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B" }, "r124": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B" }, "r125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-1" }, "r126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4" }, "r127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5" }, "r128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/235/tableOfContent" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-2" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-6" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/280/tableOfContent" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26A" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(ee)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "34", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-2" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aa)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-9" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-11" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-14" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-16" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479130/326-30-45-1" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-7" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-9" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/420/tableOfContent" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4.b.1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4.b.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4.d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4.e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-1" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(f)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-1" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-2" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-3" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-1" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-3" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(01)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3A", "Subparagraph": "(24)(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-1" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-2" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-11" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-17" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-18" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-18" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-19" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/718/tableOfContent" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1D", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "17", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480336/718-10-65-17" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479983/718-10-S45-1" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479953/718-10-S50-2" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479953/718-10-S50-3" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479953/718-10-S50-4" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479953/718-10-S50-5" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.C.Q3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.1.Q5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.3.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "720", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "730", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483044/730-10-05-1" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "730", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/740/tableOfContent" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-25" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-28" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-4" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-6" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10A" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12A", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-19" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-20" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-22" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.1.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-2" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "808", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "808", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "808", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4F" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8A" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-5" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "54B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482736/825-10-45-1A" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-30" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-32" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482804/825-20-50-1" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/842-20/tableOfContent" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "12A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "40", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479092/842-20-40-1" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-1" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/855/tableOfContent" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481444/860-30-45-1" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(4)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "912", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478345/912-310-45-11" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "940", "SubTopic": "820", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478119/940-820-50-1" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478671/942-235-S50-1" }, "r578": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1" }, "r579": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1" }, "r580": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1" }, "r581": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "740", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477617/942-740-50-1" }, "r582": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "825", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478898/942-825-50-1" }, "r583": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r584": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r585": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r586": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r587": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r588": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r589": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r590": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r591": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r592": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r593": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r594": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r595": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r596": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r597": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r598": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r599": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r600": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r601": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r602": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r603": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r604": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r605": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r606": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r607": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r608": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r609": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r610": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column J))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r611": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column K))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r612": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r613": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r614": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r615": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9" }, "r616": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r617": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r618": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r619": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r620": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r621": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r622": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.W.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1" }, "r623": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "740", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478822/944-740-50-1" }, "r624": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r625": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(h)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r626": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r627": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r628": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r629": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r630": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11" }, "r631": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13" }, "r632": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4" }, "r633": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-6" }, "r634": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4" }, "r635": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r636": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r637": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r638": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r639": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r640": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r641": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r642": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r643": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r644": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r645": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r646": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r647": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r648": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r649": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r650": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r651": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r652": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r653": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r654": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r655": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r656": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r657": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r658": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r659": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r660": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r661": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r662": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2" }, "r663": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2" }, "r664": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7" }, "r665": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r666": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r667": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r668": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r669": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r670": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r671": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r672": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r673": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r674": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r675": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r676": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r677": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r678": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r679": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r680": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r681": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r682": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r683": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r684": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r685": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r686": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r687": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r688": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r689": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r690": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r691": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r692": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r693": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6" }, "r694": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478322/948-310-S50-2" }, "r695": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1" }, "r696": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1" }, "r697": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1" }, "r698": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1" }, "r699": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1" }, "r700": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1" }, "r701": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "985", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2" }, "r702": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4" }, "r703": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "SubTopic": "10", "Topic": "825", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482881/825-10-55-10" }, "r704": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r705": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-12" }, "r706": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-11" }, "r707": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-14" }, "r708": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-18" }, "r709": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-21" }, "r710": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-24" }, "r711": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-4" }, "r712": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52" }, "r713": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482836/275-10-55-2" }, "r714": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482836/275-10-55-4" }, "r715": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482836/275-10-55-6" }, "r716": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r717": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31" }, "r718": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r719": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r720": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r721": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r722": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "48", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48" }, "r723": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "49", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49" }, "r724": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "54", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54" }, "r725": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "54", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54" }, "r726": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "54", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54" }, "r727": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A" }, "r728": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479081/326-30-55-8" }, "r729": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24" }, "r730": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B" }, "r731": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C" }, "r732": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "64", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481620/480-10-55-64" }, "r733": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r734": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r735": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r736": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5" }, "r737": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5" }, "r738": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17" }, "r739": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8" }, "r740": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r741": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r742": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "231", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231" }, "r743": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-8" }, "r744": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-41" }, "r745": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "43", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-43" }, "r746": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-47" }, "r747": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A" }, "r748": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "182", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-182" }, "r749": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "184", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-184" }, "r750": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "100", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100" }, "r751": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "100", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100" }, "r752": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "100", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100" }, "r753": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "101", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-101" }, "r754": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "102", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102" }, "r755": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "103", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103" }, "r756": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r757": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r758": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r759": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r760": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r761": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r762": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482881/825-10-55-12" }, "r763": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "53", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53" }, "r764": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10" }, "r765": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481395/860-30-55-4" }, "r766": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "942", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480095/942-10-S50-1" }, "r767": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "942", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480035/942-10-S99-6" }, "r768": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F" }, "r769": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C" }, "r770": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "605", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-11" }, "r771": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "605", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-14" }, "r772": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-17" }, "r773": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r774": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r775": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1" }, "r776": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1" }, "r777": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r778": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r779": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r780": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r781": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10" }, "r782": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11" }, "r783": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12" }, "r784": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r785": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230" }, "r786": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "415", "Subsection": "a" }, "r787": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "429" }, "r788": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "457" }, "r789": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "457", "Subsection": "b" }, "r790": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "457", "Subsection": "f" }, "r791": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "457", "Subsection": "o" }, "r792": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "457", "Subsection": "p" }, "r793": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "457", "Subsection": "r" }, "r794": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "457", "Subsection": "s" }, "r795": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "457", "Subsection": "u" }, "r796": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Subsection": "f", "Section": "457" }, "r797": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3" }, "r798": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-10" }, "r799": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "a", "Publisher": "SEC" }, "r800": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "b", "Subparagraph": "(1)", "Publisher": "SEC" }, "r801": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "b", "Subparagraph": "(2)", "Publisher": "SEC" }, "r802": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "b", "Subparagraph": "(3)", "Publisher": "SEC" }, "r803": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "c", "Subparagraph": "(2)(i)", "Publisher": "SEC" }, "r804": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "c", "Subparagraph": "(2)(ii)", "Publisher": "SEC" }, "r805": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "c", "Subparagraph": "(2)(iii)", "Publisher": "SEC" }, "r806": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r807": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r808": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4" }, "r809": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5" }, "r810": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6" }, "r811": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r812": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r813": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1" }, "r814": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-4" }, "r815": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r816": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r817": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r818": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r819": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3" }, "r820": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23" }, "r821": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24" }, "r822": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5" }, "r823": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6" }, "r824": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1" }, "r825": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18" }, "r826": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r827": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r828": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(ee)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r829": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r830": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/320/tableOfContent" }, "r831": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-1" }, "r832": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-11" }, "r833": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-9" }, "r834": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3" }, "r835": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3" }, "r836": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3" }, "r837": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r838": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-2" }, "r839": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "30", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/405-30/tableOfContent" }, "r840": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10" }, "r841": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/450/tableOfContent" }, "r842": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r843": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r844": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r845": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r846": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5" }, "r847": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r848": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r849": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r850": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r851": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r852": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r853": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r854": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r855": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r856": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r857": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r858": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r859": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r860": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r861": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r862": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r863": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r864": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r865": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r866": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r867": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r868": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r869": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r870": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r871": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r872": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r873": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r874": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "740", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479176/718-740-35-2" }, "r875": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12" }, "r876": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12" }, "r877": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12A", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A" }, "r878": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15" }, "r879": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15" }, "r880": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2" }, "r881": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3" }, "r882": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-6" }, "r883": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r884": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3" }, "r885": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480060/805-50-25-1" }, "r886": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480027/805-50-30-1" }, "r887": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480027/805-50-30-2" }, "r888": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2" }, "r889": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r890": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "54B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B" }, "r891": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r892": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r893": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r894": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r895": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r896": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E" }, "r897": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r898": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r899": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-1" }, "r900": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10" }, "r901": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11" }, "r902": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11" }, "r903": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-13" }, "r904": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r905": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r906": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-3" }, "r907": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479365/842-20-25-6" }, "r908": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3" }, "r909": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3" }, "r910": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r911": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6" }, "r912": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7" }, "r913": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7" }, "r914": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r915": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r916": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r917": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r918": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r919": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r920": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "912", "SubTopic": "730", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479532/912-730-25-1" }, "r921": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-2" }, "r922": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-2" }, "r923": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r924": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B" }, "r925": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3" }, "r926": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B" }, "r927": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B" }, "r928": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C" }, "r929": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D" }, "r930": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4G", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G" }, "r931": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r932": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r933": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r934": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r935": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r936": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r937": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r938": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r939": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r940": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r941": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r942": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r943": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r944": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r945": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r946": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r947": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r948": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r949": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r950": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r951": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r952": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-1" }, "r953": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2" }, "r954": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2" }, "r955": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4" }, "r956": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r957": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3" }, "r958": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r959": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" } } }